脳神経外科学大系　6　脳腫瘍I

出版社： 中山書店
著者：
発行日： 2004-09-30
分野： 臨床医学：外科  >  脳神経外科学
ISBN： 452172051X
シリーズ： 脳神経外科学大系
電子書籍版： 2004-09-30 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

59,400 円(税込)

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

59,400 円(税込)

購入する
特記事項：
  • 【電子書籍】電子書籍版にはDVDは付属しません。予めご了承ください。

商品紹介

本大系15巻のうち2巻を占める脳腫瘍のなかの1冊。脳腫瘍の基礎(脳腫瘍の歴史、病理、免疫など)と治療法を網羅的に解説し、各疾患についてはとくに悪性脳腫瘍を中心にまとめてある。病理などの基礎は、豊富な写真や図を用い丁寧に解説し、疾患各論は、写真はもちろんのこと、動画による実際の手術手技の詳細な解説で、視覚的理解を促している。

目次

  • 脳神経外科学大系　6　脳腫瘍I

    ―目次―

    第1章　脳腫瘍総論
    第2章　脳腫瘍の診断
    第3章　脳腫瘍の治療
    第4章　脳腫瘍症例管理法
    第5章　神経上皮由来腫瘍
    第6章　血液系腫瘍
    第7章　胚細胞腫瘍

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 脳腫瘍総論

P.11 掲載の参考文献
1) 高倉公朋. 脳腫瘍病理の歴史. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 東京 : 医学書院 ; 1999. p. 1-4.
 
2) Bailey P, Cushing H. A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis. Philadelphia : JB Lippincott ; 1926.
 
3) Cushing H. The meningioma (dural endothelioma) : Their source and favored seats of origin Brain 1922 : 45 : 282-316.
 
4) Roussy G, Oberling C. Histologic classification of tumors of the central nervous system. Arch Neurol Psychiatr 1932 ; 27 : 1281-9.
 
5) Kernohan JW, Sayle GP. Tumors of the central nervous system. In : Atlas of Tumor Pathology, sect, X, fase. 35, 37 Washington DC : AFIP ; 1952.
 
6) Zulch KJ. Brain Tumors : Their Biology and Pathology. 2nd ed. New York : Springer-Verlag ; 1965.
 
7) Zulch KJ. Histological typing of tumours of the central nervous system. In : International Histological Classification of Tumours. No. 21 Geneva : WHO : 1979.
 
8) Kleihues P, et al. Histological typing of tumours of the central nervous system. In : WHO Inernational Histological Classification of Tumours. 2nd ed. Berlin, Heidelberg, New York : Springer-Verlag : 1993.
 
9) 石田陽一. 新しいWHO脳腫瘍分類の中で特記すべき項目 (腫瘍) について. 脳と神 1994 ; 46 : 1127-32.
 
10) 久保田紀彦. 新WHO脳腫瘍分類の改良点と問題点. 脳神外科 1995 ; 23 : 97110.
 
11) Kleihues P, et al. World Health Organization Classification of Tumours : Pathology & Genetics, Tumours of Central Nervous System Lyon : IARC ; 2000.
 
12) Oka K, et al. Detection of p53 alterations in human astrocytomas using frozen tissue sections for the polymerase chain reaction. J Neurooncol 1993 ; 16 : 125-33.
 
13) Nishikawa R, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 1994 ; 91 : 7727-31.
 
14) Kyritsis AP, et al. Mutations of p16 gene in gliomas. Oncogene 1996 ; 12 : 63-7.
PubMed
15) Sonoda Y, et al. Deletion mapping of chromosome 10 in human glioma. Jpn J Cancer Res 1996 : 87 : 363-7.
PubMed
16) Reifenberger J, et al. Molecular genetic analysis of olgodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994 : 145 : 1175-90.
PubMed
17) Cairneross JG, et al. Aggressive oligodendroglioma : A chemosensitive tumor. Neurosurgery 1992 : 31 : 78-82.
 
18) 鶴尾隆. 分子標的療法の展望. 高倉公朋監修. 脳腫瘍の最新医療. 東京 : 先端医療技術研究所 ; 2003. p. 84-92.
 
19) Ram Z, et al. Therapy of malignant brain tumor by intratumoral implantation of retroviral vector-producing cells. Nat Med 1997 ; 3 : 1354-61.
PubMed
20) 中原紀元ほか. 脳腫瘍に対する遺伝子治療. 神経の進歩 2001 ; 45 : 120-9.
 
21) Jacobs SK, et al. Interleukin-2 or autologous lymphokine-activated killer cell treatment of malignant glioma : Phase I trial. Cancer Res 1986 ; 46 : 2101-4.
 
22) Tuting T, et al. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity. J Gene Med 1999 ; 1 : 400-6.
PubMed
23) Nishimura T, et al. The critical role of Th1-dominant immunity in tumor immunology. Cancer Chemother Pharmacol 2000 : 46 Suppl : 52-61.
 
24) Yung WK, et al. Multicenter phase II trial of temozolomide in patients with anaplastic astocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 1999 ; 17 : 2762-71.
PubMed
25) Watanabe E, et al. Open surgery assisted by the neuronavigator, a stereotactic articulated, sensitive arm. Neurosurgery 1991 ; 28 : 792-800.
PubMed
26) Kato A, et al. A frameless, armless navigational system for computer-assisted neurosurgery. J Neurosurg 1991 ; 74 : 845-9.
PubMed
27) Zamorano LJ, et al. Interactive intraopcrative localization using an infrared-based system. Neurol Res 1993 ; 15 : 290-8.
PubMed
28) Mori S et al. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 1999 : 45 : 265-9.
PubMed
29) 小林達也. II 腫瘍. 小林達也編. ガンマナイフ治療. 名古屋 : 名古屋大学出版会 ; 1998. p.15-23.
 
30) Ling CC, et al. Conformal radiation treatment of prostate cancer using inversely planned intensity-modulated photon beams produced with dynamic multilcaf collimation. Int J Radiat Oncol Biol Phys 1996 ; 35 : 721-30.
PubMed
P.26 掲載の参考文献
1) Wrench M, et al. Epidemiology of primary brain tumors ; Current concepts and review of the literature. Neuro-oncol 2002 : 4 : 278-99.
 
2) Nichols KE, et al. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 2001 : 10 : 83-7.
PubMed
3) Kleihues P, Ohgaki H. Primary and secondary glioblastomas : From concept to clinical diagnosis. Neuro-oncol 1999 ; 1 : 44-51.
PubMed
4) Malmer B, et al. Genentic epidemiology of glioma. Br J Cancer 2001 : 84 : 429-34.
 
5) Grossmann SA, et al. Central nervous system cancers in the first-degree relatives and spouses. Cancer Invest 1999 ; 17 : 299-308.
 
6) Thomas TL, Waxweller RL. Brain tumors and occupational risk factors. Scand J Work Environ Health 1986 ; 12 : 1-15.
 
7) Bohnen NI, Kurland LT. Brain tumor and exposure to pesticides in humans : A review of the epidemiologic data. J Neurol Sci 1995 ; 132 : 110-21.
 
8) Hagmar L, et al. Mortality and cancer morbidity in workers exposed to low levels of vinyl chloride monomer at a polyvinyl chloride processing plant. Am J Ind Med 1990 : 17 : 553-65.
 
9) Raaschou-Nielsen O, et al. Air pollution from traffic at the residence of children with cance.r Am J Epidemiol 2001 : 153 : 433-43.
 
10) Norman MA, et al. Childhood brain tumors and exposure to tobacco smoke. Cancer Epidemiol Biomarkers Prev 1996 ; 5 : 85-91.
PubMed
11) Hu J, et al. Parental cigarette smoking, hard liquor consumption and the risk of childhood brain tumors : A case control study in northeast China. Acta Oncol 2000 ; 39 : 979-84.
PubMed
12) Preston-Martin S, et al. Risk factors for gliomas and meningiomas in males in Los Angels County. Cancer Res 1989 : 49 : 6137-43.
 
13) Karlsson P, et al. Intracranial tumors after exposure to ionizing radiation during infancy : A period analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res 1998 ; 150 : 357-64.
PubMed
14) Shapiro S, et al. Radiation-induced intracranial malignant gliomas. J Neurosurg 1989 : 71 : 77-82.
PubMed
15) Salvati M, et al. A report on radiation-induced gliomas. Cancer 1991 ; 67 : 392-7.
 
16) Kheifets LI, et al. Childhood brain tumors and residential electromagnetic fields (EMF). Rev Environ Contam Toxicol 1999 ; 159 : 111-29.
PubMed
17) Muscat JE, et al. Handheld cellula telephone use and risk of brain cancer. JAMA 2000 ; 284 : 3001-7.
 
18) Davis FG, et al. Centralized databases available for describing primary brain tumor incidence, survival, and treatment : Central Brain Tumor Registry of the United States ; Surveillance, Epidemiology, and End Results ; and National Cancer Data Base. Neuro-oncol 1999 ; 1 : 205-11.
PubMed
19) CBTRUS (Central Brain Tumor Registry of the United States). Primary Brain Tumors in the United States : Statistical Report 1992-1997 Chicago : Central Brain Tumor Registy of the United States : 2000.
 
20) Jukich PJ, et al. Trends in incidence of primary brain tumors in the United States, 1985-1994 Neuro-oncol 2001 ; 3 : 141-51.
PubMed
21) Legler LM, et al. Brain and other centlal nervous system cancers : Recent trends in incidence and mortality. J Natl Cancer Inst 1999 ; 91 : 1382-90.
 
22) The Committee of Brain Tumor Registry of Japan. Report of brain tumor registy of Japan (1969-1993). 10th ed. Neurol Med Chir (Tokyo) 2000 : 40 (Suppl).
 
23) Cutler SJ, Ederer F Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958 ; 8 : 699-712.
PubMed
24) Burger PC, Green SB. Patient age, histologic features, and the length of survival in patients with glioblastoma muliforme. Cancer 1987 : 59 : 1617-25.
 
25) Curran WJ Jr, et al. Recursive partitioning analysis of prognostic factors in three oncology group malignant glioma trials. J Natl Cancer Inst 1997 : 85 : 704-10.
 
26) Matsutani M, et al. Combined chemotherapy and radiation therapy for central nervous system germ cell tumors : Preliminary results of a phase II study of the Japanese Pediatric Brain Tumor Study Group. Neurosurg Focus 1998 ; 5 : 1-5.
 
27) Packer RJ. Childhood medulloblastoma : Progress and future challenge. Brain Dev 1999 ; 21 : 751-81.
 
28) Cairneross JG, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998 ; 90 : 1473-9.
 
29) Ino Y, et al. Molecular subtype of anaplastic oligodendroglioma : Implications for patient management at diagnosis. Clin Cancer Res 2001 ; 7 : 839-45.
PubMed
P.40 掲載の参考文献
1) Forsyth PA, Posner JB. Headaches in patients with brain tumors : A study of 111 patients. Neurology 1993 ; 43 : 1678-83.
PubMed
2) Jaeckle KA. Clinical presentation and therapy of nervous system tumors. In : Bradley WG, et al, editors. Neurology in Clinical Practice. Boston : Butterworth-Heinemann ; 1991. p. 1008-30.
 
3) Gretter TE. Headache associated with intracranial abnormalities. Chap 27. In : Tollison CD, Kunkel RS, editors. Headache : Diagnosis and Treatment. Baltimore : Williams & Wilkins ; 1993. p. 221-5.
 
4) Wen PY, Black PM. Clinical presentation, evaluation, and preoperative preparation of the patient. Chap 26. In : Berger MS, Wilson CB, editors. The Gliomas. Philadelphia : WB Saunders ; 1999. p. 328-36.
 
5) Dunne PB. Anatomy and physiotogy of headache. Chap 3. In : Tollison CD, Kunkel RS, editors. Headache : Diagnosis and Treatment. Baltimore : Williams & Wilkins ; 1993. p. 13-8.
 
6) Novak GP, Moshe SL. Brainstem glioma presenting as paroxysmal headache. Dev Med Child Neurol 1985 ; 21 : 379-82.
 
7) Cascino GD. Epilepsy and brain tumors : Implications for treatment. Epilepsia 1990 ; 31 (Suppl 3) : 37-44.
 
8) Hauser WA, Annegers JF. Epidemiology of acute symptomatic seizures. Chap 8. In : Engel J Jr, Pedley TA, editors. Epilepsy. A Comprehensive Textbook. Vol 1. Philadelphia : Lippincott-Raven ; 1998. p. 87-91.
 
9) Dam AM, et al. Late-onset epilepsy : Etiology, types of seizure, and value of clinical investigation, EEG, and computerized tomography scan. Epilepsia 1985 ; 26 : 227-31.
PubMed
10) Hauser WA, et al. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota : 1935-1984. Epilepsia 1993 ; 34 : 453-68.
PubMed
11) Hesdorffer DC, Verity CM. Risk factors. Chap 6. In : Engel J Jr, Pedley TA, editors. Epilepsy. A Comprehensive Textbook. Vol 1. Philadelphia : Lippincott-Raven ; 1998. p. 59-67.
 
12) Luhdorf K, et al. Etiology of seizures in the elderly. Epilepsia 1986 ; 27 : 458-63.
PubMed
13) Lieberman DM, et al. Brain tumors during the first 2 years of life. In : Albright AL, et al, editors. Principles and Practice of Pediatric Neurosurgery. New York : Thieme ; 1999. p. 463-90.
 
14) Scott GM, Gibberd FB. Epilepsy and other factors in the prognosis of gliomas. Acta Neurol Scand 1980 ; 61 : 227-39.
PubMed
15) Ettinger AB. Structural causes of epilepsy : Tumors, cysts, stroke, and vascular malformations. Neurol Clin 1994 ; 12 : 41-56.
PubMed
16) Ketz E. Brain tumours and epilepsy. In : Vinken PJ, Bruyn GW, editors. Handbook of Clinical Neurology. Vol 15. Amsterdam : North-Holland ; 1974. p. 254-69.
 
17) Le Blanc FE, Rasmussen T. Cerebral seizures and brain tumors. In : Vinken PJ, Bruyn GW, editors. Handbook of Clinical Neurology. Vol 16. Amsterdam : North-Holland ; 1974. p. 295-301.
 
18) Pace A, et al. Epilepsy and gliomas : Incidence and treatment in 119 patients. J Exp Clin Cancer Res 1998 ; 17 : 479-82.
PubMed
19) Oberndorfer S, et al. The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Wein Klin Wochenschr 2002 : 114 : 911-6.
 
20) Daumas-Duport C, et al. Dysembryoplastic neuroepithelial tumor : A surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 1988 ; 23 : 545-56.
PubMed
21) Daumas-Duport C. Dysembryoplastic neuroepithelial tumors. Brain Pathol 1993 ; 3 : 283-95.
PubMed
22) Ildan F, et al. Intracerebral ganglioglioma : Clinical and radiological study of eleven surgically treated cases with follow-up. Neurosurg Rev 2001 ; 24 : 114-8.
PubMed
23) Sutton LN, et al. Cerebral gangliogliomas during childhood. Neurosurgery 1983 ; 13 : 124-8.
PubMed
24) Johnson JH, et al. Clinical outcome of pediatric gangliogliomas : Ninety-nine cases over 20 years. Pediatr Neurosurg 1997 ; 27 : 203-7.
PubMed
25) Haddad SF, et al. Ganglioglioma : 13 years of experience. Neurosurgery 1992 ; 31 : 171-8.
PubMed
26) Kepes JJ, et al. Pleomorphic xanthoastrocytoma : A distinetive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer 1979 ; 44 : 1839-52.
 
27) Lipper MH, et al. Pleomorphic xanthoastrocytoma, a distinctive astroglial tumor : Neuroradiologic and pathologic features. AJNR Am J Neuroradiol 1993 ; 14 : 1397-404.
PubMed
28) Burger PC, Scheithauer BW. Atlas of Tumor Pathology. Series 3. Fascicle 10. Tumors of the central nervous system. Washington DC : AFIP ; 1994. p. 96-102.
 
29) Greenberg MS. Handbook of Neurosurgery. 5th ed. Lakeland : Thieme ; 2001. p. 574-5.
 
30) Miller NR. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Vol 1, 4th ed. Baltimore, London : Williams & Wilkins ; 1982. p. 188-9.
 
31) Hoyt WF, Beeston D. The Ocular Fundus in Neurologic Disease. In : A Diagnostic Manual and Stereo Atlas. St Louis : The CV Mosby ; 1966. p. 1-23.
 
32) Price TRP, et al. Neuropsychiatric aspects of brain tumors. In : Yudofsky SC, Hales RE, editors. Synopsis of Neuropsychiatry. Washington DC : American Psychiatric Press ; 1994. p. 361-79.
 
33) Tucha O, et al. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 2000 ; 47 : 324-34.
PubMed
34) Berger MS, et al. Primary central nervous system tumors of the supratentorial compartment. In : Levin VA, editor. Cancer in the Nervous System. New York : Churchill Livingstone ; 1996. p. 57-126.
 
35) Wakai S, et al. Spontaneous intracranial hemorrhage caused by brain tumor : Its incidence and clinical significance. Neurosurgery 1982 ; 10 : 437-44.
PubMed
36) Cardoso ER, Peterson EW. Pituitary apoplexy : A review. Neurosurgery 1984 ; 14 : 363-73.
PubMed
37) Wakai S, et al. Pituitary apoplexy : Its incidence and clinical significance. J Neurosurg 1981 ; 55 : 187-93.
PubMed
38) Scott M. Spontaneous intracerebral hematoma caused by cerebral neoplasms : Report of eight verified cases. J Neurosurg 1975 ; 42 : 338-42.
 
39) Asari S, et al. Neurinomas presenting as spontaneous intratumoral hemorrhage. Neurosurgery 1992 ; 31 : 406-12.
PubMed
40) Sunada I, et al. Meningioma associated with acute subdural hematoma : Case report. Radiat Med 1998 ; 16 : 483-6.
PubMed
41) Martinez-Lage JF, et al. Meningioma with haemonhagic onset. Acta Neurochir (Wien) 1991 : 110 : 129-32.
PubMed
42) Miyoshi Y, et al. Diencephalic syndrome of emaciation in an adult associated with third ventricle intrinsic craniopharyngioma : Casc report. Neurosurgery 2003 : 52 : 224-7.
 
43) Sharma RR, et al. Diencephalic syndrome of emaciation in an adult associated with suprasellar craniophavngioma : A case report. Br J Neurosurg 1990 : 4 : 77-80.
 
44) Strobos RJ. Temporal lobc thmors. In : Vinken PJ, Bruyn GW, editors Handbook of Clinical Neurology : Tumors of the Brain and Skull. Vol. 17. Amsterdam : North Holland ; 1974. p. 281-95.
 
45) Horton JC, Hoyt WF. Quadrantic visual field defects : A hallmark of lesions in extrastriate (V2/V3) cortex. Brain 1991 : 114 : 1703-18.
PubMed
46) Nagasaka S, et al. Simple partial seizure with a focus in Brodmann area 19 : A case report. Med Bull Fukuoka Univ 1992 : 19 : 85-8.
 
47) Russell A. A diencephalic syndrome of emaciation in infancy and childhood. Arch Dis Child 1951 : 26 : 274-80.
 
48) Miller NR. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Vol 3. 4th ed Baltimore, London : Williams & Wilkins : 1988. p. 1157-9, p1354.
 
49) Wray SH. The neuro-ophthalmic and neurologic manifestations of pinealomas. In ; Schumidek HH, editor. Pineal Tumors. New York : Masson Publishing USA : 1977. p. 21-59.
 
50) Miller NR. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Vol 2. 4th ed Baltimore, London : Williams & Wilkins : 1985. p. 716-9.
 
51) Yasuoka S, et al. Foramen magnum tumor, Analysis of 57 cases of benign extramedullary thmors. J Neurosurg 1978 : 49 : 828-38.
PubMed
52) Meyer FB, et al. Benign tumors of the foramen magnum. J Neurosurg 1984 ; 61 : 136-42.
PubMed
53) Cohen ME, Duffner PK. Tumors of the diencephalons and optic pathway. In : Cohen ME, Duffner PK, editors. Brain Tumors in Children : Principles of Diagnosis and Treatment New York : Raven Press ; 1994. p.303-28.
 
54) Wanebo JE, et al. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 2003 : 98 : 82-94.
PubMed
55) 菅野洋ほか. von Hippel-Lindau病. 脳神経 1999 ; 51 : 33-40.
 
56) Osbom AG. Disorders of histogenesis : Neurocutaneous syndrome. Chap 5. In : Diagnostic Neuroradiology. St Louis : Mosby ; 1994. p. 104-6.
 
57) Gomez MR. Tuberous Sclerosis. New York : Raven Press ; 1979. p. 11-26.
 
58) Gorlin RJ, et al. Hamartoneoplastic syndromes. Chap 12. Tuberous sclelosis. Syndromes of the Head and Neck 4th ed. New York : Oxford University Press : 2001. p. 488-93.
 
59) 原徹男ほか. 神経線維腫症 (Neurofibromatosis). 脳神経 1999 : 51 : 17-31.
 
60) Gorlin RJ, et al. Hamartoneoplastic syndromes. Chap 12 The neurofibromatosis (NFl Recklinghausen type, NF2 acoustic type, other types) In : Syndromes of the Head and Neck 4th ed New Yolk : Oxford University Press : 2001. p. 469-76.
 
61) Gorlin RJ, et al. Hamartoneoplastic syndromes. Chap 12 Turcot syndrome. In : Syndromes of the Head and Neck 4th ed New York ; Oxford University Press ; 2001. p. 440-1.
 
62) Todd DW, et al. A family affected with intestinal polyposis and gliomas Ann Neurol 1981 : 10 : 390-2.
PubMed
63) Mastronardi L, et al. Associaton between neuroepithelial tumor and multiple intestinal polyposis (Turcot's syndrome) : Report of a case and critical analysis of the literature. Neurosurgery 1991 : 28 : 449-52.
 
64) Williams III DW, et al. Recurrent Lhermitte-Duclos disease : Report of two cases and association with Cowden's disease. AJNR Am J Neuroradiol 1992 : 13 : 287-90.
 
65) Padberg GW, et al. Lhermitte-Duclos disease and Cowden disease : A single phakomatosis. Ann Neurol 1991 ; 29 : 517-23.
PubMed
66) Robinson S, Cohen AR Cowden disease and Lhemitte-Duclos disease : Chalacterization of a new phakomatosis. Neurosurgery 2000 : 46 : 371-83.
PubMed
67) Gorlin RJ, et al. Hamartoneoplastic syndromes. Chap 12 Cowden syndrome (multiple hamartoma and carcinoma syndrome, Lhermitte-Duclos syndrome). In : Syndromes of the Head and Neck 4th ed New York : Oxford University Press : 2001. p. 432-7.
 
68) Hahn H, et al. Mutations of the human homolog of drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996 ; 85 : 841-51.
PubMed
69) Gorlin RJ, et al. Hamartoneoplastic syndromes. Chap 12 Gorlin (nevoid basal cell carcinoma) syndrome. In : Syndromes of the Head and Neck. 4th ed. New York : Oxford University Press : 2001. p.444-5.
 
70) Hogan RE, et al. Epilepsy in the nevoid basal-cell carcinoma syndrome (Gorlin syndrome) : Report of a case due to a focal neuronal heterotopia. Neurology 1996 : 46 : 574-6.
PubMed
71) O'Malley S, et al. Multiple neoplasms following craniospinal irradiation for medulloblastoma in patient with nevoid basal cell carcinoma syndrome : Case report. J Neurosurg 1997 : 86 : 286-8.
PubMed
72) Korezak JF, et al. Nevoid basal cell carcinoma syndrome with medulloblastoma in an African-American boy : A rare case illustrating gene-environment interaction. Am J Med Genet 1997 : 69 : 309-14.
 
73) Albrecht S, et al. Malignant meningioma in Gorlin's syndrome : Cytogenetic and p53 gene analysis. Case report. J Neurosury 1994 ; 81 : 466-71.
PubMed
74) 塚田俊彦, 山口建. 多内分泌腺腫瘍I型. ホルモンと臨 1999 : 47 : 1069-77.
 
75) Takahashi H, Hida T Carncy complex : Report of a Japanese case associated with cutaneous superficial angiomyxomas, labial lentigines, and a pituitary adenoma. J Dermatol 2002 ; 29 : 790-6.
 
76) Gorlin RJ, et al. Syndrome affecting the skin and mucosa. Chap 13 Gorlin (nevoid basal cell carcinoma) syndrome. In : Syndromes of the Head and Neck. 4th ed. New York : Oxford University Press ; 2001. p.558-61.
 
77) Tsugu H, et al. Hypothalamic hamartoma associated with multiple congenital abnormalities. Pediatr Neurosurg 1998 : 29 : 290-6.
PubMed
78) Hall JG, et al. Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postaxial polydactyly : A new syndrome? Clinical, causal, and pathogenetic considerations. Am J Med Genet 1980 ; 7 : 47-74.
PubMed
79) Pallister PD, et al. Three additional cases of the congenital hypothalamic 'hamartoblastoma' (Pallister-Hall) syndrome. Am J Med Genct 1989 ; 33 : 500-1.
 
P.61 掲載の参考文献
1) Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumours of the Nervous System. Lyon : International Ageney for Research on Cancer : 2000.
 
2) 脳腫瘍全国統計委員会・日本病理学会編. 脳腫瘍取り扱い規約. 第2版. 東京 : 金原出版 ; 2002.
 
3) Modan B, et al. Radiation-induced head and neck tumours. Lancet 1974 ; 1 : 277-9
 
4) Bigner DD, et al, editors Russel & Rubinstein's Pathology of Tumors of the Nervous System. 6th ed. London : Arnold ; 1998.
 
5) Martini F, et al. Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone thmors and of leukocytes from blood donors. Cancer 2002 ; 94 : 1037-48.
PubMed
6) Preston-Martin S, et al. Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Recs 1989 : 49 : 6137-43.
 
7) Zimmerman HM, Arnold H. Experimental brain tumors. I. Tu,ors produced with methycholanthrene. Cancer Res 1941 : 12 : 919-38.
 
8) Druckrey H, et al. Organotropic carcinogenic effects of 65 various N-nitroso-compounds on BD rats. Z Krebsforsch 1967 : 69 : 103-201.
PubMed
9) Ogawa K. Embryonal neuroepithelial tumors induced by human adenovirus type 12 in rodents. I. Tumor induction in the peripheral nervous system. Acta Neuropathol (Berl) 1989 ; 77 : 244-53.
PubMed
10) Ogawa K. Embryonal neuroepithelial tumors induced by human adenovirus type 12 in rodents. 2. Tumor induction in the central nervous system. Acta Neuropathol (Berl) 1989 : 78 : 232-44.
PubMed
11) Duffell D, et al. Neoplasms in hamsters induced by simian virus SV40 : Light and electron microscopic observations. Am J Pathol 1964 : 45 : 59-73.
PubMed
12) Varakis JN, ZuRhein GM. Experimental pineocytoma of the syrian hamster induced by a human papovavirus (JC) : A light and electron microscopic study. Acta Neuropathol (Berl) 1976 : 35 : 243-64.
PubMed
13) Nagashima K, et al. Induction of brain tumors by a newly isolated JC virus (Tokyo-1 stlain). Am J Pathol 1984 ; 116 : 455-63.
PubMed
14) Nakazato Y, Ishida Y. Brain tumors induced in hamsters by intracerebral inoculation of SR-RSV-infected embryonic brain cells. Acta Pathol Jpn 1978 : 28 : 445-57.
PubMed
15) Kumanishi T, et al. Brain tumors induced by Rous sarcoma virus, Schmidt-Ruppin strain. 3. Morphology of brain tumors induced in adult mice. J Natl Cancer Inst 1973 : 50 : 95-109.
 
16) Nakazato Y, et al. The localization of glial fibrillary acidic protein in brain tumors induced in hamsters with avian sarcoma virus. Acta Neuropathol (Berl) 1981 : 55 : 293-5.
PubMed
17) Bailey P, Cushing H. A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis. Philadelphia : Lippincott ; 1926.
 
18) Kernohan JW, Sayre GP. Tumors of the Central Nervous System : Fascicle 35, Atlas of Tumor Pathology. Washington DC : Armed Forces Institute of Pathology : 1952.
 
19) Zulch KJ. Histological Typing of Tumours of the Central Nervous System. Jeneva : World Health Organization ; 1979.
 
20) Kleihues P, et al. Histological Typing of Tumours of the Central Nervous System. World Health Organization International Histological Classification of Tumours. 2nd ed. Berlin, Heidelberg : Springer-Verlag ; 1993.
 
21) Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumours of the Nervous System. Lyon : International Agency for Research on Cancer : 1997.
 
22) Barnard RO, Geddes JF. The incidence of multifocal cerebral gliomas : A histologic study of large hemisphere sections. Cancer 1987 ; 60 : 1519-31.
PubMed
23) Fecteau AH, et al. Peritoneal metastasis of intracranial glioblastoma via a ventriculoperitoneal shunt preventing organ retrieval : Case report and review of the literature. Clin Transplant 1998 ; 12 : 348-50.
 
24) Herpers MJ, Budka H. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors : Gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma. Acta Neuropathol (Berl) 1984 ; 64 : 265-72.
PubMed
25) Kros JM, et al. Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas. Cancer 1990 ; 66 : 1204-12.
PubMed
26) Yoshida T, Nakazato Y. Characterization of refractile eosinophilic granular cells in oligodendroglial tumors. Acta Neuropathol (Berl) 2001 ; 102 : 11-9.
PubMed
27) Kawano N, et al. Clear cell ependymoma : A histological variant with diagnostic implications. Virchows Arch A Pathol Anat Histopathol 1989 ; 415 : 461-12.
 
28) Hassoun J, et al. Central neurocytoma : A synopsis of clinical and histological features. Brain Pathol 1993 : 3 : 297-306.
PubMed
29) Brat DJ, et al. Infiltrative astrocytomas with granular cell features (granular cell astrocytomas) : A study of histopathologic features, grading, and outcome. Am J Surg Pathol 2002 ; 26 : 750-7.
PubMed
30) George DH, Scheithauer BW. Central liponeurocytoma. Am J Surg Pathol 2001 ; 25 : 1551-5.
PubMed
31) Roncaroli F, et al. Lipomatous meningioma : A clinicopathologic study of 18 cases with special reference to the issue of metaplasia. Am J Surg Pathol 2001 ; 25 : 769-15.
 
32) Sharma MC, et al. Ependymoma with extensive lipidization mimicking adipose tissue : A report of five cases. Pathol Oncol Res 2000 ; 6 : 136-40.
PubMed
33) Hirato J, et al. An unusual variant of ependymoma with extensive tumor cell vacuolization. Acta Neuropathol (Berl) 1997 ; 93 : 310-6.
PubMed
34) Yamanouchi H, et al. Meshy meningioma : A potential novel variant. Neuropathology 2001 ; 21 : 236-40.
PubMed
35) Goldman JE, et al. Granulofilamentous inclusions in a meningioma. Cancer 1980 ; 46 : 156-61.
 
36) Kros JM, et al. Signet-ring cell oligodendroglioma : Report of two cases and discussion of the differential diagnosis. Acta Neuropathol (Berl) 1997 ; 93 : 638-43.
PubMed
37) Zuppan CW, et al. Ependymoma with signet-ring cells. Ultrastruct Pathol 1994 ; 18 : 43-6.
PubMed
38) Sugita Y, et al. Astroblastoma with unusual signet-ring-like cell components : A case report and literature review. Neuropathology 2002 ; 22 : 200-5.
PubMed
39) Schmidbauer M, et al. Neuroepithelial and ectomesenchymal differentiation in a primitive pineal tumor ("pineal anlage tumor"). Clin Neuropathol 1989 ; 8 : 7-10.
 
40) Rosenblum MK, et al. Melanotic ependymoma and subependymoma. Am J Surg Pathol 1990 ; 14 : 729-36.
PubMed
41) Vajtai I, et al. Melanotic astrocytoma. Acta Neuropathol (Berl) 1996 ; 91 : 549-53.
PubMed
42) Watanabe K, et al. Choroid plexus papilloma containing melanin pigment. Clin Neuropathol 1995 ; 14 : 159-61.
PubMed
43) Rorke LB, et al. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood : Definition of an entity. J Neurosurg 1996 ; 85 : 56-65.
PubMed
44) Ho DM, et al. Atypical teratoid/rhabdoid tumor of the central nervous system : A comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol (Berl) 2000 ; 99 : 482-8.
PubMed
45) Ojeda VJ, et al. Cerebral gliomas with palisading necrosis : Glioblastoma multiforme or high grade cerebral neuroblastoma? : A light and electron microscopical study of three cases. Pathology 1981 ; 19 : 161-72.
PubMed
46) Teo JG, et al. A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including "rosetted") islands : Report of 4 cases. Am J Surg Pathol 1999 ; 23 : 502-10.
PubMed
47) Komori T, et al. A rosette-forming glioneuronal tumor of the fourth ventricle : Infiatentorial form of dysembryoplastic neuroepithelial tumor? Am J Surg Pathol 2002 : 26 : 582-91.
 
48) Jouvet A, et al. Papillary tumor of the pineal region. Am J Surg Pathol 2003 ; 27 : 505-12.
PubMed
49) Daumas-Duport C. Dysembryoplastic neuroepithelial tumours. Brain Pathol 1993 ; 3 : 283-95.
PubMed
50) Iwaki T, et al. αB-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol 1993 : 143 : 487-95.
 
51) Katsetos CD, Krishna L. Lobar pilocytic astrocytomas of the cerebral hemispheres : I. Diagnosis and nosology. Clin Neuropathol 1994 : 13 : 295-305.
PubMed
52) Kawano N, et al. Eosinophilic inclusions in ependymoma represent microlumina : A light and electron microscopic study. Acta Neuropathol (Berl) 2000 ; 99 : 214-8.
PubMed
53) Rojiani AM, Dorovini-Zis K. Glomeruloid vascular structures in glioblastoma multiforme : An immunohistochemical and ultrastructural study. J Neurosurg 1996 ; 85 : 1078-84.
PubMed
54) Alguacil-Garcia A, et al. Secretory meningioma : A distinct subtype of meningioma. Am J Surg Pathol 1986 ; 10 : 102-11.
PubMed
55) Kepes JJ, et al. The role of astrocytes in the formation of carlilage in gliomas : An immunohistochemical study of four cases. Am J Pathol 1984 ; 117 : 471-83.
PubMed
56) Paulus W, Janisch W. Clinicopathologic correlations in epithelial choroid plexus neoplasms : A study of 52 cases. Acta Neuropathol (Berl) 1990 ; 80 : 635-41.
PubMed
57) Perry A, et al. The immunophenotypic spectrum of meningeal hemangiopericytoma : A comparison with fibrous meningioma and solitary fibrous tumor of meninges. Am J Surg Pathol 1997 ; 21 : 1354-60.
PubMed
58) Blumcke I, et al. The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies. Acta Neuropathol (Berl) 1999 ; 97 : 481-90.
PubMed
59) Katsetos CD, et al. Aberrant localization of the neuronal class IIIβ-tubulin in astrocytomas. Arch Pathol Lab Med 2001 ; 125 : 613-24.
 
60) Katsetos CD, et al. Localization of the neuronal class IIIβ-tubulin in oligodendrogliomas : Comparison with Ki-67 proliferative index and 1p/l9q status. J Neuropathol Exp Neurol 2002 ; 61 : 307-20.
 
61) Hirato J, et al. Expression of non-glial intermediate filament proteins in gliomas. Clin Neuropathol 1994 ; 13 : 1-11.
PubMed
62) Oh D, Prayson RA. Evaluation of epithelial and keratin markers in glioblastoma multiforme : An immunohistochemical study. Arch Pathol Lab Med 1999 ; 123 : 917-20.
PubMed
63) Brat DJ, et al. Third ventriculal chordoid glioma : A distinet clinicopathologic entity. J Neuropathol Exp Neurol 1998 : 57 : 283-90.
 
64) Lach B, et al. Angiogenic histogenesis of stromal cells in hemangioblastoma : Ultrastuctural and immunohistochemical study. Ultrastruct Pathol 1999 : 23 : 299-310.
 
65) Saito A, Nakazato Y. Evaluation of malignant features in oligodendroglial tumors. Clin Neuropathol 1999 ; 18 : 61-73.
PubMed
66) Gray MH, et al. Glial fibrillary acidic protein and keratin expression by benign and malignant nerve sheath tumors. Hum Pathol 1989 ; 20 : 1089-96.
PubMed
67) Su M, et al. An unusual meningioma variant with glial fibrillary acidic protein explession. Acta Neuropathol (Berl) 1997 ; 94 : 499-503.
PubMed
68) Nakazato Y, et al. Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomolphic adenoma of the salivary glands Lab Invest 1982 : 46 : 621-6.
PubMed
69) Zimmer C, et al. Melanoma-associated antigens in tumours of the nervous system : An immunohistochcmical study with the monoclonal antibody HMB-45. Virchows Arch A Pathol Anat Histopathol 1992 : 420 : 121-6.
 
70) Taddei GL, et al. Oligodendroglioma : HMB-45 positivity using catalyzed signal amplification method : An immunohistochemical (HMB-45, CD31, p53, Mib-1) and ultrastructural study. Appl Immunohistochem Mol Morphol 2001 ; 9 : 35-41.
PubMed
71) Duchrow M, et al. Molecular characterization of the gene locus of the human cell prolifcration-associated nuclear protein defined by monoclonal antibody Ki-67, Cell Prolif 1996 ; 29 : 1-12.
 
72) Gerdes J, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nucleal antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991 ; 138 : 867-73.
 
73) Konstantinidou AE, et al. DNA topoisomerase II α expression correlates with cell proliferation but not with recurrence in intracranial meningiomas. Histopathology 2001 : 39 : 402-8.
 
74) Perentes E, Rubinstein LJ. Immunohistochemical recognition of human neuroepithelial tumors by anti-Leu 7 (HNK-1) monoclonal antibody. Acta Neuropathol (Berl) 1986 : 69 : 227-33.
PubMed
75) Antuncs NL, et al. Intracranial Ewing sarcoma/ 'peripheral' primitive neuroectodermal tumor of dural origin with molecular genetic confirmation. J Neurooncol 2001 : 51 : 51-6.
 
76) Wolf HK, et al. NeuN : A useful neuronal marker for diagnostic histopathology. J Histochem Cytochem 1996 : 44 : 1167-71.
PubMed
77) Parker JR, et al. Antineuronal nuclei immunohistochemical staining patterns in childhood ependymomas. J Child Neurol 2001 : 16 : 548-52.
PubMed
78) Miettinen M, Rapola J. Immunohistochemical spectrum of rhabdomyosarcoma and rhabdomyosarcoma-like tumors : Expression of cytokeratin and the 68-kD neurofilament protein. Am J Surg Pathol 1989 ; 13 : 120-32.
PubMed
79) Cras P, et al. γ-enolase and glial fibrillary acidic protein in nervous system tumors : An immunohistochemical study using specific monoclonal antibodies. Acta Neuropathol (Berl) 1988 : 75 : 377-84.
 
80) Yaziji H, et al. Role of p53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesions. Am J Surg Pathol 1996 ; 20 (9) : 1086-90.
PubMed
81) Shinoda J, et al. Immunohistochemical study of placental alkaline phosphatase in primary intracranial germ-cell tumors. J Neurosurg 1985 : 63 : 733-9.
PubMed
82) Albrecht S, et al. Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases. Mod Pathol 1991 : 4 : 610-4.
PubMed
83) Reifenberger G, et al. Chordoid glioma of the third ventricle : Immunohistochemical and molecular genetic characterization of a novel tumor entity. Brain Pathol 1999 ; 9 : 617-26.
PubMed
84) Arai H, et al. A novel marker of Schwann cells and myelin of the peripheral nervous system. Pathol Int 1998 : 48 : 206-14.
PubMed
85) Grant JW, von Deimling A. Primary T-cell lymphoma of the central nervous system. Arch Pathol Lab Med 1990 : 114 : 24-7.
PubMed
86) Tabuchi K, Nishimoto A. Atlas of Brain Tumors : Light-and Electron-Microscopic Features. Tokyo : Splinger-Verlag : 1988.
 
87) Liberski PP, Kordek R. Ultrastructural pathology of glial brain tumors revisited : A review. Ultrastruct Pathol 1997, 21 : 1-31.
PubMed
88) Dinda AK, et al. Rosenthal fibres : An immunohistochemical, ultrastructural and immunoelectron microscopic study. Acta Neuropathol (Berl) 1990 ; 79 : 456-60.
PubMed
89) Hitotsumatsu T, et al. Cytoplasmic inclusions of astrocytic elements of glial tumors : Special reference to round granulated body and eosinophilic hyaline droplets. Acta Neuropathol (Berl) 1994 : 88 : 501-10.
PubMed
90) Sarasa JL, et al. Crystals in an oligodendroglioma : An optical, histochemical, and ultrastructural study. Ultrastruct Pathol 1990 : 14 : 151-9.
 
91) Kepes JJ. The fine strueture of hyaline inclusions (pseudopsammoma bodies) in meningiomas. J Neuropathol Exp Neurol 1975 ; 34 : 282-94.
 
92) Sara A, et al. Ultrastructure of ependymoma. Ultrastruct Pathol 1994 ; 18 : 33-42.
PubMed
93) Dardick I, et al. Ultrastructural spectrum of hemangiopericytoma : A compalative study of fetal, adult, and neoplastic pericytes Ultlastruct Pathol 1989 : 13 : 111-54.
PubMed
94) Nutt CL, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003 : 63 : 1602-7.
PubMed
95) Ueki K, et al. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 2002 : 8 : 196-201.
PubMed
96) Reifenberger G, Louis DN. Oligodendroglioma : Toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 2003 ; 62 : 111-26.
PubMed
97) Burger PC, et al. Small cell architecture : A histological equivalent of EGFR amplification in glioblastoma multiforme? J Neuropathol Exp Neurol 2001 : 60 : 1099-104.
PubMed
98) Biemat W, et al. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol 1995 ; 54 : 651-6.
 
99) Biegel JA, et al. Alterations of the hSNF5/IN11 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002 ; 8 : 3461-7.
 
100) Kumar S, et al. Detection of EWS-FLI-1 fusion in Ewing's sarcoma/peripheral primitive neuroectodermal tumor by fluorcscence in situ hybridization using formalin-fixed paraffin-embedded tissue. Hum Pathol 1999 ; 30 : 324-30.
 
101) Kuroda Y, et al. Autopsy Report of primary CNS B-cell lymphoma indistinguishable from multiple sclerosis : Diagnosis with the immunoglobulin gene reanangements analysis. J Neurol Sci 1992 : 111 : 173-9.
PubMed
102) 中里洋一. 現代病理学大系23c. 神経疾患 III. 東京 : 中山書店 ; 1993. p152.
 
103) 山口晴保. 神経特異S-100蛋白, GFA蛋白のラット神経組織, ヒト脳腫瘍組織内局在に関する免疫組織学的研究. 脳と神経 1980 : 32 : 1055-64.
 
P.87 掲載の参考文献
1) Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARS Press ; 2000.
 
2) Heldin CH. Protein tyrosine kinase receptors. Cancer Surv 1996 ; 27 : 7-24.
PubMed
3) Willis AI, et al. Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein induced vascular smooth muscle cell chemotaxis. J Vasc Surg 2000 ; 31 : 1160-7.
PubMed
4) Louis DN. The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 1994 ; 53 : 11-21.
PubMed
5) Bogler O, et al. The p53 gene and its role in human brain tumors. Glia 1995 ; 15 : 308-27.
PubMed
6) Shen CJ. Tumor surveillance via the ARF-p53 pathway. Genes Dev 1998 ; 12 : 2984-91.
 
7) Sherr CJ. Cancer cell cycles. Science 1996 ; 274 : 1672-1.
PubMed
8) Henson JW, et al. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994 ; 36 : 714-21.
PubMed
9) Reifenberger G, et al. Amplification of muitiple genes from chromosomal region 12q13-14 in human malignant gliomas : Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 1994 ; 54 : 4299-303.
 
10) Quelle DE, et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995 ; 83 : 993-1000.
PubMed
11) Schmidt EE, et al. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994 ; 54 : 6321-4.
 
12) Nishikawa R, et al. Loss of P16INK4 expression is frequent in high grade gliomas. Cancer Res 1995 ; 55 : 1941-5.
PubMed
13) Costello JF, et al. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 1996 : 56 : 2405-10.
PubMed
14) Ueki K, et al. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely corelated. Cancer Res 1996 ; 56 : 150-3.
 
15) Fults D, Pedone C. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme. Genes Chromosomes Cancer 1993 : 7 : 173-7.
 
16) Li J, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997 ; 275 : 1943-7.
PubMed
17) Steck PA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997 ; 15 : 356-62.
PubMed
18) Wang SI, et al. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997 ; 57 : 4183-6.
PubMed
19) Maher EA, et al. Malignant glioma : Genetics and biology of a grave matter. Genes Dev 2001 ; 15 : 1311-33.
PubMed
20) Stambolic V, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998 ; 95 : 29-39.
PubMed
21) Tamura M, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998 ; 280 : 1614-7.
PubMed
22) Holland EC, et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 2000 : 25 : 55-7.
PubMed
23) Ueki K, et al. ANOVA, a putative astrocytic RNA-binding protein gene that maps to chromosome 19q13.3. Neurogenetics 1997 ; 1 : 31-6.
PubMed
24) Fults D, et al. Allelotype of human malignant astrocytoma. Cancer Res 1990 ; 50 : 5784-9.
PubMed
25) Rubio MP, et al. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 1994 : 54 : 45-1.
PubMed
26) Watanabe K, et al. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 19961. 6 : 217-23 ; discussion 23-4.
 
27) Ichimura K, et al. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 2000 ; 60 : 417-24.
PubMed
28) Reifenberger J, et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994 : 145 : 1115-90.
 
29) Smith JS, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000 ; 18 : 636-45.
PubMed
30) Ueki K, et al. Conelation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 2002 ; 8 : 196-201.
 
31) Cairncross JG, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998 ; 90 : 1473-9.
PubMed
32) Mukasa A, et al. Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p. Oncogene 2002 ; 21 : 3961-8.
PubMed
33) Ino Y, et al. Molecular subtypes of anaplastic oligodendroglioma : Implications for patient management at diagnosis. Clin Cancer Res 2001 ; 7 : 839-45.
PubMed
34) Segal RA, et al. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 1994 ; 91 : 12861-71.
 
35) Pomeroy SL, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002 ; 415 : 436-42.
PubMed
36) Holland EC. Gliomagenesis : Genetic alterations and mouse models. Nat Rev Genet 2001 ; 2 : 120-9.
PubMed
37) Garber JE, et al. The American Society of Clinical Oncology position on genetic testing : Implications for health care providers : Workshop no. 4. Cancer 1997 ; 80 : 632-4.
 
38) Xu GF, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990 ; 62 : 599-608.
PubMed
39) Jacks T, et al. Tumour predisposition in mice heterozygous for a targeted mutation in Nfl. Nat Genet 1994 ; 7 : 353-61.
 
40) Aoki S, et al. Neurofibromatosis types 1 and 2 : Cranial MR findings. Radiology 1989 ; 172 : 527-34.
PubMed
41) Trofatter JA, et al. A novel moesin-, ezrin-, radixin like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993 : 72 : 791-800.
PubMed
42) Gusella JF, et al. Neurofibromatosis 2 : Loss of merlin's protective spell. Curr Opin Genet Dev 1996 ; 6 : 81-92.
 
43) Merel P, et al. Screening for germ line mutations in the NF2 gene. Genes Chromosomes Cancer 1995 ; 12 : 117-21.
PubMed
44) Latif F, et al. Identification of the von Hippel Lindau disease tumor suppressor gene. Science 1993 ; 260 : 1317-20.
PubMed
45) Kaelin WG Jr. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2002 ; 2 : 613-82.
 
46) Ohh M, Kaelin WG Jr. The von Hippel-Lindau tumour suppressor protein : New perspectives. Mol Med Today 1999 ; 5 : 257-63.
PubMed
47) Friedrich CA. Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet 2001 ; 10 : 763-7.
PubMed
48) The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993 ; 75 : 1305-15.
PubMed
49) van Slegtenhorst M, et al. Identilication of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997 ; 277 : 805-8.
 
50) Plank TL, et al. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 1998 ; 58 : 4766-70.
PubMed
51) Malkin D, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990 ; 250 : 1233-8.
 
52) Srivastava S, et al. Germ line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990 ; 348 : 747-9.
 
53) Bell DW, et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 1999 ; 286 : 2528-31.
 
54) Liaw D, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997 ; 16 : 64-7.
PubMed
55) Hamilton SR, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995 ; 332 : 839-47.
PubMed
56) Hahn H, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996 ; 85 : 841-51.
PubMed
57) Chandrasekharappa SC, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997 ; 216 : 404-7.
 
58) Hermanson M, et al. Association of loss of heterozygosity on chromosome 17p with high platelet derived growth factor α receptor expression in human malignant gliomas. Cancer Res 1996 ; 56 : 164-71.
 
59) Hermanson M, et al. Platelet-derived growth lactor and its receptors in human glioma tissue : Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992 : 52 : 3213-9.
 
60) Noble M, et al. Platelet-derived growth factor promotes division and motility anci inhibits premature differentiation of the oligodendrocyte/type 2 astrocyte progenitor cell. Nature 1988 ; 333 : 560-2.
 
61) Hamel W, Westphal M. Growth factors in gliomas revisited. Acta Neurochir (Wien) 2000 ; 142 : 113-37 ; discussion 37-8.
 
62) Ekstrand AJ, et al. Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vlvo. Cancer Res 1991 ; 51 : 2164-72.
 
63) Collins VP. Gene amplification in human gliomas. Glia 1995 ; 15 : 289-96.
PubMed
64) Ekstrand AJ, et al. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA 1992 ; 89 : 4309-13.
PubMed
65) Nishikawa R, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 1994 ; 91 : 1727-31.
 
66) Nagane M, et al. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 1996 ; 56 : 5079-86.
PubMed
67) Nagane M, et al. Drug resistance of human glioblastoma cells conferred by a tumor specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci USA 1998 ; 95 : 5724-9.
PubMed
68) Nagane M, et al. Aberrant receptor signaling in human malignant gliomas : Mechanisms and therapeutic implications. Cancer Lett 2001 : 162 Suppl : S17-21.
 
69) Arteaga CL, Johnson DH. Tyrosine kinase inhibitors-ZD1839 (Iressa). Curr Opin Oncol 2001 ; 13 : 491-8.
PubMed
70) Mishima K, et al. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor. Cancer Res 2001 : 61 : 5349-54.
 
71) Nagane M, et al. Human glioblastoma xenografts overexpressing a tumor specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor. J Neurosurg 2001 ; 95 : 472-9.
PubMed
72) Morrison RS, et al. Basic fibroblast growth tactor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J Neurooncol 1994 ; 18 : 207-16.
 
73) Morrison RS. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 1991 ; 266 : 728-34.
PubMed
74) Plate KH, et al. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 1993 ; 53 : 5822-7.
 
75) Hanis AL. Hypoxia : A key regulatory factor in tumour growth. Nat Rev Cancer 2002 ; 2 : 38-47 .
 
76) Cheng SY, et al. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc Natl Acad Sci USA 1996 ; 93 : 8502-1.
PubMed
77) Yuan F, et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 1996 ; 93 : 14765-70.
PubMed
78) Millauer B, et al. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994 ; 367 : 576-9.
PubMed
79) Kerr JF, et al. Apoptosis : A basic biologicJ phenomenon with wide-ranging implications in tissue kinctics. Br J Cancer 1972 : 26 ; 239-57.
PubMed
80) Kitanaka C, Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 1999 : 6 : 508-15.
PubMed
81) Hengartner MO, et al. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 1992 ; 356 : 494-9.
PubMed
82) Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elegans. Cell 1986 ; 44 : 817-29.
PubMed
83) Ashkenazi A, Dixit VM. Death receptors. Signaling and modulation Science 1998 : 281 : 1305-8.
PubMed
84) Huang DC, Strasser A BH3-Only ploteins-essenial initiators of apoptotic cell death Cell 2000 ; 103 : 839-42.
PubMed
85) Sheikh MS, Fornace AJ Dcath and decoy receptors and p53-mediated apoptosis Lcukellua 2000 : 14 : 1509-13.
 
86) Nagane M, et al. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res 2000 ; 60 : 847-53.
PubMed
87) Vousden KH. p53 : Death star. Cell 2000 ; 103 : 691-4.
PubMed
88) Sheikh MS, Fomace AJ. Role of p53 family membersin apoptosis. J Cell Physiol 2000 ; 182 : 171-81.
 
89) Wang XW, et al. The XPB and XPD DNA hclicases arc components of the p53-mediated apoptosis pathway. Genes Dev 1996 : 10 : 1219-32.
 
90) Susin SA, et al. Mitochondrial release of caspase-2 and-9 during the apoptotic Process. J Exp Med 1999 ; 189 : 381-94.
PubMed
91) Susin sA, et al. Molecular characterization of mitochondrial apoptosis-inducing factor Nature 1999 ; 397 : 441-6.
PubMed
92) Du C, et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000 ; 102 : 33-42.
PubMed
93) Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997 : 387 : 773-6.
PubMed
94) Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell 1994 ; 79 : 189-92.
PubMed
95) Yuan J, et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-Converting enzyme. Cell 1993 ; 75 : 641-52.
 
96) 永根基雄. 細胞死と細胞寿命-アポトーシス, テロメア. 生塩之敬ほか編. 脳神経外科医に必要な分子細胞生物学. 東京 ; 三輪書店 ; 2001. p35-47.
 
97) Enari M, et al. A caspase-activated DNase that degrades DNA during apoptosis, and is inhibitor ICAD. Nature 1998 : 391 : 43-50.
PubMed
98) Irmler M, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997 ; 388 : 190-5.
PubMed
99) Deveraux QL, Reed JC. IAP family proteins Suppressors of apoptosis. Genes Dev 1999 ; 13 : 239-52.
PubMed
100) Ambrosini G, et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997 : 3 : 917-21.
PubMed
101) Ellis RE, et al. Genes required for the engulfment of cell corpses during programmed cell death in Caenorhabditis elegans. Genetics 1991 : 129 : 79-94.
PubMed
102) Zhou Z, et al. CED-1 is a transmemblane receptor that mediates cell corpse engulfment in C. elegans. Cell 2001 ; 104 : 43-56.
 
103) Wu YC, Horvitz HR. C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180. Nature 1998 ; 392 : 501-4.
PubMed
104) Reddien PW, Horvitz HR. CED-2/CrkII and CED-10/Rac control phagocytosis and cell migration in Caenorhabditis elegans. Nat Cell Biol 2000 ; 2 : 131-6.
PubMed
105) Marguet D, et al. Engulfment of apoptotic cells involvcs the redistribution of membrane phosphatidylserine on phagocyte and prey. Nat Cell Biol 1999 : 1 : 454-6.
PubMed
106) Krieser RT, White K. Engulfment mechanism of apoptotic cells. Curr Opin Cell Biol 2002 ; 14 : 734-8.
 
107) 永根基雄. 脳腫瘍の遺伝子異常. Clin Neurosci 2003 ; 21 : 518-9.
 
P.102 掲載の参考文献
1) De Micco C. Immunology of central nervous system tumors. J Neuroimmunol 1989 ; 25 : 93-108.
PubMed
2) Shrikant P, Benveniste N. The central nervous system as an immunocompetent organ. J Neuroimmunol 1996 ; 157 : 1819-21.
 
3) Gohn V, et al. Broad tumor-associated expression and recognition by tumor-derived γδT cells of MICA and MICB. Proc Natl Acad Sci USA 1999 : 96 : 6819-84.
 
4) Widner H, et al. Immune response in deep cervical lymph nodes and spleen in the mouse after antigen deposition in different intracerebral sites. Scand J Immunol 1988 ; 28 : 563-71.
PubMed
5) Bo L, et al. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994 ; 51 : 135-46.
 
6) Williams K, et al. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Etr J Immunol 1994 ; 24 : 3031-7.
 
7) Meeusen EN, et al. Tissue-specific migration of lymphocytes : A key role for Th1 and Th2 cells. Immunol Today 1996 ; 17 : 421-4.
PubMed
8) Chi DD, et al. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol 1997 ; 150 : 2143-52.
PubMed
9) Sahin U, et al. Expression of cancer testis genes in human brain tumors. Clin Cancer Res 2000 ; 6 : 3916-22.
PubMed
10) Carrithers MD, et al. Role of genetic background in P selectin-dependent immune surveillance of the central nervous system. J Neuroimmunol 2002 ; 129 ; 51-7.
 
11) Qing Z, et al. Inhibition of antigen specific T cell trafficking into the central nervous system via blocking PECAM/CD31 molecule. J Neuropathol Exp Neurol 2001 ; 60 : 798-807.
PubMed
12) Hickey WF. Leukocyte traffic in the central nervous system : The participants and their roles. Semin Immunol 1999 ; 11 : 125-37.
 
13) Wekerle H, Fierz W. T cell approach to demyelinating diseases. Springer Semin Immunopathol 1985 ; 8 ; 97-110.
PubMed
14) Fabry Z, et al. Nervous lissue as an immune compartment : The dialect of the immune response in the CNS. Immunol Today 1994 : 15 : 218-24.
PubMed
15) Pryce G, etal. Factors controlling T cell migration cross rat cerebral endothelium in vitro. J Neuroimmunol 1991 : 75 : 84-94.
 
16) Irani DN. The susceptibility of mice to immune-mediated neurologic disease correlates with the degree to which their lymphocytes resist the effects of brain derived gangliosides. J Immunol 1998 ; 161 : 2746-52.
PubMed
17) Gordon LB, et al. Normal cerebrospinal fluid suppresses the in vitro development of cytotoxic T cells : Role of the brain microenvironment in CNS immune regulation. J Neuroimmunol 1998 ; 88 : 77-84.
PubMed
18) Tran EH, et al. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 1998 ; 161 : 3767-75.
 
19) Brabb T, et al. In situ tolerance within the central nervous system as a mechanism fbr preventing autoimmunity. J Exp Med 2000 ; 192 : 871-80.
 
20) Matyszak MK, et al. Microglia induce myelin basic protein-specific T cell energy or T cell activation, according to their state of activation. Eur J Immunol 1999 : 29 : 3063-76.
PubMed
21) Okada H, et al. Bone marrow-derived dendritic cells pulsed with a tumor specific peptide elicit effective anti tumor immunity against intracranial neoplasms. Int J Cancer 1998 ; 78 : 196-201.
PubMed
22) Walker PR, et al. The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells. J Immunol 2000 : 165 : 3128-35.
PubMed
23) Dix AR, et al. Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 1999 ; 100 : 216-32.
PubMed
24) Perrin G, et al. Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset. Int Immunol 1999 : 11 : 1337-49.
 
25) Brooks WH, et al. Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 1978 ; 4 : 219-24.
PubMed
26) Morfbrd LA, et al. T cell receptor mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol 1997 : 159 : 4415-25.
 
27) Prins RM, et al. Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with deoreased function and apoptosis. Cancer Immunol Immunother 2001 ; 50 : 285-92.
 
28) Elliott LH, et al. Suppression of high affinity IL-2 receptors on mitogen activated Iymphocytes by glioma derived suppressor factor. J Neurooncol 1992 : 14 : 1-7.
 
29) Bodmer S, et al. Immunosuppression and transforming growth factor-β in glioblastoma : Preferential production of transforming growth factor-β2. J Immunol 1989 ; 143 : 3222-9.
 
30) Gorelik L, Flavell RA. Transforming growth factor-β in T-cell biology. Nat Rev Immunol 2002 ; 2 : 46-53.
 
31) Jachimczak P, et al. The effect of transforming growth factor-2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. J Neurosurg 1993 ; 78 : 944-51.
PubMed
32) Lynch DH, et al. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995 ; 16 : 569-14.
PubMed
33) Nagata S, Golstein P. The Fas death factor. Science 1995 ; 267 : 1449-56.
PubMed
34) Saas P, et al. Fas ligand expression by astrocytoma in vivo : Maintaining immune privilege in the brain. J Clin Invest 1997 ; 99 : 1173-8.
 
35) Walker PR, et al. The role of Fas ligand (CD95L) in immune escape : The tumor cell strikes back. J Immunol 1997 ; 158 : 4521-4.
 
36) Didenko VV, et al. Apoptosis of T lymphocytes invading glioblastomas multiforme : A possible tumor defense mechanism. J Neurosurg 2002 ; 96 : 580-4.
PubMed
37) Hahne M, et al. Melanoma cell expression of Fas (Apo-1/CD95) ligand : Implications for tumor immune escape. Science 1996 ; 274 : 1363-6.
PubMed
38) SeinoK, etal. Antitumor effect of locally produced CD95 ligand. Nat Med 1997 ; 3 : 165-70.
 
39) Wiendl H, et al. A functional role of HLA G expression in human gliomas : An altemative strategy of immune escape. J Immunol 2002 ; 168 : 4772-80.
 
40) Wischhusen J, et al. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. Cancer Res 2002 ; 62 : 2592-9.
PubMed
41) Held-Feindt J, Mentlein R CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors. Int J Cancer 2002 ; 98 : 352-6.
PubMed
42) Bainbridge D, et al. HLA-G remains a myste, Trends Immunol 2001 ; 22 : 548-52.
PubMed
43) Jacquot S. CD27/CD70 interactions regulate T dependent B cell differendation. Immunol Res 2000 ; 21 : 23-30.
PubMed
44) Massa PT, et al. cell type-specific regulation of major histocompaubility complex (MHC) Class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia 1993 ; 8 : 201-7.
PubMed
45) Pamey IF, et al. Human glioma immunobiology in vitro. Implications for immunogene therapy. Neurosurgery 2000 ; 46 : 1169-77.
PubMed
46) Redwine JM, et al. In vivo expression of major histocompaibility complex molecules on oligodendrocytes and neurons during viral infection. Am J Pathol 2001 ; 159 : 1219-24.
PubMed
47) Preston-Martin S, et al. Brain tumor risk in children in relation to use of electric blankets and water bed heaters : Results from the United States West Coast Childhood Brain Tumor Study. Am J Epidemiol 1996 ; 143 : 1116-22.
PubMed
48) Sadetzki S, et al. An iatrogenic epidemic of benign meningioma. Am J Epidemiol 2000 ; 151 : 266-72.
PubMed
49) Ron E, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988 ; 319 : 1033-9.
PubMed
50) Walter AW, et al. Seconday brain tumors in children treated for acute lymphoblasic leukemia at St Jude Children's Research Hospital. J Clin Oncol 1998 ; 16 : 3761-7.
 
51) Cote TR, et al. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996 ; 88 : 675-9.
 
52) Pathell PA, et al. Primary central nervous system lymphoma in the transplant patient. Neurol Clin 1988 ; 6 : 297-303.
 
53) Choucair AK, et al. Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg 1986 ; 65 : 654-8.
PubMed
54) Janeway CA Jr, et al. Immunobiology : The Immune Systems in Health and Disease. New York, London : Garland Publishing. 2001. p.260.
 
55) Ransohoff RM, et al. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003 ; 3 : 569-81.
 
P.113 掲載の参考文献
1) Rcport of Brain tumor Registry of Japan (1969-1996) 11th ed Neurol Med Chir (Tokyo) 2003 : 43 (Suppl).
 
2) Kuratsu J, Ushio Y. Epidemiological study of primary intracranial tumors in childhood. Pediatr Neurosurg 1996 : 25 : 240-7.
PubMed
3) Pollack IF. Brain tumors in children. N Engl J Med 1994 : 331 : 1500-7.
PubMed
4) Young JL, Miller RW. incidence of malignant tumors in U. S. children. J Pediatr 1975 ; 86 : 254-8.
 
5) Duffner PK, et al. Survival of children with brain tumors : SEER Program, 1973-1980. Neurology 1986 : 36 : 597-601.
PubMed
6) Rorke LB, Schut L. Introductory survey of pediatric brain tumors. In : McLaurin RL, et al, editors. Pediatric Neurosurgery : Surgery of the Developing Nervous System. 2nd ed Philadelphia : WB Saunders ; 1989. p. 335-7.
 
7) Albright AL. Brain tumors in neonates, infants, and toddlers. Contemp Neurosurg 1985 : 7 : 1-8.
 
8) Stiller CA, Nectoux J. International incidence of childhood brain and spinal tumours. Int J Epidemiol 1994 : 23 : 458-64.
PubMed
9) Jooma R, et al. Intracranial neoplasms during the first year of life : Analysis of one hundred consecutive cases. Neurosurgery 1984 ; 14 : 31-41.
PubMed
10) Wakai S, et al. Congenital brain tumor. Surg Neurol 1984 : 21 : 597-609.
PubMed
11) 松谷雅生ほか. 小児の脳腫瘍. 太田富雄, 松谷雅生編. 脳神経外科. 改訂8版. 京都 : 金芳堂 ; 2001. p.452-4.
 
12) Cohen ME, Duffner PK. Supratcntorial hemispheric astrocytomas. In : Cohen ME, Duffner PK, editors. Brain Tumors in Children 2nd ed. New York : Raven Press : 1994. p.263-84.
 
13) Scott EW, Mickle JP. Pediatric diencephalic gliomas : A review of 18 cases. Pediatr Neurosci 1987 ; 13 : 225-32.
PubMed
14) Balagura S, et al. Precocious pubelty of cerebral origin. Surg Neurol 1979 : 11 : 315-26.
PubMed
15) Lund AM, Skooby F. Optic gliomas in children with neurofibromatosis type 1. Eur J Pediatr 1991 : 150 : 835-8.
 
16) Ishii N, et al. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma deversity using a p53 functional assay. Int J Cancer 1998 : 76 : 797-800.
 
17) Sure U, et al. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol 1997 : 56 : 782-9.
PubMed
18) Cheng Y, et al. Genetic alterations in pediatric high-grade astrocytomas. Hum Pathol 1999 : 30 : 1284-90.
PubMed
19) Gjerris F, et al. Malignancy and long-term survivalin brain tumours of infancy and childhood. Acta Neurol Scand 1976 : 53 : 61-71.
 
20) Giangaspero F, et al. Medulloblastoma. In : Kleihues P, Caveneee WK, editors. Pathology and Genetics : Tumours of the Nervous System Lyon : International Ageney for Rescalch on Cancer : 2000. p. 129-37.
 
21) Schutz BR, et al. Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosomes Cancer 1996 ; 16 : 196-203.
PubMed
22) Scheurlen WG, et al. Molecular analysis of childhood prmitive neuroectodermal brain tumors defines markers associated with poor outcome. J Clin Oncol 1998 ; 16 : 2478-85.
 
23) Evans AE, et al. The treatment of medulloblastoma. J Neurosurg 1990 ; 72 : 572-82.
PubMed
24) Duffner PK, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993 ; 328 : 1725-31.
PubMed
25) Zeltzer PM, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children : Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999 ; 17 : 832-45.
 
26) Robenson PL, et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children : A report of the Children's Cancer Group. J Neurosurg 1998 : 88 : 695-703.
 
27) Cohen ME, Duffner PK. Ependymoma. In : Cohen ME, Duffner PK, editors. Brain Tumors in Children 2nd ed. New York : Raven Press : 1994. p. 219-39.
 
28) Duffner PK, et al. Prognostic fractors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg 1998 : 28 ; 215-22.
 
29) 松谷雅生ほか. 胚細胞腫瘍. 太田富雄, 松谷雅生編. 脳神経外科. 改訂8版. 東京 : 金芳堂 ; 2000. p. 676-93.
 
30) Matsutani M, et al. Primary intracranial germ cell tumors : A clinical analysis of 153 histologically verified cases. J Neurosurg 1997 : 86 : 446-55.
 
31) Stahnke N, et al. Long-term follow-up of children with craniopharyngioma. Eur J Pediatr 1984 : 142 ; 179-85.
PubMed
32) Thapar K, et al. Estrogen receptor gene expression in craniopharyngiomas : An in situ hybridization study. Neurosurgery 1994 : 35 : 1012-7.
 
33) Honegger J, et al. Progesterone receptor gene expression in craniopharyngiomas and evidence for biological activity. Neurosurgery 1997 : 41 : 1359-64.
PubMed
34) Lunsford LD, et al. Stereotactic options in the management of craniophawngioma. Pediatr Neurosurg 1994 : 21 : 90-7.
PubMed
35) Abe T, Ludecke DK. Transnasal surgery for iniadiaphragmatic craniophalyngiomas in children. Neurosurgery 1999 ; 44 : 957-66.
PubMed
36) Dyer EH, et al. Transsphenoidal surgery for pituitary adenomas in children. Neurosurgery 1994 : 34 : 207-12.
PubMed
37) Partington MD, et al. Pituitary adenomas in childhood and adolescence : Results of transsphenoidal surgery. J Neurosurg 1994 ; 80 : 209-16.
PubMed
38) Mindermann T, Wilson CB. Pediatric pituitary adenomas. Neurosurgery 1995 : 36 : 259-69.
PubMed
39) Knappe UJ, Ludecke DK. Transnasal microsurgery in children and adolescents with Cushing's disease. Neurosurgery 1996 : 39 : 484-93.
PubMed
40) Abe T, Lidecke DK. Transnasal surgery for prolactin-secreting pituitary adenomas in childhood and adolescence. Surg Neurol 2002 ; 57 : 369-79.
 
41) Abe T, et al. Growth hormone-secreting pituitary adenomas in childhood and adolescence : Features and results of transnasal surgery. Neurosurgery 1999 : 45 : 1-10.
PubMed
42) Abe T, et al. Clinically nonsecreting pituitary adenomas in childhood and adolescence. Neurosurgery 1998 : 42 : 744-51.
PubMed
P.119 掲載の参考文献
1) Report of brain Tumor REgistry of Japan (1969-1996) 11th ed. Neurol Med Chir (Tokyo) 2003 : 43 (Suppl).
 
2) 久保長生, 高倉公朋. 老年者の脳腫瘍の頻度と特徴. 老と疾 1994 ; 7 : 13-6.
 
3) 竹島秀雄ほか. 高齢者脳腫瘍の最近の動向. Geriatric Neurosurgery 2001 ; 14 : 3-6.
 
4) Kuratsu J, et al. Trends in the incidence of primary intracranial tumors in Kumamoto, Japan. Int J Clin Oncol 2001 : 6 : 183-91.
PubMed
5) Teramoto A, et al. Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 1994 : 193 : 161-4.
PubMed
6) Kuratsu J, Ushio Y. Epidemiological study of primary intracranial tumours in elderly people. J Neurol Neurosurg Psychiatry 1997 : 63 : 116-8.
 
7) Greig NH, et al. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990 ; 82 : 1621-4.
PubMed
8) Radhakrishnan K, et al. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 1995 : 37 : 67-73.
PubMed
9) Lovaste MG, et al. Epidemiology of primary neoplasms : Experiment in the province of Trento (Italy), 1977-1984. Neuroepidemiology 1986 : 5 : 220-32.
PubMed
10) Tomita T, Raimondi AJ. Brain tumors in the elderly. JAMA 1981 : 246 : 53-5.
PubMed
11) Davis DL, et al. Is brain cancer mortality increasing in industrial countries? Am J Ind Med 1991 : 19 : 421-31.
 
12) Boyle P, et al. Is the increased incidence of primary malignant brain tumors in the elderly real? J Natl Cancer Inst 1990 ; 82 : 1594-6.
 
13) Davis DL, et al. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 1990 : 336 : 474-81.
PubMed
14) 亀山茂樹, 田中隆―. 老年者に多い脳腫瘍の症状と診断-Meningioma (髄膜腫). 老と疾 1994 ; 7 : 22-7.
 
15) 間中信也. 老年者の脳腫瘍と痙攣. 老と疾 1993 ; 6 : 45-9.
 
16) 松本正博, 中澤省三. 老年者に多い脳腫瘍の症状と診断-Metastaic brain tumor (転移性脳腫瘍). 老と疾 1994 ; 7 : 58-64.
 
17) 竹下岩男, 福井仁士. 老年者に多い脳腫瘍の症状と診断-Glioblastoma multiforme (多形膠芽腫). 老と疾 1994 ; 7 : 36-41.
 
18) 岩佐網三ほか. 高齢者髄膜腫の治療方針と予後について. 久保田紀彦編. 髄膜腫の外科. 大阪 : メディカ出版 ; 1997. p. 210-5.
 
19) 泉山仁ほか. 高齢者髄膜腫の手術成績. Geriatric Neurosurgery 1998 ; 11 : 89-96.
 
20) Kuratsu J, et al. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 2000 ; 92 : 766-70.
PubMed
21) Niiro M, et al. Natural history of elderly patients with asymptomtic meningiomas. J Neurol Neurosurg Psychiatry 2000 ; 68 : 25-8.
 
22) 中邨裕之ほか. 高齢者転移性脳腫瘍に対するガンマナイフの治療成績. Geriatric Neurosurgery 2000 ; 13 : 67-70.
 
23) Basso U, et al. Recommendations for the management of malignant gliomas in the elderly. Expert Rev Anticancer 2003 ; 3 : 643-54.
PubMed
24) Nelson DF, et al. Combined modality approach to treatment of malignant gliomas-reevaluation of RTOG 7401/ECOG 1374 with long-term follow-up : A joint study of the Radiation Therapy Oncology Group and the Eastern Cooperaive Oncology Group. NCI Monogr ; 1988 : 279-84.
 
25) Chinot OL, et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 2004 : 100 : 2208-14.
 
26) Grau JJ, et al. Radiotherapy of the brain in elderly patients. Eur J Cancer 2000 ; 36 : 443-52.
PubMed
27) 泉本修一ほか. 高齢者悪性リンパ腫の予後不良因子についての検討. Geriatric Neurosurgery 2001 ; 14 : 51-55.
 
28) Dong Y, et al. Stereotactic radiosurgery in the treatment of primary central nervous system lymphoma. Chin Med J (Engl) 2003 : 116 ; 1166-70.
PubMed
29) 寺本明, 高倉公朋. 高齢者の下垂体腺腫. 老と疾 1991 ; 4 : 84-7.
 
30) 魚住徹ほか. 老年者に多い脳腫瘍の症状と診断-Pituitary adenoma (下垂体腺腫). 老と疾 1994 ; 7 : 49-57.
 
31) Turner HE, et al. Rituitary tumours in the elderly : A 20 year experience. Eur J Endocrinol 1999 ; 140 : 383-9.
PubMed
32) Puchner MJA, et al. Pituitary surgery in eldeny patients with acromegaly. Neurosurgery 1995 : 36 : 677-84.
 
33) 阿部琢巳ほか. 高齢者ACTH産生腺腫 (クッシング病) における経鼻的腫瘍摘出術. Geriatric Neurosurgery 1998 : 11 : 131-4.
 
34) Kurosaki M, et al. Surgical treatment of clinically nonsecreting pituitary adenomas in elderly patients. Neurosurgery 2000 ; 47 : 843-9.
PubMed
35) Fraioli B, et al. The surgical treatment of pituitary adenomas in the eighth decade. Surg Neurol 1999 : 51 ; 261-7.
PubMed
36) Van der Lely AJ, et al. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients : Influence of age and sex. Clin Endocrinol (Oxf) 1992 : 37 ; 181-5.
PubMed
37) Minniti G, et al. Surgical treatment and clinical outcome of GH-secreing adenomas in elderly patients. Acta Neurochir 2001 : 143 : 1205-11.
 
38) 阿部琢巳. 経鼻的下垂体腫瘍摘出術-術式および工夫. 脳神外科 2003 : 31 ; 955-74.
 
39) 松谷雅生. 老年者の脳腫瘍の治療-放射線療法. 老と疾 1994 ; 7 : 71-6.
 
40) Alexander E III, et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995 ; 87 : 34-40.
 
P.126 掲載の参考文献
1) Kopelson G, et al. Management of intramedullary spinal cord tumors. Radiology 1980 : 135 : 473-9.
PubMed
2) Kurland LT. The frequency of intracranial and intraspinal neoplasms in the resident population of Rochester, Minnesota. J Neurosurg 1958 : 15 : 627-41.
PubMed
3) Preston-Martin S. Descriptive epidemiology of primary tumors of the spinal cold and spinal meninges in Los Angeles County, 1972-1985. Neuroepidemiology 1990 : 9 ; 106-11.
 
4) Cheng MK. Spinal cord tumors in the People's Republic of China : A statistical review. Neurosurgery 1982 : 10 : 22-4.
PubMed
5) Greenberg MS. 脊椎・脊髄腫瘍. 黒岩敏彦監訳. グリーンバーグ脳神経外科ハンドブック. 原著5版. 京都 : 金芳堂 ; 2002. p653-72.
 
6) 戸山芳昭. 髄内腫瘍の治療成績. Spine Frontier 1995 : 2 : 25-37.
 
7) Stein MB. Spinal tumor. In : Rowland LP, editor. Merritt's Textbook of Neurology. 7th ed. Philadelphia : Lea & Febiger ; 1984. p. 264-5.
 
8) Stein MB, McCormick PC. Spinal cord tumors in adults. In : Youmans JR, editor Neurological Surgery 4th ed Philadelphia : WB Saunders ; 1996. p. 3102-22.
 
9) Constantini S, Epstein FJ. Intraspinal tumors in infants and children. In : Youmans JR, editor Neurological Surgery. 4th ed. Philadelphia : WB Saunders : 1996. p. 3123-33.
 
10) 花北順哉. 硬膜内髄外腫瘍の外科 (2). 日獨医報 1999 ; 44 : 514-28.
 
11) Solero CL, et al. Spinal meningiomas : Review of 174 operated cases. Neurosurgery 1989 : 25 : 153-60.
PubMed
12) Klekamp J, Samii M. Surgical results for spinal meningiomas. Surg Neurol 1999 : 52 : 552-62.
PubMed
13) Cheang CM, et al. An analysis of intraspinal tumors in south Taiwan. Kaohsiung J Med Sci 1997 : 13 : 229-36.
PubMed
14) Darwish BS, et al. Intramedullary ancient schwannoma of the cervical spinal cord ; Case report and review of literature. J Clin Neurosci 2002 : 9 : 321-3.
PubMed
15) Seppala MT, Haltia MJ. Spinal malignant nerve-sheath tumor or cellular schwannoma? : A striking difference in prognosis. J Neurosurg 1993 ; 79 : 528-32.
 
16) Cohen AR, et al. Malignant astrocytomas of the spinal cord. J Neurosurg 1989 ; 70 : 50-4.
PubMed
17) Abdel-Wahab M, et al. Prognostic factors and survival in patients with spinal cord gliomas after radiation therapy. Am J Clin Oncol 1999 : 22 : 344-51.
PubMed
18) Samii M, Klekamp J. Surgica results of 100 intramedullary tumors in relation to accompanying syringomyelia. Neurosurgery 1994 : 35 : 865-73.
 
19) 長谷川光広ほか. 脊髄腫瘍の疫学. 脊椎脊髄 2003 ; 16 : 640-5.
 
20) 花北順哉. 脊椎・脊髄腫瘍. 太田富雄, 松谷雅生編. 脳神経外科. 改訂8版. 京都 : 金芳堂 ; 2001. p1487-514.
 
21) 岩崎喜信. 脊髄腫瘍. 阿部弘ほか編. 脳神経外科疾患の手術と適応 I. 第2版. 東京 : 朝倉書店 ; 2003. p537-51.
 
22) 山本隆充, 片山容―. 脊椎・脊髄手術. 片山容一, 山本隆充編. 脳神経外科手術のための神経モニタリングアトラス. 東京 : 医学書院 : 2003. p. 99-106.
 
23) 白土博樹, 橋本井子. 脊椎脊髄腫瘍に対する放射線治療の最前線. 脊椎脊髄 1999 ; 12 : 507-13.
 
24) Katagiri H, et al. Clinical results of nonsurgical treatment for spinal metastases. Int J Radiat Oncol Biol Phys 1998 : 42 : 1127-32.
PubMed
25) Kopelson G. Radiation tolerance of the spinal cord previously-damaged by tumor and operation : Long term neurological improvement and time-dose-volume relationships after irradiation of intraspinal gliomas. Int J Radiat Oncol Biol Phys 1982 ; 8 : 925-9.
PubMed
26) Ryu S, et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer 2003 ; 15 : 2013-8.
 
27) Chamberlain MC. Salvage chemotherapy for recurrent spinal cord ependymoma. Cancer 2002 : 95 : 997-1002.
PubMed
P.136 掲載の参考文献
1) 佐藤一史. 頭蓋骨腫瘍. 佐藤一史編. 脳腫瘍の病理と臨床. 東京 : 診断と治療社 ; 2002. p275-9.
 
2) 河本圭司ほか. 頭蓋骨腫瘍分類・軟骨腫・良性軟骨芽細胞腫・軟骨肉腫. 脳神外科 2004 ; 32 : 427-35.
 
3) 日本整形外科学会 骨・軟部腫瘍委員会編. 整形外科・病理 悪性骨腫瘍取扱い規約. 第3版. 東京 : 金原出版 ; 2000.
 
4) Fletcher CDM, et al, editors. WHO Classification of Bone Tumours. In : Kleihues P, Sobin LH, series editors. Pathology & Genetics. Tumours of Soft Tissue and Bone. World Health Organization Classification of Tumours. Lyon : IARC Press : 2002. p. 225-368.
 
5) Unni KK, Dahlin DC. Dahlin's Bone Tumors : General Aspects and Data on 11,087 cases 5th ed. Philadelphia : Lippincott-Raven ; 1996.
 
6) Haddad FS, et al. Cranial osteomas : Their classification and management. Report on a giant osteoma and review of the literature. Surg Neurol 1997 : 48 : 143-7.
PubMed
7) Noterman J, et al. Monstrous skull osteomas in a probable Gardner's syndrome : Case report. Surg Neurol 1998 : 49 : 302-5.
 
8) Hardwidge C, Varma TRK. Intracranial aerocele as a complication of frontal sinus osteoma. Surg Neurol 1985 ; 24 : 401-4.
 
9) Iffenecker C, et al. 0steoid osteoma of the petrous bone. Neuroradiology 1997 : 39 : 821-3.
PubMed
10) Dutton J Intracranial solitary chondroma : Case report. J Neurosurg 1978 : 49 : 460-3.
PubMed
11) Salazar J. Choroid plexus papilloma with chondroma : Case report. Neurosurgery 1986 : 18 : 781-3.
PubMed
12) Constans JP, et al. Giant intradiploic epidermoid cysts of the skull : Report of two cases. J Neurosurg 1985 : 62 : 445-8.
 
13) Tsuruda JS, et al. Diffusion-weighted MR imaging of the brain : Value of differentiating between extraaxial cysts and epidermoid tumors. AJR Am J Roentgenol 1990 ; 155 : 1059-68.
PubMed
14) Yamamoto M, et al. Giant cell tumor of the sphenoid bone : Long-term follow-up of two cases after chemotherapy. Surg Neurol 1998 : 52 : 547-52.
 
15) 北井隆平ほか. 全身大量メソトレキセート療法とカルボプラチン動注療法が奏効した小児頭蓋骨骨肉腫の1例. 脳神外科 1995 ; 23 : 157-61.
 
16) 阿部琢巳ほか. 頭皮下腫瘤を形成した転移性頭蓋骨腫瘍. 脳神外科 1999 ; 51 : 353-9.
 
17) 前山巌. 骨転移癌の臨床像. 骨転移-病態. 診断・治療. 治療 1985 ; 2 : 7-14.
 
18) Nakagawa Y, et al. Spontaneous epidural hematoma from a hepatocellular carcinoma metastasis to the skull. Neurol Med Chir (Tokyo) 1992 ; 32 : 300-2.
 
19) 案田岳夫ほか. 巨大頭皮下腫瘤を形成した多発性骨髄腫の1例. 脳神外科 1994 ; 22 : 455-60.
 
20) 佐藤光夫ほか. 巨大な頭部腫瘤を形成した頭蓋骨原発悪性リンパ腫の1例. 脳神外科 1993 ; 21 : 1061-4.
 
21) Kuratsu J, et al. Brain and skull metastasis of hepatic or pancreatic cancer : Report of six cases. Neurol Med Chir (Tokyo) 1990 : 30 : 476-82.
PubMed
22) Isaka T, et al. Direct ethanol injection for skull metastasis from hepatocellular carcinoma : The technique and consequences of a therapeutic trial. Neurol Res 1998 : 20 : 731-41.
 
23) Thomas JE, Baker HL. Assessment of roentgenographic lucencies of the skull : A systematic approach. Neurology 1975 : 25 : 99-106.
 
24) Rawlings CE, Wilkins RH. Solitary eosinophilic granuloma of the skull. Neurosurgery 1984 ; 15 : 155-61.
PubMed
25) Mitnick JS, Pinto RS. CT in the diagnosis of cosinophilic granuloma. J Comput Assist Tomogr 1980 : 4 : 791-3.
 
26) 北原功雄ほか. 側頭筋, 硬膜に浸潤をきたした好酸球性肉芽腫の1例-MRIを中心にした診断. CI研究 1994 ; 16 : 51-5.
 
27) Abe T, et al. Optic nerve decompression for orbitofrontal fibrous dysplasia. Skull Base Surg 2002 : 12 : 145-53.
 
28) Chen YR, et al. Optic nerve decompression in fibrous dysplasis : Indications, efficacy, and safety. Plast Reconstr Surg 1997 : 99 : 22-30.
 
29) Harris WH, et al. The natural history of fibrous dysplasia. Am J Orthop 1962 : 44A : 207-33.
 
30) Hasegawa T, et al. Unilateral hyperostosis frontalis interna : Case report. J Neurosurg 1983 : 59 : 710-3.
PubMed

2章 脳腫瘍の診断

P.161 掲載の参考文献
1) 今村陽子. 臨床高次脳機能評価マニュアル. 東京 : 新興医学出版社 ; 1998.
 
2) 田崎義昭, 斎藤佳雄. ベッドサイドの神経の診かた. 第15版. 東京 : 南山堂 ; 1993.
 
3) Patten J. Neurological Differential Diagnosis. London : Harold Starke : 1978.
 
4) 太田富雄, 松谷雅生. 脳神経外科学. 改訂第8版. 京都 : 金芳堂 ; 2000.
 
5) 平山恵造. 神経症候学. 東京 : 文光堂 ; 1977.
 
6) Plum F, Posner JB. Diagnosis of Stupor and Coma. 3rd ed. Philadelphia : FA Davis : 1980.
 
7) Schneider CS, et al. Correlative Neurosurgery. vol I, II. 3rd ed. Springfield : Charles C Thomas 1982.
 
8) Haymaker W. Bing's Local Diagnosis in Neurological Diseases. 15th ed. St Louis ; CV Mosby : 1969.
 
9) Needham CW. Neurological Syndromes of the Brain. Springfield : Charles C Thomas : 1973.
 
10) 西澤茂ほか. False localizing signとして三叉神経障害を呈した第4脳室choroid plexus papillomaの1例. 脳神外科 1989 ; 17 : 273-7.
 
11) 橋本信夫. 脳神経外科臨床指針. 東京 : 中外医学社 ; 2002.
 
12) 青木茂樹. よくわかる脳MRI. 東京 : 秀潤社 ; 1998.
 
13) Osborn AG. Diagnostic Neuroradiology. St Louis ; CV Mosby ; 1994.
 
14) Atlas SW. Magnetic Resonance Imaging of the Brain and Spine. 2nd ed. Philadelphia, New York : Lippincott-Raven ; 1996.
 
15) 三木幸雄. 脳. 頭頸部のMRI. 東京 : メジカルビュー社 ; 2000.
 
16) Elster AD. High-resolution, dynamic pituitary MR imaging : Standard of care or academic pastime? AJR Am J Roentogenol 1990 ; 163 : 680-2.
PubMed
17) Nishizawa S, et al. Magnetic resonance cisternography in using the fast spin echo method for the evaluation of vestibular schwannoma. Neurol Med Chir (Tokyo) 1999 : 39 : 282-7.
PubMed
18) Yokota N, et al. Facial nerve schwannoma in the cerebellopontine cistern : Findings on high resolution CT and MR cisternography. Br J Neurosurg 1999 : 13 : 512-5.
 
19) Maeda M, et al. Hyperacute infarction : A comparison of CT and MRI, including diffusion-weighted imaging. Neuroradiology 1999 ; 41 : 175-8.
PubMed
20) Schaefer PW, et al. Diffusion-weighted MR imaging of the brain. Radiology 2000 : 217 : 331-45.
PubMed
21) 三木幸雄. 脳疾患における拡散強調画像とmagnetization tansfer画像. 日磁気共鳴医会誌 1999 ; 19 : 354-65.
 
22) Katada K. MR imaging of brain Surface structures : Surface anatomy scanning (SAS). Neuroradiology 1990 ; 32 : 439-48.
PubMed
23) Tsuchiya K, et al. Combination of surface anatomy MRI and MR venography to demonstate cerebral cortex and cortical veins on one image. J Comput Assist Tomogr 1998 : 22 : 972-5.
 
24) Ishikawa M, et al. Glucose consumption in recurrent gliomas. Neurosurgery 1993 ; 33 : 28-33.
PubMed
25) Alavi JB, et al. Positron emission tomography in patients with glioma : A predictor of prognosis. Cancer 1988 : 62 : 1074-8.
PubMed
26) DiChiro G. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors : A powerful diagnostic and prognostic tool. Invest Radiol 1986 ; 22 : 360-71.
 
27) DiChiro G, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors : PET and neuropathological studies. AJNR Am J Neuroradiol 1988 ; 8 : 1083-91.
 
28) Landolt AM, et al. Pituiatry Adenomas. New York : Churchill Livingstone ; 1996.
 
29) 影山直樹, 井村裕夫. 下垂体腺腫. 東京 : 医学書院 ; 1986.
 
30) 高倉公朋. 脳神経外科シリーズ-下垂体部・第3脳室腫瘍. 東京 : 現代医療社 ; 1989.
 
31) Wilson JD, Foster DW. Textbook of Endocrinology. 7th ed. Philadelphia : WB Saunders ; 1985.
 
32) DeGroot LJ, Jameson JL. Endocrinology 14th ed. Philadelphia : WB Saunders ; 2001.
 
33) Mazzaferri EL, Samaan N. Endocirne Tumors. Oxford : Blackwell Scientific Publications ; 1993.
 
34) Nishizawa S, et al. Surgical indicatioons for and limitations of staged transsphenoidal surgery for large pituitary tumors. Neurol Med Chir (Tokyo) 1998 ; 38 : 213-20.
 
35) Nishizawa S, et al. What can predict postoperative "endocrinological cure" in Cusing's disease? Neurosurgery 1999 ; 45 : 239-44.
 
36) 西澤茂ほか. 鞍上部胚細胞性腫瘍の長期成績からみた手術適応について. 小児の脳神 1993 ; 18 : 455-9.
 
37) Kleihues P, Cavenee WK. Pathology & Genctics : Tumours of the Nervous System. World Health Organization Classification of Tumours. Lyon : IARC Press ; 2000.
 
38) Yokota N, et al. Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 2002 ; 101 : 198-201.
PubMed
39) 平野朝雄. 神経病理を学ぶ人のために. 第2版. 東京 : 医学書院 ; 1986.
 
40) 平野朝雄. カラーアトラス神経病理. 第2版. 東京 : 医学書院 ; 1988.
 
41) 日本脳腫瘍病理学会. 脳腫瘍臨床病理カラーアトラス. 第2版. 東京 : 医学書院 ; 1999.
 
42) 高倉公朋. 脳神経外科シリーズ-悪性神経膠腫. 東京 : 現代医療社 ; 1989.
 
43) Lallier TE. Cell lineage and cell migration in the neural crest. Ann NY Acad Sci 1991 ; 615 : 158-71.
PubMed
44) 堀嘉昭. Phacomatosisの症状と症候. クリニカルニューロサイエンス 1987 ; 9 ; 1021-4.
 
45) Louis DN, von Deimling A. Hereditary tumor syndrome of the nervous system : Overview and rare syndromes. Brain Pathol 1955 ; 5 : 145-51.
 
46) National Insitute of Health Concensus Development Conference. Neurofibromatosis. Conference Statement. Arch Neurol 1988 ; 45 : 575-8.
 
47) Cichowski K, Jacks T. NF1 tumor suppressor gene function : Narrowing the GAP. Cell 2001 ; 104 : 593-604.
PubMed
48) Liebermann F, Korf BR. Emerging approaches toward the treatment of ncurofibromatoses Genet Med 1999 ; 1 ; 158-64.
PubMed
49) Hengstschlager M, et al. Tuberous sclerosis gene products in proliferation control. Mutat Res 2001 ; 488 : 233-9.
PubMed
50) Glenn GM, et al. Von Hippel-Lindau dsease ; Clinical review and molecular genetics. Probl Urol 1990 ; 4 : 312-30.
 
51) Nishizawa S, et al. Thera;peutic strategy for incidentally found pituitary tumors ("pituitary incidentalomas"). Neurosurgery 1998 ; 43 : 1344-50.
 

3章 脳腫瘍の治療

P.171 掲載の参考文献
1) Lacroix, et al. A multivariate analysis of 416 patients with glioblastoma multiforme : Prognosis, extent of resection and survival. J Neurosurg 2001 ; 95 : 190-8.
 
2) Ojemann GA, et al. Cortical language localization in left, dominant hemisphere : An electrical stimulation mapping investigation in 117 patients. J Neurosurg 1989 : 71 : 316-26.
 
3) 後藤昌三ほか. Juvenile nasopharyngeal angiofibromaに対する液体塞栓物質HEMA-MMAを用いたpre-operative embolizationの有用性. Neuro-Oncol 2001 ; 11 : 22-7.
 
4) 清木義勝ほか. 脳外科手術用立体視三次元ビデオ顕微鏡システムの開発と臨床応用. 脳神外科 2002 ; 30 : 601-6.
 
5) Muacevic A, et al. Surgery and radiothcrapy compared with gamma knife radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 1999 ; 91 : 35-43.
PubMed
6) Sperduto PW, et al. Stereotactic radio surgery with whole brain radiation therapy improves survival in patients with brain metastases : Report of radiation therapy oncology group phase III study 95-08. Int J Radiat Oncol Biol Phys 2002 ; 54 : 3.
 
7) Adler JR, et al. The Neutoron 1000 : A system for frameless stercotactic radiosurgery. Neurol Surg 1994 ; 5 : 127-33.
 
8) 大塚隆嗣. ウサギ脳におけるLinac stereotactic irradiation後の脳血流動態および病理組織学的変化. 脳神外科 1996 ; 24 : 801-7.
 
9) Fitzek MM, et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme : Results of phase II prospective trial. J Neurosurg 1999 ; 91 : 251-60.
 
10) 久保長生ほか. 神経疾患の新しい治療. 脳腫瘍の術中放射線治療. 神研の進歩 2001 ; 45 : 679-25.
 
11) Mizoe J, et al. Fast neutron therapy for malignant gliomas ; Results from MRS study Strahlenther Onkol 1993 ; 169 : 222-7.
 
12) Sweet WH. Early history of development of boron neutron capture therapy of tumors. J Neurooncol 1997 : 33 : 19-26.
 
13) Siu AS, et al. Comparison of miniature multileaf collimation with circular collimation for stercotactic treatment. Int J Radiat Oncol Biol Phys 1997 : 37 : 679-88.
 
14) Glioma Meta-analysis Trialists (GMT) Group. Chemotherapy in adult high grade glioma : A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002 ; 359 : 1011.
 
15) Cairncross JG, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1988 : 90 : 1473-9.
 
16) Abrey LE, et al. Long-term survivalin primary CNS lymphoma. J Clin Oncol 1998 : 16 : 859-63.
 
17) Hartl FU, et al. Molecular chaperons in cellular protein folding. Nature 1996 ; 381 : 571-80.
PubMed
18) 田中隆一ほか. 脳腫瘍の温熱療法-悪性グリオーマのRF組織内加温法. 加納永一監修. 集学的痛治療の研究と臨床. 東京 : 篠原出版新社 ; 2002. p. 305-13.
 
19) Freeman SM, et al. Immune system in suidde-gene thrapy. Lncet 1997 : 349 : 2-3.
 
20) Mizuno M, et al. Growth inhibilon of glioma cells transfected with the human β-interferon gene by liposome coupled with a monoclonal antibody. Cancer Res 1990 ; 50 : 7826-9.
 
21) 周郷延雄ほか. 合成三次元SPECTを用いた転移性脳腫瘍のradiosurgery後極早期の効果判定, 腫瘍代謝と周囲低血流領域の数量的検討. 脳神外科 1997 ; 20 : 515-21.
 
22) 大石仁志ほか. 聴神経腫瘍のRadiosurgery前後における201Tl SPECTによる検討. 東邦医会誌 1995 ; 42 : 263-8.
Medical*Online
23) 周郷延雄ほか. 3D 201TlCl SPECTによる神経膠芽腫のviabilityの画像化, SPECT及びCTの統合三次元画像を用いて. 日コンピュータ外会誌 1998 ; 6 : 49-52.
 
P.191 掲載の参考文献
1) Sugita K. Microneurosurgical Atlas. Berlin ; Springer-Verlag ; 1985. p. 2.
 
2) 山上岩男ほか. 小脳橋角部腫瘍摘出における聴力の術中モニタリング-ABRとCNAPの比較検討. 脳神外科 2002 ; 30 : 275-82.
 
3) Al-Mefty O. Clinoidal meningiomas. J Neurosurg 1990 ; 73 : 840-9.
PubMed
4) Shibuya M, et al. Bifrontal basal interhemispheric approach to craniopharyngioma resection with or without division of the anterior communicating artery. J Neurosurg 1996 ; 84 : 951-6.
PubMed
5) 田中隆―. 松果体部腫瘍に対するlateral-semiprone positionによるoccipital transtentorial approach. 脳神外科 1990 ; 18 : 413-22.
 
6) Spetzler RF, et al. Preservaion of olfaction in anterior craniofacial approachcs. J Neurosurg 1993 ; 79 : 48-52.
 
7) Saito K, et al. Recovery of olfactory function after an anterior craniofacial approach. Skull Base Surg 1999 ; 9 : 201-6.
PubMed
8) Hakuba A, et al. A combined orbitozygomatic infratemporal epidural and subdural approach for lesions involving the entire cavernous sinus. J Neurosurg 1989 ; 71 : 699-704.
PubMed
9) 河瀬斌. Anterior transpetrosal approach. 脳神外科 1998 ; 26 : 304-13.
 
10) Day JD, et al. Microanatomical study of the extradural middle fossa approach to the petroclival and posterior cavernous sinus region : Description of the rhomboid construct. Neurosurgery 1994 : 34 : 1009-16.
 
11) Miller CG, et al. Transpetrosal approach : Surgical anatomy and technique. Neurosurgry 1993 ; 33 : 461-9.
 
12) 永谷哲也ほか. 内視鏡下経蝶形骨洞手術. 河瀬斌編. 脳神経外科advanced pracicc 3 神経内視鏡手術. 東京 : メジカルビュー社 ; 2001. p92-105.
 
13) 大上史朗ほか. 運動領近傍神経膠腫症例に対する運動機能温存手術-術前の運動野同定と術中モニタリングの有用性. 脳神外科 1998 ; 26 : 599-606.
 
14) Haglund MM, et al. Cortical localization of temporal lobe language sites in patients with gliomas. Neurosurgery 1994 ; 34 : 567-76.
PubMed
15) Duffau H, et al. Intraoperative mapping of the subcortical language pathways using direct stimulations : An anatomo-functional study. Brain 2002 ; 125 : 199-214.
PubMed
16) Paleologos TS, et al. Clinical validation of true frameless stereotactic biopsy : Analysis of the first 125 consecutive cases. Neurosurgery 2001 ; 49 : 830-5.
PubMed
P.201 掲載の参考文献
1) 宮城邦彦. 神経内視鏡の工学機能的特徴と臨床上の特徴. 大井静夫編. 神経内視鏡の基礎知識と手術手技. 東京 : 三輪書店 ; 1996. p31-7.
 
2) 大井静夫, 佐藤潔. Neuroendoscopic surgeryのinstrumentationと適応, 手技. 大井静夫編. 神経内視鏡の基礎知識と手術手技. 東京 : 三輪書店 ; 1996. p21-30.
 
3) Pemeczky A, Fries G Endoscope-assisted brain surgery : Part 1-evolution, basic concept, and current technique. Neurosurgery 42 : 1998 : 219-25.
PubMed
4) Oka K, et al. Neuroendoscopic approach to tectal tumors : A consecutive series. J Neurosurg 1999 ; 91 : 964-70.
 
5) Oi S, et al. Efficacy of neuroendoscopic procedures in minimally invasive pletrential management of pincal region tumors : A prospective study. J Neurosurg 2000 : 93 : 245-53.
 
6) Heilman CB, et al. Endoscopic sphenoidotomy approach to the sella. Neurosurgery 1997 : 41 : 602-7.
 
7) Jho HD. Endoscopic pituitary surgery. Pituitary 1999 ; 2 : 139-54.
PubMed
8) Oysuki T, et al. Stereotactic endoscopic resection of angiographically occult vascular malformations. Acta Neurochir Suppl 1994 : 61 : 98-101.
 
9) Decq P, et al. Endoscopic management of colloid cysts. Neurosurgery 1998 ; 42 : 1288-96.
PubMed
10) Rodziewicz GS, et al. Endoscopic colloid cyst surgery. Neurosurgery 2000 : 46 : 655-62.
PubMed
11) Taneda M, et al. Endoscopic image display system mounted on the surgical microscope. Minim Invasive Neurosurg 1995 ; 38 : 57-8.
 
12) 種子田護. 頭蓋底腫瘍の内視鏡支援手術. 嘉山孝正編. Advanced technologyを用いた脳腫瘍の外科. 大阪 : メディカ出版 ; 2001. p222-7.
 
13) Reidenbach HD Technological fundamentals of endoscopic hemostasis. Acta Neurochir Suppl (Wien) 1992 ; 54 : 26-33.
PubMed
14) 蛯名国彦ほか. 脳内血腫除去術における定位的脳手術用内視鏡システムの開発と臨床応用. 脳卒中の外科 1995 ; 23 : 109-15.
Medical*Online
15) Fukuhara T, et al. Risk factors for failure of endoscopic third ventriculostomy for obstructive hydrocephalus. Neurosurgery 2000 ; 46 : 1100-11.
PubMed
16) Hopf NJ, Grunert P. Endoscopic third ventriculostomy : Outcome analysis of 100 consecutive procedures. Neurosurgery 1999 ; 44 : 795-806.
PubMed
17) Oi S, et al. Pathophysiology of long-standing overt ventriculomegaly in adults. J Neurosurg 2000 ; 92 : 933-40.
PubMed
18) Buxton N, et al. Neuroendoscopic third ventriculostomy for failed shunts. Surg Neurol 2003 ; 60 : 201-4.
PubMed
19) Nishiyama K, et al. Changes in cerebrospinal fluid hydrodynamics following endoscopic third ventriculostomy for shunt-dependent noncommunicating hydrocephalus. J Neurosurg 2003 : 98 : 1027-31.
PubMed
20) Mitchell P, Mathew B. Third ventriculostomy in normal plessure hydrocephalus. Br J Neurosurg 1999 : 13 : 382-5.
 
21) Meier U, Zeilinger FS Endoscopic ventriculostomy versus shunt operation in normal pressure hydrocephalus : Diagnosis and indication. Acta Neurochir Suppl 2000 ; 76 : 563-6.
PubMed
22) Kelly PJ. Stereotactie third ventriculostomy in patients with nontumoral adolescent/adult onset aqueductal stenosis and symptomatic hydrocephalus. J Neurosurg 1991 ; 75 : 865-73.
PubMed
23) Oi S. Clinical application and future prospect of neuroendoscopic surgery. 脳と発達 31 : 1999, 299-304.
 
24) Griffith HB, Veerapen R. A direct transnasal approach to the sphenoid sinus : Technical note. J Neurosurg 1987 : 66 : 140-2.
 
25) 永谷哲也ほか. 内視鏡下経鼻的経蝶形骨洞手術. 三宅悦夫編. 最新脳神経外科手術. 京都 : 金芳堂 ; 2003. p239-50.
 
P.206 掲載の参考文献
1) Lawton MT, et al. A comparative clinical evaluation of current frameless stereotactic systems ; Acuracy, performance, and surgeon preference. Perspectives in Neurological Surgery 1998 : 9 : 47-62.
 
2) Watanabe E, et al. Open surgery assisted by the neuronavigator, a stereotactic articulaled, sensitive arm. Neurosurg 1991 ; 28 : 792-800.
 
3) Kato A, et al. A frameless, armless navigational system for computer assisted neurosurgery. J Neurosurgery 1991 ; 74 : 845-9.
PubMed
4) Roessler K, et al. Frameless stereotacic guided neurosurgery : Clinical experience with an infrared based pointer device navigation system. Acta Neurochir (Wien) 1997 : 139 : 551-9.
 
5) Roberts DW, et al. A frameless stereotaxic integration of computerized tomographic imaging and the operating microscope. J Neurosurg 1986 ; 65 : 545-9.
PubMed
6) 渡辺英寿ほか. ニューロナビゲーターと脳磁図による中心溝の決定. 脳と神経 1993 ; 45 : 1027-32.
 
7) Kawamata T, et al. Endoscopic augumented reality navigation system for endonasal transsphenoidal surgery to treat pituitary tumors : Technical note. Neurosurgery 2003 : 50 : 1393-7.
 
8) Wilkinson ID, et al. Motor functional MRI for pre-operaive and intraoperative neurosurgical guidance. Br J Radiol 2003 ; 76 : 98-103.
 
9) Broggi G, et al. CT-guided neurosuregery : Preliminary experience. Acta Neurochir Suppl 2003 : 85 : 101-4.
 
10) Gwinn R, et al. Use of portable CT scanner during resection of subeortical supratentorial astrocytomas of childhood. Pediatr Neurosurg 2000 ; 32 : 37-43.
PubMed
11) Ferrant M, et al. Serial resistration of intraoperative MR images of the brain. Med Image Anal 2002 ; 6 : 337-59.
 
12) Suzuki A, et al. Intraoperative localization of the central sulcus by cortical somatosensory evoked potenials in brain tumor. J Neurosurg 1992 ; 76 : 867-70.
 
13) Katayatna Y, et al. Cortico-spinal direct response in humans : Identification of the motor cortex during intracranial surgery under general anesthesia. J Neurol Neurosurg Psychiatry 1998 ; 51 : 50-9.
 
14) Holodny AI, Ollenschlager M. Diffusion imaging in brain tumors. Neuroimaging Clin N Am 2002 ; 12 : 107-24.
PubMed
15) Guye M, et al. Combined functional MRI and tractography to demonstrate the connecivity of the human primary motor cortex in vivo. Neuroimage 2003 ; 19 : 1349-60.
 
16) Krombach A, et al. Virtual endoscopy combined with intraoperative neuronavigation for planning of endoscopic surgery in patients with occlusive hydrocephalus and intracranial cysts. Neuroradiology 2002 ; 44 : 279-85.
PubMed
P.210 掲載の参考文献
1) Taylor RH, et al. Computer-integrated revision total hip replacement surgery : Concept and preliminary results. Med Image Anal 1999 ; 3 : 301-19.
PubMed
2) Mohr FW, et al. Computer-enhanced "robotic" cardiac surgery : Experience in 148 patients. J Thorac Cardiovase Surg 2001 ; 121 : 842-53.
PubMed
3) Reichenspurner H, et al. Use of the voice-controlled and computer-assisted surgical system ZEUS for endoscopic coronary artery bypass grafting. J Thorac Cardiovase Surg 1999 ; 118 : 11-6.
PubMed
4) Hongo K, et al. Microscopie-manipulator system for minimally invasive neurosurgery. In : Lemke HU, et al, editors. Computer Assisted Radiology and Surgery. Amsterdam : Excerpta Medica ; 2001. p. 265-9.
 
5) Kan K, et al. Development of HUMAN system with three micro manipulators for minimally invasive neurosurgery. In : Lemke HU, et al, editors. Computer Assisted Radiology and Surgery. Amsterdam : Excerpta Medica ; 2001. p. 144-9.
 
6) Kawai T, et al. Development of exchangable microforceps for a micromanipulator system. Adv Robotics 2001 ; 15 : 301-5.
 
7) Koyama J, et al. Endoscopic telerobotics for neurosurgery : Preliminary study for optimal distance between an object lens and a target. Neurol Res 2002 ; 24 : 373-6.
 
8) Hongo K, et al. NeuRobot : Telecontrolled micromanipulator system for minimally invasive microneurosurgery. Neurosurgery 2002 ; 51 : 985-8.
PubMed
9) Goto T, et al. Feasibility of using the potassium titanyl phosphate laser with micromanipulators in robotics neurosurgery : A preliminary study in the rat. J Neurosurg 2003 ; 98 : 131-5.
 
10) 後藤哲哉ほか. NeuRobot (Microscopic-Micromanipulator System) のエチレンオキサイドガスによる滅菌について-臨床使用に向けて. 信州医誌 2002 ; 50 : 347-52.
 
11) Goto T, et al. Clinical application of robotic telemanipulation system in neurosurgery : Case report. J Neurosurg 2003 : 99 : 1082-4.
PubMed
P.223 掲載の参考文献
1) Tome WA, Fowler JF. On cold spotsin tumor subvolumes. Med Phys 2002 ; 29 : 1590-8.
PubMed
2) Berg NO, Lindgren M. Relation between field size and tolerance of rabbit's brain to Roentgen irradiation (200 kV) via a slit-shaped field. Acta Radiol 1963 : 1 : 147-68.
 
3) Shirato H, et al. Lack of latc skin necrosis in man after high-dose irradiation using small field sizes : Experiences of grid therapy. Br J Radiol 1990 ; 63 : 871-4.
 
4) Wambersie A, Landberg T. ICRU Report 62 : Prescribing, Recording, and Reporting Photon Bearn Therapy (Supplement to ICRU Report 50). International Commission on Radiation Units and Measurements : ICRU Report 62, 1999 http://www.icru.org/n_992_4.htm
 
5) Huang E, et al. Intensity-modulated radiation therapy for pediatric medulloblastoma : Early report on the reduction of ototoxicity. Int J Radiat Oncol BioI Phys 2002 ; 52 (3) : 599-605.
 
6) Carrie C, et al. Impact of targeting deviations on outcome in medulloblastoma : Study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 1999 ; 45 (2) : 435-9.
PubMed
7) Aoyama H, et al. Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial gerrn cell tumors. J Clin Oncol 2002 : 20 (3) ; 857-65.
PubMed
8) Nishihori T, et al. Three-dimensional conformal radiotherapy for astrocytic tumors involving the eloquent area in children and young adults. J Neurooncol 2002 ; 60 (2) : 177-83.
 
9) Pirzkall A, et al. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas : Preliminary clinical experience. Int J Radiat Oncol Biol Phys 2003 : 55 (2) : 362-72.
PubMed
10) Nakamura JL, et al. Comparison of intensity-modulated radiosurgery with gamma knife radiosurgery for challenging skull base lesions. Int J Radiat Oncol Biol Phys 2003 ; 55 (1) : 99-109.
PubMed
11) Andrews DW, et al. Whole brain radiation therapy with or without stercotactic radiosurgery boost for patients with one to three brain metastases ; Phase III results of the RTOG 9508 randomised trial. Lancet 2004 ; 363 (9422) : 1665-72.
 
12) Leksell DG. Stereotactic radiosurgery : Curent status and future trends Slereotact. Funct Neurosurg 1993, 61 (Suppl 1) : 1-5.
 
13) Adler JR Jr, et al. The Cyberknife : A fameless robotic system for radiosurgery. Stereotact Funct Neurosurg 1997 : 69 (1-4 Pt 2) : 124-8.
 
14) Astor MB, et al. Preclinical studies with the photon radiosurgery system (PRS). Int J Radiat Oncol Biol Phys 2000 : 47 (3) : 809-13.
PubMed
15) Selker RG, et al. The Brain Tumor Cooperative Group NIH Trial 87-01 : A randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine. Neurosurgery 2002 : 51 (2) : 343-55.
PubMed
16) Iwadate Y, et al. High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant or wild-type p53. Int J Radiat Oncol Biol Phys 2001 ; 50 (3) : 803-8.
PubMed
17) Ono K, et al. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCV II tumors in mice. Int J Radiat Oncol Biol Phys 1999 : 43 (2) : 431-6.
 
P.233 掲載の参考文献
1) Walker MD, et al. Evaluation of BCNU and/or radotterapy in the treatment of anaplastic gliomas : A cooperaive clinical trial. J Neurosurg 1978 ; 49 : 333-43.
 
2) 星野孝夫. 悪性脳腫瘍の化学療法-そのpharmakokinetics. 脳神外科 1980 ; 8 : 1007-16.
 
3) Shapiro WR. Chemotherapy of malignant gliomas Studies of the BTCG. Rev Neurol 1992 : 148 : 428-34.
PubMed
4) Nelson DF, et al. Hyperfractionated radiation therapy and bis-chloroethyl nitrosourea in the treatment of malignant glioma-possible advantage observed at 72.0 Gy in 1.2 Gy B. I. D. fractions : Report of the radiaion therapy oncology group protocol 8302. Int J Radiat Oncol Biol Phys 1993 ; 25 : 193-207.
 
5) Levin VA, et al. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarvazine, lomusine, and vincristine for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys 1996 ; 32 : 75-83.
 
6) Yoshida J, et al. Long term follow-up results of 175 patients with malignant glioma : Importance of radical tumor resection and post operative adjuvant therapy with interferon, ACNU and radiation. Act Neurochir (Wien) 1994 ; 127 : 55-9.
 
7) Takakura K, et al. Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 1986 ; 64 : 53-7.
PubMed
8) Glioma Meta-analysis Trialists (GMT) Group. Chemotherapy for high-grade glioma. The Chokurane Library. Oxford : Update Software ; 2003.
 
9) Huncharek M, et al. Multi-drug versus single agent chemotherapy for high grade astrocytoma : Results of a meta-analysis. Anticancer Res 1998 : 18 : 4693-8.
PubMed
10) Cairneross JG, Macdonald DR. Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988 ; 23 : 360-4.
 
11) Cairneross JG, et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994 ; 12 : 2013-21.
 
12) Kim L, et al. Procabazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas. J Neurosurg 1996 ; 85 : 602-7.
 
13) Mason WP, et al. Low-grade oligodendroglioma responds to chemotherapy. Neurology 1996 ; 46 : 203-7.
PubMed
14) Lachance DH, et al. Cyclophosphamide, doxorubicin, vincristine and predonisone for primary central nervous system lymphoma : Short-duraion response and multiforcal intracerebral recurrence preceding radiotherapy. Neurology 1994 : 44 : 1721-7.
 
15) Schultz C, et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas : Initial report of Radiaion Oncology Group Protocol 88-06. J Clin Oncol 1996 : 14 : 556-64.
 
16) Weller M. Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol 1999 ; 43 : 237-9.
PubMed
17) DeAngelis LM, et al. Primary CNS lymphoma : Combined treatment with chemotherapy and radiotherapy. Neurology 1990 : 40 : 80-6.
PubMed
18) Pirotte B, et al. Glucocorticoid-induced long-term remission in primary cerebral lymphoma : Case report and review of literature. J Neurooncol 1997 : 32 : 63-9.
PubMed
19) DeAngelis LM. Current management of primary central nervous system lymphoma. Oncology 1995 ; 9 : 63-71.
PubMed
20) Nelson DF. Radiotherapy in the treatment of primaly central nervous system lymphoma (PCNSL). J Neurooncol 1999 : 43 : 241-7.
 
21) DeAngelis LM, et al. Combined modality therapy for primary CNS lymphpma. J Clin Oncol 1992 ; 10 : 635-43.
 
22) 中枢神経原発悪性リンパ腫研究会 (有田憲生ほか, 事務局 : 兵庫医科大学脳神経外科) 資料.
 
23) 有田憲生. 中枢神経系原発悪性リンパ腫の治療. 脳外誌 2004 ; 13 : 433-40.
 
24) Hiraga s, et al. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cereblospinal fluid and intensified tumor response in primary central nervous system lymphomas. J Neurosurg 1999 ; 91 ; 221-30.
 
25) Abrey LE, et al. Long-term survial in primary CNS lymphoma. J Clin Oncol 1998 ; 16 : 859-63.
 
26) Abrey LE, et al. Treatment for primary CNS lymphoma : The next step. J Clin Oncol 2000 ; 18 : 3144-50.
PubMed
27) Matsutani M, et al. Primary intracranial germ cell tumors : A clinical analysis of 153 histologically verified cases. J Neurosurg 1997 : 86 : 446-55.
 
28) Matsutani M, et al. Combined chemotherapy and radiation therapy for CNS germ cell tumors : The Japanese experience. J Neurooncol 2001 : 54 : 311-6.
PubMed
29) 松谷雅生. 厚生労働省「脳高次機能保全をはかった小児悪性脳腫瘍治療法の確立 : 12-15」班会議資料・報告.
 
30) Nagane M, et al. Expression of O6-methylguanine-DNA methyltransferase and chloroethyl-nitlosourea resistance of human brain tumors. Jpn J Clin Oncol 1993 : 22 : 143-9.
 
31) Hotta T, et al. Interrelationship between O6-alkylguanine-DNA alkyltranstransferase activity and susceptibility to chloroethylnitrosoureas in several glioma cell lines. J Neurooncol 1993 ; 17 : 1-7.
PubMed
32) Bobola MS, et al. Contribution of O6 methylguaninc-DNA methytransferase to resistance to 1-3- (2-chloroethyl) -1-nitrosourea in human brain tumor-derived cell lines. Mol Carcinog 1995 : 13 : 81-8.
 
33) Gomi A, et al. Elevated expression of DNA polymerase β gene in glioma cell lines with acquired resistance to 1- (4-amino-2-methyl-5-pyrimidinyl) methyl-3- (2-chlorocthyl) -3-nitrosourea. Biochem Biophys Res Commun 1996 : 227 : 558-63.
 
34) Esteller M, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000 ; 343 : 1350-4.
PubMed
35) Chen CJ, et al. Internal duplication and homology with bacterial transport proteins in the mdr-1 (P-glycoprotein) gene from multidrug-resistance human cells. Cell 1986 ; 47 : 381-9.
 
36) Toth K, et al. MDRI P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Am J Pathol 1996 ; 149 : 853-8.
 
37) Tsuruo T, et al. Overcoming of vineristine resistance in P388 liukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981 ; 41 : 1967-72.
 
38) Koike K, et al. 0verexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins. Jpn J Cancer Res 1996 ; 87 : 765-72.
PubMed
39) Abe T, et al. Chemosensitisation of spontaneous multidrug resistance by a 1, 4-dihydropyridine analogue and verapamil : In human glioma cell lines overexpressing MRP or MDRI. Br J Cancer 1995 ; 72 : 418-23.
PubMed
40) Hiesiger EM, et al. Results of randomized trial compaling intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults : Brain Tumor Cooperative Group trial 8420A. J Neurooncol 1995 ; 25 : 143-54.
PubMed
41) Ushio Y, et al. Ventriculolumber perfusion of 3- [(4-amino-2-methyl-5-pyriminidyl) -methyl] -1- (2-chloroethyl-1-nitrosourea hydrochloride for subarachnoid dissemination of gliomas. J Neurooncol 1998 : 38 : 207-12.
 
42) Neuwelt EA, et al. Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-barrier modificaion in glioblastoma. Neurosurgery 1986 ; 19 ; 573-82.
 
43) Gabbai AA, et al. High-dose methotrexate for non-AIDS primary central nervous system lymphoma. J Neurosurg 1989 : 70 : 190-4.
PubMed
44) Baranzelli MC, et al. An attempt to treat pediatric intracranial α FP and β HCG secreting germ cell tumors with chemotherapy alonc : SFOP experience with 18 cases. J Neurooncol 1998 : 37 : 229-39.
 
45) Ladenstein R, et al. The European experience with megadose therapy and autologous bone, marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ celltumors and brain tumors. Wien Med Wochenschr 1995 ; 145 : 55-7.
 
46) Finiay JL, et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. J Clin Oncol 1996 ; 14 : 2495-503.
 
47) Fernandez H-Hidalgo OA, et al. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas : Beneflt for selected. Patients. Bone Marrow Transplant 1996 ; 18 : 143-9.
 
48) Bouffet E, et al. High-dose carmustine for high-grade gliomas in childhood. Cancer Chemother Pharmacol 1997 ; 39 : 376-9.
PubMed
49) Danson SJ, Middleton MR. Temozolomide : A novel oral alkylating agent. Expert Rev Anticancer Ther 2001 : 1 (1) : 13-9.
PubMed
50) Stupp R, et al. Current and future developments in the use of temozolomide for treatment of brain tumours. Lancet Oncol 2001 : 2 : 552-60.
PubMed
51) Gilbert MR, et al. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiaion therapy. Neuro-oncol 2002 ; 4 : 261-7.
 
52) Gaya A, et al. The use of temozolomide in recurent malignant gliomas. Cancer Treat Rev 2002 ; 28 : 115-20.
 
P.238 掲載の参考文献
1) 澤村豊. サイトカインネットワーク. Clin Neurosci 2001 ; 19 : 27-9.
 
2) 今西二郎. サイトカインと疾患-はじめに. 今西二郎編. 別冊・医学のあゆみ. サイトカインと疾患. 東京 : 医歯薬出版 ; Jul. 2000. p. 12.
 
3) 小川道雄. 侵襲とサイトカイン. サイトカインによる情報伝達と臨床. 東京 : メジカルセンス ; 1997. p.8-13.
 
4) 松谷雅生. 脳腫瘍のBRM療法. 後藤文男ほか編. Annual Review神経 1995. 東京 : 中外医学社 ; 1995. p170-5.
 
5) 永井政勝. 悪性脳腫瘍に対するHuman Fibroblast Interferonの臨床的検討. 日癌治療会誌 1983 ; 18 : 60-8.
 
6) Takakura K, et al. Effects of ACNU and rdiotherapy on malignant glioma. J Neurosurg 1986 ; 64 : 53-7.
 
7) 永井政勝. 悪性脳腫瘍に対するBRM療法の進歩. 癌と化療 1991 ; 18 : 1880-94.
 
8) Yoshida Y, et al. Long-term follow-up results of 175 patients with malignant glioma ; Importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation. Acta Neurochir (Wien) 1994 ; 127 : 55-9.
 
9) Yung WKA, et al. A pilot study of recombinant interferon beta (IFN-β ser) in patients with recurrent glioma. J Neurooncol 1990 ; 9 : 29-34.
 
10) Duff TA, et al. Phase II trial of interferon-β for treatment of recurrent glioblastoma multiforme. J Neurosurg 1986 ; 64 : 408-13.
 
11) Yung WKA, et al. Intravenous recombinant interferon beta in patients with recurrent malignant gliomas : A phase I/II study. J Clin Oncol 1991 ; 9 : 1945-9.
 
12) Yung WKA, et al. Conventional radiation followed by recombinant interferon-beta for newly diagnosed glioblastoma. A RTOG (Radiation Therapy Oncology Group) phase II study (RTOG 97-10). Int J Radiat Oncol Biol Phys 2001 ; 3 (Suppl) : 206.
 
P.244 掲載の参考文献
1) 田中隆一. 脳腫瘍の温熱療法-最近の進歩. Annual Review神経. 東京 : 中外医学社 ; 2003. p. 163-8.
 
2) 田中隆一ほか. 脳腫瘍の温熱療法-悪性グリオーマのRF組織内加温法. 加納永一監修. 集学的癌治療の研究と臨床. 東京 : 篠原出版新社 ; 2002. p. 305-13.
 
3) Takahashi H, et al. Clinical results of hyperthermia for brain tumors. In : Tanaka R, editor. Advances in Hyperthemic Oncology 2000. Niigata : Koko-do ; 2001. p. 132-6.
 
4) 高橋英明, 日中隆一. 7-2-2. RF組織内加温法. 高倉公朋監修. 先端医療シリーズ 18 脳神経外科-脳腫瘍の最新医療. 東京 : 先端医療技術研究所 ; 2003. p232-8.
 
5) Uzuka T, et al. Planning of hyperthermic treatment for malignant glioma using computer simulation. Int J Hyperthermia 2001 ; 17 : 114-22.
PubMed
6) Sneed PK, et al. Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery 1995 : 36 : 898-903 ; discussion 903-4.
 
7) Sneed PK, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998 ; 40 (2) : 287-95.
 
8) Kobayashi T, et al. Intersitial hyperthermia of malignant brain tumors by implant heating system ; Clinical experience. J Neurooncol 1991 ; 10 : 153-63.
 
9) Stea B, et al. Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas : A comparative survival analysis. Int J Radiat Oncol Biol Phys 1994 ; 30 (3) : 591-600.
PubMed
10) Sugiyama K, et al. Stereotactic interstitial laser-hyperthermia using Nd-YAG laser. Stereotact Funct Neurosurg 1990 ; 54-55 : 501-5.
 
11) Menovsky T, et al. Intersitial laser thermotherapy in neurosurgery : A review. Acta Neurochir 1996 ; 138 : 1019-26.
 
12) Kakinuma K, et al. Targeing chemotherapy for malignant brain tumor using thermosensitive liposome and localized hyperthermia. J Neurosurg 1996 ; 84 : 180-4.
 
13) Kakinuma K, et al. Drug delivery to the brain using thermosensitive liposome and local hyperthermia. Int J Hyperthermia 1996 ; 12 : 157-65.
 
P.251 掲載の参考文献
1) Klazo I. Neuropathological aspects of brain edema. J Neulopathol Exp Neurol 1967 ; 26 : 1-14.
PubMed
2) Samdani AF, et al. Brain edema A review of current ideas. Neurosurgery Quarterly 1999 ; 9 : 120-37.
 
3) 西川亮. 脳実質性悪性腫瘍. テント上腫瘍 (大脳). 松谷雅生ほか編. 脳神経外科周術期管理のすべて. 東京 : メジカルビュー社 ; 2000. p 110-20.
 
4) 水島裕ほか編著. 今日の治療薬. 東京 : 南江堂 ; 1999. p184-93.
 
5) 官地幸隆. グルココルチコイド製剤の体内動態と臨床応用. ホルモンと臨 1978 ; 26 : 15-22.
 
6) 岩瀬誠ほか. 悪心・嘔吐-5-HT3, 5-HT3に関連する薬-アザセトロン, グラニセトロンなど. 医薬ジャーナル 2000 ; 36 : 1407-13.
 
7) American Society of Health-Systcem Pharmacists. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric paients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm 1999 ; 56 : 729-64.
 
8) Gralla RJ, et al. Recommendaions for the use of antiemetics : Evidence-based clinical practice guidelines. J Clin Oncol 1999 ; 17 : 2971-94.
 
9) Systemic Treatment Disease Site Group, Cancer Care Ontario. Use of 5-HT3 receptor-antagonists in patients receiving moderately or highly emetogenic chemotherapy. Practice guideline #12-3. 2003 Jan [online update]. http://www.cancercare.on.ca/access_1108.htmからダウンロード可能.
 
10) Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993 ; 81 : 2844-53.
PubMed
12) Ozer H, et al. 2000 update of recommendaions for the use of hematopoietic colony-stimulating factors ; Evidence-based, clinical practice guidelines. J Clin Oncol 2000 ; 18 : 3558-85.
 
13) 日本癌治療学会臨床試験委員会. G-CSF適正使用ガイドライン. Int J Clin Oncol 2001 ; 6 (Suppl) : 1-24.
 
14) Pfund Z, et al. Headache in intracranial tumors. Cephalalgia 1999 ; 19 : 787-90.
 
15) Forsyth PA, Posner JB. Headache in patients with brain tumors : A study of 111 patients. Neurology 1993 ; 43 : 1678-83.
PubMed
16) Suwanwela N, et al. Headache in brain tumor : A cross-sectional study. Headache 1994 ; 34 : 435-8.
PubMed
11 別所正美. 抗癌剤とG-CSF製剤を同時投与してはいけない! 治療 (増刊号) 2003 : 86 : 796-8.
 
P.263 掲載の参考文献
1) Culver KW, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992 ; 256 : 1550-2.
PubMed
2) Ram Z, et al. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 1993 : 53 : 83-8.
PubMed
3) Ram Z, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 1997 : 3 : 1354-61.
PubMed
4) Sampson JH, et al. Subcutaneous vaccination with irradiated, cytokine-producing tumor celis stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. Proc Natl Acad Sci USA 1996 : 93 : 10399-404.
 
5) Wakimoto H, et al. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4. Cancer Res 1996 : 56 : 1828-33.
PubMed
6) Sobol RE, et al. Interleukin-2 gene therapy in a patient with glioblastoma. Gene Ther 1995 : 2 : 164-7.
 
7) Okada H, et al. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine. Gene Ther 1999 : 6 : 219-26.
PubMed
8) Mizuno M, et al. Growth inhibition of glioma cells tansfected with the human beta-interferon gene by liposomes coupled with a monoclonal antibody. Cancer Res 1990 : 50, 7826-9.
 
9) Yagi K, et al. Interferon-β endogenously produced by intratumoral injection of cationic liposome-encapsulated gene ; Cytocidal effect on glioma transplanted into nude mouse brain. Biochem Mol Biol Int 1994 : 32 : 167-71.
 
10) Mizuno M, Yoshida J. Effect of human interferon β gene transir upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells. Cancer Immunol Immunother 1998 : 47 : 227-32.
 
11) Natsume A. et al. Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse. Gene Ther 1999 ; 6 : 1626-33.
 
12) Yoshida J, et al. Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human β-interferon gene using cationic liposomes. Hum Gene Ther 2004 : 15 : 77-86.
 
13) Lang FF, et al. Adenovirus-mediated p53 gene therapy for human gliomas. Neurosurgery 1999 ; 45 : 1093-104.
PubMed
14) Folkman J. Tumor angiogenesis : Therapeutic implications. N Engl J Med 1971 ; 285 : 1182-6.
PubMed
15) Tanaka T, et al. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res 1998 : 58 : 3362-9.
PubMed
16) Takayama K, et al. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. Cancer Res 2000 : 60 : 2169-77.
PubMed
17) Quattrocchi KB, et al. Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant glioma. J Neurooncol 1999 : 45 : 141-57.
PubMed
18) Liau LM, et al. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J Neurosurg 1999 ; 90 : 1115-24.
PubMed
19) Aoki H, et al. Dendritic cells pulsed with tumor extract-cationic liposome complex increase the inducion of cytotoxic T lymphocytes in mouse brain tumor. Cancer Immunol Immunother 2001 : 50 : 463-8.
 
20) Alijagic S, et al. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 1995 : 25 : 3100-7.
PubMed
21) Reeves ME, et al. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res 1996 : 56 : 5672-7.
PubMed
22) Butterfield LH, et al. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adcnovirus. J Immunol 1998 : 161 : 5607-13.
PubMed
23) Nakahara N, et al. Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-β gene vector and dendritic cells. Cancer Gene Ther 2003 : 10 : 549-58.
 
24) Okamoto S, et al. Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor. Br J Cancer 1996 : 73 ; 1366-72.
PubMed
25) Takasu S, et al. Radioimmunoscinchigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor. J Neurooncol 2003 : 63 : 247-56.
PubMed
26) Ehtesham M, et al. Intratumoral dendritic cell vaccination clicits potent tumoricidal immunty against malignant glioma in rats. J Immunother 2003 : 26 : 107-16.
 
27) Kikuchi T, et al. Intratumoral injection of dendritic and irradiated glioma cells induces anti-tumor effects in a mouse brain tumor model. Cancer Immunol Immunother 2002 : 51 : 424-30.
 
28) Hunter WD, et al. Attenuated, replication-competent herpes simplex virus type 1 mutant G207 : Safety evaluation of intracerebral injection in nonhuman primates. J Virol 1999 ; 73 : 6319-26.
PubMed
29) Todo T, et al. Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-cometent herpes simplex virus. Hum Gene Ther 1999 ; 10, 2741-55.
PubMed
30) Cairncross JG, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998 : 90 : 1473-9.
PubMed
31) Schmidt MC, et al. Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 2002 : 61 : 321-8.
PubMed
32) Culver KW, Blaese RM. Grene therapy for cancer. Trends Genet 1994 : 10 : 174-8.
 

4章 脳腫瘍症例管理法

P.285 掲載の参考文献
1) Girgis A, et al. Consensus guidelines for medical practitioners. J Clin Oncol 1995 : 13 : 2449-56.
PubMed
2) 下山正徳. インフォームド・コンセント-歴史的展開と最近の動向. 臨科学 1997 ; 33 : 389-97.
 
3) Niimi M, et al. The influence of handling censored data on estimating progression-free survival in cancer clinical trials (JCOG9913-A). Jpn J Clin Oncol 2002 : 32 (1) : 19-26.
 
4) Goodman SN. Have you ever meta-analysis you didn't like? Ann Intern Med 1991 : 114 : 244-6.
PubMed
5) LeLorier J, et al. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997 ; 337 : 536-42.
PubMed
6) 上田慶二. 治験におけるGCPの現状と問題点-GCPはどのように変わるのか. 厚生省GCP説明会. 東京 : ミクス ; 1996. p. 60-78.
 
7) 厚生省医薬安全局GCP研究会監修. 改訂GCPハンドブック. 東京 : 薬業時報社 ; 1997.
 
8) 厚生省医薬安全局GCP研究会監修. 医師のための治験ハンドブック. 改訂第4版. 東京 : エルゼビア・サイエンスミクス ; 1997.
 
9) 脳腫瘍全国統計委員会編. 脳腫瘍全国集計調査報告9巻. 1996. p. 67-75.
 
10) Wakabayashi T, et al. Efficacy of adjuvant therapy with procarbazine, MCNU, and vincristine for oligodendroglial tumors. Neurol Med Chir (Tokyo) 2001 : 41 : 115-120.
PubMed
11) Reifenberger J, et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994 ; 145 : 1175-90.
PubMed
12) Rorke LB, et al. Central nervous system atypical teratoid/rhabdoid tumor of infancy and childhood. J Neurooncol 1995 ; 24 : 21-8.
PubMed
13) Salva J, et al. Mutation of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst 2000 : 92 (8) : 648-50.
 
14) Menon AG, et al. Progress toward the isolatyion and characterization of the genes causing neurofibromatosis. Brain Pathol 1990 : 1 : 33-40.
PubMed
15) Yoshida J, et al. A statistical study of central neurofibromatosis in Japan. In : Ishibashi Y, Mori Y, editors. Tuberous Sclerosis and Neurofibromatosis : Epidemiology, Pathophysiology, Biology and Management New York : Elservier Science Publishers BV ; 1990. p. 315-21.
 
16) Baser ME, et al. Predictors of vestibular schwannoma growth in patients with neurofibromatosis type 2. J Neurosurg 2002 : 96 : 217-22.
PubMed
17) Latif F, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993 : 260 : 1317-20.
PubMed
18) Shepherd CW, et al. Tuberous sclerosis complex in Olmsted country, Minnesota, 1950-1989. Arch Neurol 1991 ; 48 : 400-1.
 
19) Japan socicty for Cancer Therapy. Criteria for the evaluation of the clinical effects solid cancer chemotherapy. J Jpn Soc Cancer Ther 1993 : 28 : 101-30.
 
20) JCOG運営委員会. 固形癌の治療効果判定のための新ガイドライン (RECISTガイドライン) -日本語訳JCOG版. 東京 : Excepta Medica, Japan/Elsevier Science ; 2002.
 
21) Therasse P, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000 ; 92 : 205-16.
PubMed
22) Yoshida J, et al. Long-term follow-up results of 175 patients with malignant glioma : Importance of radical tumour resection and postoperative adjuvant therapy with interferon, ACNU and radiation. Acta Neurochir (Wien) 1994 ; 127 : 55-9.
PubMed
23) Duff JM, et al. Long-term outcomes for surgically resected craniopharyngioma. Neurosurgery 2000 : 46 : 291-302.
 
24) Kobayashi T, et al. Effects and prognostic factors in the treatment of craniopharyngioma by gamma knife. In : Kondziolka D, editor. Radiosurgery. Basel : Karger ; 1999. p.192-204.
 
25) Yoshida J, et al. Prognosis of intracranial germ cell tumours : Effectiveness of chemotherapy with cisplain and etoposide (CDDP and VP-16). Acta Neurochir (Wien) 1993 ; 120 : 111-7.
 
26) Kobayashi T, et al. Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumours : An experimental and clinical study. J Neurosurg 1989 ; 70 : 676-81.
PubMed
27) Sawamura Y, et al. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma. J Neurosurg 1998 : 88 : 66-72.
PubMed
28) Matsutani M, et al. Primary intracranial germ cell tumors : A clinical analysis of 153 histologically verified cases. J Neurosurg 1997 ; 86 : 446-55.
 
29) Sure U, et al. Staging, scoring and grading of medulloblastoma : A postoperative prognosis predicting system based on the cases of a single institute. Acta Neurochir (Wien) 1995 ; 132 : 59-65.
PubMed
30) Schmiegelow M, et al. A population-based study of thyroid functin after radiotherapy and chemotherapy for a childhood brain tumor. J Clin Endocrinol Metab 2003 ; 88 : 136-40.
 
31) David KM, et al. Medulloblastoma : Is the 5-year survival rate improving? : A review of 80 cases from a single institution. J Neurosurg 1997 ; 86 : 13-21.
PubMed
32) Evans AE, et al. The treatment of medulloblastoma. J Neurosurg 1990 ; 72 : 572-82.
PubMed
33) Ajani JA, et al. Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 1990 ; 8 : 147-59.
PubMed
34) Tobinai K, et al. Toxicity grading criteria of the Japan Clinical Oncology Group. Jpn J Clin Oncol 1993 ; 23 : 250-7.
PubMed
35) Donovan K, et al. Measuring the quality of life of cancer patients. J Clin Oncol 1989 : 7 : 959.
PubMed
36) Aaronson NK, et al. A modular approach to quality of life assessment in cancer clinical trials. Recent results. Cancer Res 1988 ; 111 : 231.
PubMed
37) Drummond MF. Economics in cancer care. Eur J Cancer 1995 : 31A : 1387.
PubMed
38) Cox F, Hirsh J. Ondansetron : A cost-effective advance in anti-emetic therapy. Dncology 1993 : 50 : 186-90.
 
39) 久繁哲徳. 医療システムの転換と経済的評価. 保険診療 1995 : 50 (2) : 21-6.
 
40) JCOG運営委員会編. NCI-CTCの日本語訳JCOG版について. 癌と化学療法 1999 : 26 (8) : 1084-144
 

5章 神経上皮由来腫瘍

P.293 掲載の参考文献
1) Burger PC, et al, editors. Surgical Pathology of the Nervous System and its Coverings. 4th ed. Philadelphia : Churchill Livingstone ; 2002. p. 160-378.
 
2) Kleihues P, Cavenee WK, editors. Pattrology and Genetics, Tumours of the Nervous System. Lyon : Intemational Agency for Research on Cancer ; 2000. p. 9-39.
 
3) Ironside JW, et al, editors. Asrocytic Tumours. London : Churchill Livingstone ; 2002. p. 53-120.
 
4) Shiraishi T, Tabuchi K. Genetic allerations of human brain tumors as molecular prognostic factors. Neuropathology 2003 ; 23 : 95-108.
PubMed
5) The Committee of Brain Tumor Registry of Japan. Report of brain tumor statistics in Japan. 10th ed. Neurol Med Chir (Tokyo) 2000 ; 40 (Suppl) : 110-6.
 
6) Watanabe K, et al. Immunohistochemical assessment of p53 protein accumulation and tumor growth fraction during the progression of astrocytomas. In : Nagai M, editor Brain Tumor Research and Therapy. Tokyo : Springer-Verlag ; 1996. p. 255-62.
 
7) Barker FG, Israel MA. Molecular genetics. In : Berger MS, Wilson CB, editors. The Glioma. Rhiladelphia WB Saunders ; 1999. p. 39-51.
 
8) Sidransky D, et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992 ; 355 : 846-7.
PubMed
9) Wen PY, Black PN. Clinical presentation, evaluation and preoperative preparation of the patient. In : Berger MS, Wilson CB, editors. The Glioma. Philadelphia : WB Saunders ; 1999. p. 328-36.
 
10) Laws ER Jr, et al. Neurosurgical management of low-grade astrocytoma of the cerebral hemisphere. J Neurosurg 1984 ; 61 : 665-73.
 
11) Soffietti R, et al. Prognostic factors in well-differentiated cerebral asrocytomas in the adults. Neurosurgery 1989 ; 2A : 686-92.
 
12) Shaw EG, et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 1989 ; 70 : 853-61.
PubMed
13) North CA, et al. Low-grade cerebral astrocytomas : Survival and quality of life after radiation therapy. Cancer 1990 ; 66 : 6-14.
PubMed
14) Philippon JH, et al. Supratentorial low-grade astrocytomas in adults. Neurosurgery 1993 ; 32 : 554-9.
PubMed
15) Kida Y, et al. Gamma knife radiosurgery for low-grade astrocytomas : Results of long-term follow up. J Neurosurg 2000 ; 93 (Suppl 3) : 42-6.
 
16) Eyre HJ, et al. A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas : A Southwest Oncology Group study. J Neurosurg 1993 ; 78 : 909-14.
 
17) Ohgaki H, Kleihues P. Molecular pathology of human gliomas. In : Tabuchi K, Shiraishi T, editors. Brain Tumor Research and Therapy in the Postsequence Era. Fukuoka : Kyushu Univ Press ; 2002. p. 13-9.
 
P.297 掲載の参考文献
1) Kleihues P, et al. Anaplastic astrocytoma. In : Kleihues P, Cavenee WK, editors. Pathology & Genetics, Tumours of the Nervous System. Lyon : Intemational Agency for Research on Cancer ; 2000. p. 27-8.
 
2) The Committee of Brain Tumor Registry of Japan. Report of brain tumor statistics in Japan. 10th ed. Neurol Med Chir (Tokyo) 2000 ; 40 (Suppl).
 
3) Shiraishi T, Tabuchi K. Genetic alterations of human brain tumors as molecular prognostic factors. Neuropathology 2003 ; 23 : 95-108.
PubMed
P.307 掲載の参考文献
1) Tabuchi K, Nishimoto A. Atlas of Brain Tumors Tokyo : Springer-Verlag : 1988. p. 59-73.
 
2) Ohgaki, et al. Gliosarcoma. In : Kleihues P, Cavenee WK, editors Pathology & Genetics, Tumours of the Nervous System Lyon : International Agency for Research on Cancer ; 2000. p. 42-4.
 
3) Kleihues P, Cavenee WK, editors. Pathology & Genetics, Tumours of the Nervous System Lyon : International Agency for Research on Cancer ; 2000.
 
4) Wilson CB. Glioblastoma : The past, tge present, and the future. Clin Neurosurg 1992 : 38 : 32-48.
 
5) 篠田淳ほか. Gross total resectionは術後の神経症状を悪化させることなくghoblastoma患者の生存期間を延長させ得るか? 嘉山孝正編. Advanced technologyを用いた脳腫瘍の外科. 大阪 : メディカ出版 ; 2001. p. 48-59.
 
6) Haynor DR, Maravilla K. The role of functional imaging in the surgical management of brain neoplasm. In : Berger MS, Wilson CB, editors. The Gliomas. Philadelphia : WB Saundcrs ; 1999. p. 337-41.
 
7) 梶本宣永ほか, 光ファイバーを用いた蛍光標識腫瘍センサーの開発. 田渕和雄, 白石哲也編. ポストシークエンス時代における脳腫瘍の研究と治療. 福岡 : 九州大学出版会 ; 2002. p311-6.
 
8) 片山容一, 山本隆充編. 脳神経外科手術のための神経モニタリングアトラス. 東京 : 医学書院 ; 2003. p23-49.
 
9) Black PM, et al. Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 1999 : 45 : 423-31.
 
10) Roux FE, Tremoulet M. Organization of language areas in bilingual patients : A conical stimulation study. J Neurosurg 2002 ; 97 : 857-64.
 
11) The Committee of Brain Tumor Registry of Japan. Report of brain tumor statistics in Japan. 10th ed. Neurol Med Chir (Tokyo) 2000 ; 40 (Suppl).
 
12) Curran WJ Jr, et al. Issues in the use of conventional and altered fractionation radiation therapy for pediatric and adult gliomas. In : Berger MS, Wilson CB, editors The Gliomas Philadelphia : WB Saunders ; 1999. p. 480-8.
 
13) Shrieve DC, et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost ; Prognostic factors and long-term outcome. J Neurosurg 1999 : 90 : 72-7.
PubMed
14) Fine HA, et al. Meta-analysis of radiation therapy with and without adluvant chemotherapy for malignant gliomas in adults. Cancer 1993 ; 71 : 2585-97.
PubMed
15) Brada M, et al. Multicenter phase II trial of temozolomide vs procarbazine in patients with glioblastoma multiforme at first relapse. Ann Oncol 2001 ; 12 : 259-66.
 
16) Ram Z, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med 1997 : 12 : 1354-61.
PubMed
17) Martuza RL, et al. Experimental study of human glioma by means of a genetically engineered virus mutant. Science 1991 ; 252 : 854-6.
 
18) 白石哲也, 田渕和雄. 癌分子標的治療薬開発の現況と脳腫瘍治療への応用. 脳神外科 2003 : 31 : 365-81.
 
19) 脳腫瘍全国統計委員会編. 脳腫瘍取扱い規約. 東京 : 金原出版 ; 2002. p. 22.
 
P.314 掲載の参考文献
1) Wimmer K, et al. Mutational and expression analysis of the NF1 gene argues agahst a role as tumor suppressor in sporadic pilocytic astrocytomas. J Neuropathol Exp Neurol 2002 ; 61 : 896-902.
PubMed
2) Gutmann DH, et al. Comparaive gene expression profile analysis of neuroibromatosis 1-associated and sporadic pilocytic astrocytomas. Cancer Res 2002 ; 62 : 2085-91.
 
3) Li J, et al. Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology 2001 ; 56 : 885-90.
PubMed
4) Hunter S, et al. Differenial expression between pilocytic and anaplastic astrocytomas. Identification apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms. J Neuropathol Exp Neurol 2002 ; 61 : 275-81.
 
5) Singhal S, et al. Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 2002 ; 87 : 65-70.
PubMed
6) Kato T, et al. Cisplatin/vincritine chemotherapy for hypothalamic/visual pathway astrocytomas in young children. J Neurooncol 1998 ; 37 : 263-70.
 
7) Hadjipanayis CG, et al. Stereotactic radiosurgery for pilocytic astrocytomas when multimodal therapy is necessary. J Neurosurg 2002 ; 97 : 56-64.
 
8) Chan MY, et al. Potential prognostic factors of relapse-free survivalin cildhood optic prathway glioma : A multivariate analysis. Pediatr Neurosurg 1998 ; 29 : 23-8.
 
9) Austin EJ, Alvor EC Jr. Recurrences of cerebellar astrocytomas : A violation of Collins law. J Neurosurg 1988 ; 68 : 41-7.
 
10) Dirks PB, et al. Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 1994 : 34 : 68-78.
PubMed
11) 杉山一彦ほか. 大脳半球juvenile pilocyic astocytomaの1例-20か月間に腫瘍が出現, 増大した症例. 脳と神 1999 ; 51 : 149-53
 
12) Pollack IF, et al. The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 1993 ; 78 : 859-63.
 
P.317 掲載の参考文献
1) Kepes JJ, et al. Pleomorphic xanthoastrocytoma : A distinctive meningocerebral glioma of young subjects with relatively favorable prognosis : A study of 12 cases. Cancer 1979 : 44 : 1839-52.
PubMed
2) Kepes JJ, et al. Pleomorphic xanthoastrocytoma. In : Kleihues P, Cavenee, WK, editors. Pathology and Genetics of Tumours of the Nervous System. Lyon : International Agency for Research on Cancer ; 1997. p. 34-6.
 
3) Kleihues P, et al. Histological Typing of Tumours of the Central Nervous system : WHO International Histological Classification of Tumours. 2nd ed. Berlin, Heiderberg, New York : Springer-Verlag ; 1993. p. 1-5.
 
4) Weldon-Linne CM, et al. Pleomorphic xanthoastrocytoma : Ultrastructural and immunohistochemical study of a case with a rapidly fatal outcome following surgery. Cancer 1983 ; 52 : 2055-63.
PubMed
5) Kaulich K, et al. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas. J Neuropathol Exp Neurol 2002 ; 61 : 1092-9.
PubMed
6) Giannini C, et al. Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma. Neurogenetics 2001 : 3 : 159-62.
PubMed
7) Ohta S, et al. Eighteen-year survival of a patient with malignant pleomorphic xanthoastrocytoma associated with von Recklinghausen neurofibromatosis. Br J Neurosurg 1999 ; 13 : 420-2.
 
8) von Deimling A, et al. Deletions on the long arm ofchromosome 17 in pilocytic astrocytoma. Acta neuropathol (Berl) 1993 ; 86 : 81-5.
 
9) Giannini C, et al. Pleomorphic xanthoastrocytoma : What do we really know about it? Cancer 1999 ; 85 : 2033-45.
PubMed
10) Fouladi M, et al. Pleomorphic xanthoastrocytoma : Favorable outcome after complete surgical resection. Neuro-oncol 2001 ; 3 : 184-92.
PubMed
11) Giannini C, et al. Immunophenotype of pleomorphic xanthoastrocytoma. Am J Surg Pathol 2002 ; 26 : 479-85.
PubMed
12) Perry A, et al. Comparative pleomorphic xanthoastrocytoma and ganglioglioma : Report of four cases and review of the literature. Am J Surg Pathol 1997 ; 21 : 763-71.
 
13) Lipper MH, et al. Pleomorphic xanthoastrocytoma, a distinctive astroglial tumor : Neuroradiologic and pathologic features. AJNR Am J Neuroradiol 1993 : 14 : 1397-404.
PubMed
14) Tsuyuguchi N, et al. Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with. AJNR Am J Neuroradiol 2001 ; 22 : 311-3.
PubMed
15) Tien RD, et al. Pleomorphic xanthoastrocytoma of the brain : MR findings in six patients. AJNR Am J Neuroradiol 1992 ; 159 : 1287-90.
 
16) Pierallini A, et al. Pleomorphic xanthoastrocytoma with CT and MRI appearance of meningioma. Neuroradiology 1999 ; 41 : 30-4.
PubMed
17) Macaulay RJB, et al. Increased mitotic activity as a negative prognostic indicator in pleomorphic xanthoastrocytoma : Case report. J Neurosurg 1993 ; 79 : 761-8.
 
18) Tonn JC, et al. Pleomorphic xantioastrocytoma : Report of six cases with special consideration of diagnostic and therapeutic pitfalls. Surg Neurol 1997 ; 50 : 385-6.
 
19) Leonard N, et al. Fatal pleomorphic xanthoastrocytoma with meningeal gliomatosis. Histopathology 1998 ; 32 : 357-78.
 
P.322 掲載の参考文献
1) Gyure KA, Prayson RA Subependymal giant cell astrocytoma : A clinicopathologic study with HMB45 and MIB-1 immunohistochcmical analysis. Mod Pathol 1997 ; 10 : 313-7.
 
2) Boesel CP, et al. Brain hamartomas and tumors associated with tuberous sclerosis. Neurosurgery 1979 : 4 : 410-7.
PubMed
3) Yamamoto K, et al. Rapid regrowth of solitary subependymal giant cell astrocytoma : Case report. Neurol Med Chir (Tokyo) 2002 : 42 : 224-7.
PubMed
4) Zuccaro G, et al. Lateral ventricle tumors in children : A series of 54 cases. Childs Nerv Syst 1999 ; 15 : 774-85.
PubMed
5) Kim SK, et al. Biological behavior and tumorigenesis of subependymal giant cell astrocytoma. J Neurooncol 2001 ; 52 : 217-25.
PubMed
6) Morimoto K, Mogami H. Sequential CT study of subependymal giant-cell astrocytoma associated with tuberous sclerosis : Case report. J Neurosurg 1985 ; 165 : 847-77 .
 
7) Crino PB, Henske EP. New developments in the neurobiology of the tuberous sclerosis complex. Neurology 1999 : 53 : 1384-90.
PubMed
8) Carbonara C, et al. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also or the TSC1 gene. Hum Mol Genet 1994 : 3 : 1829-32.
PubMed
9) Green AJ, et al. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 1994 ; 3 : 1833-4.
PubMed
10) Green AJ, et al. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 1994 ; 6 : 193-6.
PubMed
11) Henske EP, et al. Alleic loss is frequent in tuberous sclerosis kidney lesions but rare inbrain lesions. Am J Hum Genet 1996 : 59 : 400-6.
 
12) Soucek T, et al. Role of tuberous sclerosis gene-2 product in cell cycle control : Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter G phase. J Biol Chem 1997 : 272 : 29301-8.
 
13) Arai Y, et al. Loss of the TSC2 product tuberin in subependymal giant cell tumors. Acta Neuropathol (Berl) 1999 ; 98 : 233-9.
PubMed
14) Richardson EP. Pathology of tuberous sclerosis : Neuropathologic aspects. Ann N Y Acad Sci 1991 : 615 : 128-39.
PubMed
15) 田中順一ほか. 結節性硬化症に伴う上衣下巨細胞性星膠腫の免疫組織化学. 脳と発達 1989 ; 21 : 222-6.
 
16) Nishio S, et al. Tumours around the foramen of Monro ; Clinical and neuroimaging features and their differential diagnosis. J Clin Neurosci 2002 ; 9 : 137-41.
PubMed
17) DeAngelis LM, et al. Intracranial Tumors : Diagnosis and Treatment London : Malun Dunitz ; 2002. p. 167-8.
 
18) Beems T, Grotenhuis JA. Subependymal giant-cell astrocytoma in tuberous sclcrosis : Endoscopic images and the implications for therapy. Minim Invasive Neurosurg 2001 ; 44 : 58-60.
PubMed
19) Gaab M, Schroeder H. Neuroendoscopic approach to intraventricular lesions. J Neurosurg 1998 : 88 : 496-505.
PubMed
20) Apuzzo MLJ, Litofsky NSS. Surgery in and around the anterior their ventricle. In : Apuzzo MLJ, editor. Brain Surgery. vol. 1. New York : Churchill Livingstone : 1993. p. 541-79.
 
P.333 掲載の参考文献
1) Reifenberger G, et al. Oligodendroglial tumors and mixed gliomas. In : Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumors of the Nervous System. Lyon : IARC Press ; 2000. p. 55-70.
 
2) Mclendon RE, et al. Oligodendroglioma. In : Bigner DD, et al, editors. Russell & Rubinstein's Pathology of Tumours of the Nervous System. London : Edward Arnold ; 1998. p. 370-87.
 
3) Caimeross JG, Macdonald DR. Successful chemotherapy for recurent malignant oligodendroglioma. Ann Neurol 1988 ; 23 : 360-4.
 
4) Cairncross JG, Macdonald DR. Chemotherapy for oligodendroglioma : Progress report. Arch Neurol 1991 ; 48 : 225-7.
PubMed
5) Caimeross JG, et al. Aggressive oligodendroglioma : A chemosensitive tumor. Neurosurgery 1992 ; 31 : 78-82.
 
6) Caimeross JG, et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994 ; 12 : 2013-21.
 
7) Reifenberger G, et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994 : . 145 : 1175-90.
PubMed
8) Maintz O, et al. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997 ; 56 : 1098-104.
 
9) Cairncross JG, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998 ; 90 : 1473-9.
PubMed
10) Bigner DD Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am J Pathol 1999 ; 155 : 375-86.
PubMed
11) Smith JS, et al. Localization of common dclction regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 1999 ; 18 : 4144-52.
PubMed
12) Ino Y, et al. Molecular subtypcs of anaplastic oligodendroglioma : Implications for patient management at diagnosis. Clin Cancer Res 2001 ; 7 : 839-45.
PubMed
13) Ueki K, et al. Correlation of histology and molecular genetic analysis of 1p, 19q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglialtumors. Clin Cancer Res 2002 ; 8 : 196-201.
PubMed
14) CBTRUS (Cental Brain Tumor Registry of the United States). Year 2001 Annual Statisics Report Brain Tumors in the US 1992-7 Available at http://www.cbtrus.org/2001/2001stats_report.htm
 
15) Mork SJ, et al. Oligodendroglioma : Incidence and biological behavior in a defined population. J Neurosurg 1985 : 63 : 881-9.
 
16) The Committee of Brain Tumor Registry of Japan. Report of brain tumor registry of Japan (1969-1993). Neurol Med Chir (Tokyo) 2000 : 40 (Suppl).
 
17) Shaw EG, et al. Oligodendrogliomas : The Mayo Clinic experience. J Neurosurg 1992 : 76 : 428-34.
 
18) Celli P, et al. Cerebral oligodendroglioma : Plognostic factors and life history. Neurosurgery 1994 : 35 : 1018-35.
PubMed
19) Lee YY, Van Tassel P. Intracranial oligodendrogliomas : Imaging findings in 35 untreated cases. AJR Am J Roentgenol 1989 ; 152 : 1263-70.
 
20) Herpers MJ, Budka H. Glial fibrillav acidic protein (GFAP) in oligodendroglial tumors : Gliofibrillary oligodendroglioma and trasitional oligoastrocytoma as subtypcs of oligodendroglioma. Acta Neuropathol (Berl) 1984 : 64 : 265-72.
 
21) Kros JM, et al. Ultastractural chalacterization of transitional cells in oligodendrogliomas. J Neuropathol Exp Neurol 1992 ; 51 : 186-93.
PubMed
22) Lu QR, et al. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci USA 2001 : 98 : 10851-6.
PubMed
23) Smith JS, et al. Alteradons of chromosome arms 1p alnd 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000 : 18 : 636-45.
 
24) Bauman GS, et al. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 2000 : 48 : 825-30.
PubMed
25) Berger MS, et al. The effect of extent of resection on recurrence in padents with low grade cerebral hemisphere gliomas. Cancer 1994 : 74 : 1784-91.
 
26) Sawaya R, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 1998 : 42 : 1044-56.
 
27) Berger MS, et al. Brain mapping techniques to maximize resection, safety, and scizure control in children with brain tumors. Neurosurgery 1989 : 25 : 786-92.
PubMed
28) 隈部俊宏ほか. 運動領野周辺神経膠腫に対する手術-術前解剖学的及び機能マッピングの融合とニューロナビゲーションシステム及び術中マッピング併用による運動機能温存手術. 脳神外科 2001 ; 10 : 56-64.
 
29) 松本健五ほか. 深部および機能的重要領域におけるグリオーマの手術-機能的マッピング, 術中モニター, ナビゲーションの応用. 脳神外科 1997 ; 25 : 17-28.
 
30) Taylor MD, Berstein M Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors : A prospective trial of 200 cases. J Neurosurg 1999 ; 90 : 35-41.
 
31) Black PM, et al. Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 1999 : 45 : 423-33.
 
32) Sutherland GR, et al. A mobile high-field magnetic resonance system for neurosurgery. J Neurosurg 1999 : 91 : 804-13.
PubMed
33) Bohinski RJ, et al. Glioma resection in a shared-resource magnetic resonance operating room after optimal image-guided frameless stereotactic resection. Neurosurgery 2001 : 48 : 731-44.
 
34) Kuroiwa T, et al. Development of a fluorescein operative microscope for use during malignant glioma surgery : A technical note and preliminary report. Surg Neurol 1998 ; 50 : 41-9.
PubMed
35) Braun V, et al. Functional cranial neuronavigation : Direct integration of fMRI and PET data. J Neuroradiol 2000 ; 27 : 157-63.
 
36) Coenen VA, et al. Three-dimensional visualization of the pyramidal tract in a neuronavigation system during brain tumor surgery : First experiences and technical note. Neurosurgery 2001 : 49 : 86-93.
 
37) 松本健五ほか. 脳腫瘍に対するimage guided stereotactic biopsy-71例の経験. 脳神外科 1995 ; 23 : 897-903.
 
38) Ulm AJ, et al. Stercotactic biopsy aided by a computer graphics workstation : Experience with 200 consecutive cases. Neurosurgery 2001 ; 49 : 830-7.
 
39) Wallner KE, et al. Treatment of oligodendrogliomas with or without postoperative irradiation. J Neurosurg 1988 ; 68 : 684-8.
 
40) Gannett DE, et al. The role of postoperative irradiation in the treatment of oligodendroglioma. Int J Radiat Oncol Biol Phys 1994 ; 30 : 567-73.
PubMed
41) Reedy DP, et al. Role of radiation therapy in the treatment of cerebral oligodendroglioma : An analysis of 57 cases and a literature review. Neurosurgery 1983 : 13 : 499-503.
 
42) Bullard DE, et al. Oligodendroglioma : An analysis of the value of radiation therapy. Cancer 1987 : 60 : 2179-88.
PubMed
43) Sarkar A, et al. Evaluation of gamma knife radiosurgery in the treatment of oligodendrogliomas and mixed oligodendroastrocytomas. J Neurosurg 2002 : 97 (Suppl) : 653-6.
 
44) Mason WP, et al. Low-grade oligodendroglioma responds to chemotherapy. Neurology 1996 : 46 : 203-7.
PubMed
45) van den Bent M, et al. Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group Neurology 1998 : 51 : 1140-5.
PubMed
46) Dehghani F, et al. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas : A study of 89 cases Acta Neuropathol (Bell) 1998 : 95 : 493-504.
 
47) Jeuken JW, et al. Identification of subgroups of high-grade oligodendroglial tumors by comparative genontic hybridization. J Neuropathol Exp Neurol 1999 ; 58 : 606-12.
PubMed
48) Takakura K, et al. Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 1986 ; 64 : 53-7.
PubMed
49) van den Bent M, et al. Recent developments in the molecular charaeterization and treatment of oligodendroglial tumors Neuro-oncol 2003 : 5 : 128-38.
PubMed
50) Wakabayashi T, et al. Efficacy of adjuvant therapy with procarbazine, MCNU, and vincristine for oligodendroglial tumors. Neurol Med Chir (Tokyo) 2001 : 41 : 115-20.
PubMed
P.339 掲載の参考文献
1) Reifenberger G, et al. Oligodendroglial tumors and mixed gliomas. In : Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumors of the Nervous System. Lyon : IARC Press ; 2000. p. 55-70.
 
2) Hart HN, et al. Mixed gliomas. Cancer 1974 ; 33 : 134-40.
 
3) CBTRUS (Central Brain Tumor Registry of the United States) Year 2001 Annual Statistics Reporr : Brain Tumors in the US 1992-1997. Available at http://www.cbtrus.org/2001/2001stats_report.htm
 
4) The Commiuee of Brain Tumor Registry of Japan. Report of brain tumor registry of Japan (1969-1993). Neurol Med Chir (Tokyo) 2000 ; 40 (Suppl).
 
5) Shaw EG, et al. Mixed oligoastrocytomas : A survival and prognostic factor analysis. Neurosurgery 1994 ; 34 : 577-82.
PubMed
6) Kraus JA, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995 ; 54 : 91-5.
PubMed
7) Reifenberger G. et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994 : 145 : 1175-90.
PubMed
8) Maintz D, et al. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997 : 56 : 1098-104.
PubMed
9) Smith JS, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oilgodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000 ; 18 : 636-45.
PubMed
10) Jeuken JW, et al. Identification of subgroups of high grade oligodendroglial tumors by comparative genomic hybridization. J Neuropathol Exp Neurol 1999 ; 58 : 606-12.
PubMed
P.352 掲載の参考文献
1) Kleihues P, et al. Histological typing of tumours of the central nervous system In : World Health Organization International Histological Classification of Tumours 2nd ed Berlin, Heiderbcrg : Springer-Verlag ; 1993.
 
2) 脳腫瘍全国統計委員会, 日本病理学会編. 脳腫瘍取り扱い規約-臨床と病理カラーアトラス. 東京 : 金原出版 ; 1995.
 
3) Duncan JA, Hoffman HJ. Intracranial ependymomas In : Kayo AH, Lows ER Jr, editors Brain Tumors Edinburgh : Churchill Livingstone ; 1995. p.493-504.
 
4) Schiffer D. Brain Tumors : Biology, Pathology, and Clinical References 2nd ed Berlini Springer ; 1997.
 
5) Fokce EC Jr, Earle KM Ependymomas : Clinical and Pathological aspects J Neurosurg 1969 ; 30 : 585-94.
 
6) Kricheff II, et al. Intracranial ependymomas : Factors influcncing prognosis. J Neurosurg 1964 ; 21 : 7-14.
PubMed
7) Zulch KJ. Brain tumors : Their Biology and Pathology 3rd ed Berlin, Heidelberg : Springer-Verlag ; 1986.
 
8) Prayson RA. Clinicopathologic study of 61 paticnts with epcndymoma including MIB-1 immunohistochemistry Ann Diagn Pathol 1999 ; 3 : 11-8.
 
9) Kudo H, et al. Ependymoma diagnosed in the first year of life in Japan in collaboration with the International Society for Pediatric Neurosurgery. Childs Nerv Syst 1990 ; 6 : 375-8.
PubMed
10) Hendrick E, Raffel C. Tumors of the fourth ventricle : Ependymomas, choroids plexus papillomas and dermoid cysts. In : Pediatric Neurosurgery. Philadelphia : WB Saunders ; 1989. p. 366-11.
 
11) Nazar GB, et al. Infratentorial ependymomas in childhood : Prognostic factors and treatment. J Neurosurg 1990 ; 72 : 408-17.
PubMed
12) Schiffer D, et al. Histologic prognostic factors in ependymoma. Chiids Nerv Syst 1991 ; 7 : 177-82.
PubMed
13) Wiestler OD, et al. Ependymoma. In : Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press ; 1997.
 
14) Carter M, et al. Genetic abnormalities detected in ependymomas by comparative genomic hybridization. Br J Cancer 2002 : 86 : 929-39.
PubMed
15) Bijlsma EK, et al. Molecular analysis of genetic changes in ependymomas. Genes Chromosomes Cancer 1995 ; 13 : 272-7.
PubMed
16) Fink KL, et al. Infrequency of p53 gene mutations in ependymomas. J Neurooncol 1996 ; 27 : 111-5.
PubMed
17) Ohgaki H, et al. Mutation of the p53 tumor suppressor gene in neoplasms of the central nervous system. Mol Carcinog 1993 ; 8 : 74-80.
PubMed
18) Tominaga T, et al. Anaplastic ependymomas : Clinical features and tumour suppressor gene p53 analysis. Acta Neurochir (Wien) 1995 : 135 : 163-70.
PubMed
19) Rusenblum MK. Ependymal tumors : A review of their diagnostic surgical pathology. Pediatr Neurosurg 1998 ; 88 : 160-5.
 
20) Friede RL, Pollak A. The cytogenetic basis for classifying ependymomas. J Neuropathol Exp Neurol 1978 ; 37 : 103-18.
PubMed
21) Smyth MD, et al. Intracranial ependymomas of childhood : Current management strategies. Pediatr Neurosurg 2000 ; 33 : 138-50.
PubMed
22) Pollack IF, et al. Intracranial ependymomas of childhood : Long-term outcome and prognostic factors. Neurosurgery 1995 ; 37 : 536-47.
 
23) Culley D, et al. An analysis of factors determining the need for ventriculoperitoneal shunts following posterior fossa tumor surgery in children. Neurosurgery 1994 ; 34 : 402-8.
 
24) Tominaga T, et al. Transcingula teapproach to lateral ventricle tumors : Technical caser eport. Neurosurg Rev 1996 ; 19 : 105-8.
 
25) Stafford SL, et al. Stereotactic radiosurgery for recurrent ependymoma. Cancer 2000 ; 88 : 870-5.
PubMed
27) Guyotat J, et al. Intracranial ependymomas in adult patients : Analysesofprognosticfactors. J Neurooncol 2002 ; 60 : 255-68.
PubMed
28) Figarella-Branger D, et al. Prognostic factors in intracranial ependymomas in children. J Neurosurg 2000 ; 93 : 605-13.
 
29) Vinchon M, et al. Supratentorial ependymomas in children. Pediatr Neurosurg 2001 ; 341-77 -87 .
 
30) Schifter D, et al. Ependymoma : Intemal correlations among pathological signs : The anaplastic variant. Neurosurgery 1991 ; 29 : 206-10.
 
31) Horn B, et al. A multi-institutional retrospective study of intracranial ependymoma in children : Identification of risk factors. J Pediatr Hematol Oncol 1999 ; 21 : 203-11.
 
32) Sonneland PRL, et al. Myxopapillary ependymoma : A clinicopathogenic and immunohistochemical study of 77 cases. Cancer 1985 ; 56 : 883-93.
 
33) Hanbali F, et al. Spinal cord ependymoma : Radical surgical resection and outcome. Neurosurgery 2002 ; 51 : 1162-72.
PubMed
352
 
P.362 掲載の参考文献
1) Aguzzi A, et al. Choroid plexus tumours. In : Kleihues P, Cavenee WK, editors. Pathology & Genetics. Tumours of the Nervous System. Lyon : IARC Press ; 2000. p. 83-6.
 
2) Reed UC, et al. Brain tumors in the first two years of life : A review of forty cases. Pediatr Neurosurg 1993 ; 19 : 180-5.
 
3) Yuasa H, et al. Primary carcinoma of the choroid plexus in Li-Fraumeni syndrome : Case report. Neurosurgery 1993 ; 32 : 131-4.
 
4) Carter AB, et al. Choroid plexus carcinoma presenting as an intraparenchymal mass. J Neurosurg 2001 : 95 : 1040-4.
 
5) Irsutti M, et al. Suprasellar seeding of a benign choroid plexus papilloma of the fourth ventricle with local recurrence. Neuroradiology 2000 : 42 : 657-61.
PubMed
6) Nakano I, et al. Choroid plexus papilloma in the posterior third ventricle : Case report Neurosurgery 1997 : 40 : 1279-82.
PubMed
7) Greene RC. Extraventricular and intraccrebellar papilloma of the choroid plexus. J Neuropathol Exp Neurol 1951 ; 10 : 204-7.
PubMed
8) Azzam NI, Timperley WR. Intracranial cyst due to ectopic choroid plexus. J Neurosurg 1981 ; 55 : 651-3.
 
9) Coates TL, et al. Pediatric choroid plexus neoplasms : MR, CT, and pathologic correlation. Radiology 1989 ; 173 : 81-8.
PubMed
10) Garcia-Valtuille R, et al. Adult choroid plexus papilloma of the posterior fossa mimicking a hemangioblastoma. J Neurosurg 2000 : 92 : 870-2.
PubMed
11) Rollins NK, et al. Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors. Pediatr Neurosurg 1995 ; 22 : 8-14.
PubMed
12) Do HM, et al. Choroid plexus papilloma of the third ventricle : Angiography, preoperative embolization, and histology. Neuroradiology 2001 : 43 : 503-6.
PubMed
13) Yoshino A, et al. Multiple choroid plexus papillomas of the lateral ventricle distinet from villous hypertrophy. J Neurosurg 1998 : 88 : 581-5.
 
14) Sarkar C, et al. Choroid plexus papilloma : A clinicopathological study of 23 cases. Surg Neurol 1999 : 52 : 37-9.
PubMed
15) Doran SE, et al. Bone formation within a choroid plexus papilloma. Pediatr Neurosurg 1995 : 23 : 216-8.
PubMed
16) Salazar J, et al. Choroid plexus papilloma with chondroma : Case report. Neurosurgery 1986 ; 18 : 781-3.
PubMed
17) 水野誠ほか. 脈絡叢に限局性転移を示した腎細胞癌の1症例. 脳神外科 1992 ; 20 (4) : 469-4.
 
18) Radaideh MM, et al. Unusual small choroid plexus cyst obstructing the foramen of Monro : Case report. AJNR Am J Neuroradiol 2002 ; 23 : 841-3.
PubMed
19) Hatashita S, et al. Choroid plexus cyst of the lateral ventricle in an elderly man. J Neurosurg 1984 ; 60 : 435-7.
 
20) Bramwit M, et al. Inflammatory pseudotumor of the choroid plexus. AJNR Am J Neuroradiol 1997 : 18 : 1307-9.
PubMed
21) Jaeger M, et al. Intraventricular trigonal ganglioma arising from the choroid plexus. Acta Neurochir (Wien) 2001 : 143 : 953-5.
 
22) McEvoy AW, et al. Metastratic choroid plexus papilloma. A case report. J Neurooncol 2002 : 56 : 241-6.
PubMed
23) Leblanc R, et al. Diffuse craniospinal seeding from a benign fourth ventricle choroid plexus papilloma. J Neurosurg 1998 : 88 : 757-60.
PubMed
24) Heese O, et al. Diffuse arachnoidal enhancement of a well differentiated choroid plexus papilloma. Acta Neurochir (Wien) 2002 ; 144 : 723-8.
PubMed
25) Tacconi L, et al. Choroid plexus papillomas ; Consideration of a surgical series of 33 cases. Acta Neurochir (Wien) 1996 : 138 : 802-10.
PubMed
26) Nagib MG, O'Fallon MT. Lateral ventricle choroid plexus papilloma in childhood : Management and complications. Surg Neurol 2000 ; 54 : 366-72.
PubMed
27) Pencalet P, et al. Papillomas and carcinomas of the choroid plexus in children. J Neurosurg 1998 ; 88 : 521-8.
 
28) Levy ML, et al. Choroid plexus tumors in children : Significance of stromal invasion. Neurosurgery 2001 : 48 : 303-9.
PubMed
29) Shinoda J, et al. Choroid plexus carcinoma in infants : Report of two cases and review of the literature. Acta Neurochir (Wien) 1998 : 140 : 557-63.
PubMed
30) Chow E, et al. Pediatric choroid plexus neoplasms. Int J Radiat Oncol Biol Phys 1999 : 44 : 249-54.
PubMed
31) McGirr SJ, et al. Choroid plexus papillomas : Long-term follow-up results in a surgically treated scries. J Neurosurg 1988 : 69 : 843-9.
 
32) Valencak J, et al. Evidence of therapeutic efficacy of CCNU in recurrent choroid plexus papilloma. J Neurooncol 2000 ; 49 : 263-8.
PubMed
33) St Clair SK, et al. Current managementt of choroid plexus carcinoma in children. Pediatr Neurosurg 1991-92 : 17 : 225-33.
 
34) Souweidane MM, et al. Volumetric reduction of a choroid plexus carcinoma using preoperative chemotherapy. J Neurooncol 1999 ; 43 : 167-71.
PubMed
35) Ellenbogen RG, et al. Tumors of the choroid plexus in children0 Neurosurgery 1989 : 25 : 327-35.
 
36) Pauls W, Janisch W. Clinicopathologic correlations in epithelial choroid plexus neoplasms : A study of 52 cases. Acta Neuropathol (Berl) 1990 ; 80 : 635-41.
 
37) Diengdoh JV, Shaw MD. Oncocytic variant of choroid plexus papilloma. Cancer 1993 : 71 : 855-8.
PubMed
P.372 掲載の参考文献
1) Kleihucs P, et al. Histological typing of tumors of the central nervous system. In : World Health Organization International Histological Classification of Tumours 2nd ed Berlin, Heidelberg : Springer-Verlag : 1993.
 
2) 平野朝雄, 富安斉. 神経病理を学ぶ人のために. 東京 : 医学書院 ; 2003. p302-5.
 
3) 脳腫瘍全国統計委員会, 日本病理学会編. 臨床・病理 脳腫瘍取り扱い規約-臨床と病理カラーアトラス. 東京 : 金原出版 ; 2002. p. 116-7.
 
4) Kleihues P, Cavenee WK, editors. Pathology & Genetics. Tumours of the Nervous System. Lyon : International Ageney for Research on Cancer : 1997.
 
5) 中里洋一. II 脳腫瘍のWHO分類と問題点. 高倉公朋ほか編. 脳神経外科Advanced Practice 5 神経膠腫. 東京 : メジカルビュー社 ; 2002. p34-41.
 
6) Bailey P, Cushing H. A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis. Philadelphia : JB Lippincott ; 1926.
 
7) Bailey P, Bucy P Astroblastoma of the brain. Acta Psychiat Neurol 1930 : 5 : 439-61.
 
8) Kubota T, et al. The fine structure of astroblastoma. Cancer 1985 : 55 : 745-50.
PubMed
9) Rubinstein LJ, Herman MM. The astroblastoma and its possible cytogenic relationship to the tanycyte : An electron microscopic, immunohistochemical, tissue-and organ-culture study. Acta Neuropathol (Berl) 1989 : 78 : 472-83.
 
10) 山下純宏, 長谷川光広. 18 Astroblastoma 星状芽腫. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 東京 : 医学書院 ; 1999. p53.
 
11) 久保田紀彦. 4 星芽腫 Astroblastoma. 久保田紀彦, 佐藤一史編. 脳腫瘍の病理と臨床. 東京 : 診断と治療社 ; 2002. p. 73-8.
 
12) Pizer BL, et al. Congenital astoblastoma : An immunohistochemical study : Case report. J Neurosurg 1995 : 83 : 550-5.
PubMed
13) Brat DJ, et al. Astroblastoma : Clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization. Brain Pathol 2000 : 10 : 342-52.
PubMed
14) Jay V, et al. Astroblastoma : Report of a case with ultrastructural, cell kinetic, and cytogenetic analysis. Pediatr Pathol 1993 ; 13 : 323-32.
PubMed
15) Bonnin JM, Rubinstein LJ. Astroblastoma : A pathological study of 23 tumors, with a postoperative follow-up in 13 patients. Neurosurgery 1989 ; 25 : 6-13.
PubMed
16) Nevins S. Gliomatosis cerebri. Brain 1938 ; 61 : 170-91.
 
17) Scheinker IM, Evans JP Diffuse cerebral gliomatosis. J Neuropathol Exp Neurol 1943 : 2 : 178-89.
 
18) Jennings MT, et al. Gliomatosis cerebri presenting as intractable epilepsy during carly childhood. J Child Neurol 1995 : 10 : 37-45.
 
19) Altigas J, et al. Review article gliomatosis cerebri : Clinical and histological findings. Clin Neuropathol 1985 : 4 : 135-48.
 
20) 岡崎春雄, Scheithauer BW. "大脳" 神経膠腫症. Gliomatosis cerebri. 岡崎春雄, 今津修訳. 神経病理学アトラス. 東京 : 医学書院 ; 1996. p. 72-3.
 
21) Nishioka H, Ito H. Difficulties in the antemortem diagnosis of gliomatosis cerebri : Report of a case with diffuse increase of gemistocyte-like cells, mimicking reactive gliosis. Br JNeurosurg 1996 : 10 : 103-8.
PubMed
22) Hecht BK, et al. Chromosomes in gliomatosis cerebri. Genes Chromosomes Cancer 1995 ; 14 : 149-53.
PubMed
23) 植木敬介ほか. 画像診断と生検によるGliomatosis Cerebriの臨床診断. 脳神外科 1990 ; 18 : 89-93.
 
24) Peretti-Viton P, et al. Histological and MR correlation in gliomatosis cerebri. J Neurooncol 2002 : 59 : 249-59.
 
25) Pyhtinen J, Paakko E. A difficult diagnosis of gliomatosis cercbri. Neuroradiology 1996 : 38 : 444-8.
PubMed
26) Horst E, et al. Radiation therapy approach in gliomatosis cerebri : Case report and literature review. Acta Oncol 2000 : 39 : 747-51.
PubMed
27) Shintani S, et al. Serial positron emission tomography (PET) in gliomatosis cerebri treated with radiotherapy : A case report. J Neurol Sci 2000 ; 173 : 25-31.
PubMed
28) Kim DG, et al. Gliomatosis cerebri : Clnical features, treatment, and prognosis. Acta Nerochir (Wien) 1998 : 140 : 755-62.
 
29) Brat DJ, et al. Third ventricular chordoid glioma : A distinct clinicopathologic entity. J Neuropathol Exp Neurol 1998 : 57 : 283-90.
PubMed
30) Vajtai I, et al. Chordoid glioma of the third ventricle ; Confirmatow report of a new entity. Hum Pathol 1999 : 30 : 723-6.
PubMed
31) 小田正哉ほか. Thild ventricular chordoid gliomaの1手術例. 脳神外科 2002 ; 30 : 973-9.
 
32) Pasquier B, et al. Chordoid glioma of the third ventricle : A report of two new cases, with further evidence supporting an ependymal differentiation, and review of the literature. Am J Surg Pathol 2002 : 26 : 1330-42.
PubMed
33) 藤岡保範, 長島和郎. 21. Third ventricular chordoid glioma 第3脳室脊索腫様膠腫. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 東京 : 医学書院 ; 1999. p. 57.
 
34) 佐藤一史. 5 脊索腫様神経膠腫 Chordoid glioma. 久保田紀彦, 佐藤一史編. 脳腫瘍の病理と臨床. 東京 : 診断と治療社 ; 2002. p. 78-80.
 
35) Cenacchi G, et al. Chordoid glioma of the third ventricle : An ultrastructural study of three cases with a histogenetic hypothcsis. Am J Surg Pathol 2001 : 25 : 401-5.
PubMed
36) Reifenberger G, et al. Chordoid glioma of the third ventricle : Immunohistochemical and molecular genetic characterization of a novel tumor entity. Brain Pathol 1999 ; 9 : 617-26.
PubMed
37) Grand S, et al. Chordoid glioma of the third ventricle ; CT and MRI, including perfusion data. Neuroradiology 2002 ; 44 : 842-6.
PubMed
P.395 掲載の参考文献
1) Wiestler OD, et al. Cowden disease and dysplastic ganglioglioma of the cerebellum/Lhermitte-Duclos disease. In : Kleihues P, Cavenee WK, editors. Pathology & Genetics Tumours of the Nervous System. Lyon : IARC Press ; 2000. p. 235-7.
 
2) Williard W, et al. Cowden disease : A case report with analysis at the molecular level. Cancer 1992 ; 69 : 2969-74.
 
3) Hanssen AM, et al. Cowden syndrome : Report of a large family with macrocephaly and increased severity of signs in subsequent generations. Clin Genet 1993 ; 44 : 281-6.
PubMed
4) Liaw D, et al. Germline mutation of the FITEN gene in Cowden disease : An inherited breast and thyroid cancer syndrome. Nat Genet 1997: 16 : 64-7.
 
5) Vinchon M, et al. Association of Lhermitte-Duclos and Cowden disease : Report of a new case and review of the literature. J Neurol Neurosurg Psychiatry 1994 ; 57 : 699-704.
PubMed
6) Milbouw G, et al. Clinical and radiological aspects of dysplastic ganglioglioma (Lhermitte-Duclos disease) : A report of two cases with review of the literature. Neurosurgery 1988 ; 20 : 124-8.
 
7) Ogasawara K, et al. Blood flow and oxygen metabolism in a case of Lhermitte-Duclos disease : Results of positron emission tomography. J Neurooncol 2001 ; 55 : 59-61.
 
8) Hair LS, et al. Immunohistochemistry and proliferative activity in Lhermitte-Duclos disease. Acta Neuropathol (Berl) 1992 ; 84 : 570-3.
PubMed
9) Taratuto AL, et al. Desmoplastic infantiie ganglioglioma. In : Kleihues P, Cavenee WK, editors. Pathology & Genetics Tumours of the Nervous System. Lyon : IARC Press ; 2000. p. 99-102.
 
10) Horten BC, Rubinstein LJ. Primary cerebral neuroblastoma : A clinicopathological study of 35 cases. Brain 1976 ; 99 : 735-56.
PubMed
11) Taratuto AL, et al. Superficial cerebral astrocytoma attached to dura. Report of six cases in infants. Cancer 1984 ; 54 : 2505-12.
PubMed
12) VandenBerg SR, et al. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential ("desmoplastic infantile ganglioglioma"). J Neurosurg 1987 : 66 : 58-71.
PubMed
13) de Chadarevian JP, et al. Desmoplastic cerebral astrocytoma of infancy : Light microscopy, immunohistochemistry, and ultrastructure. Cancer 1990 ; 66 : 173-9.
PubMed
14) VandenBerg SR. Desmoplastic infantile ganglioglioma and desmoplastic cerebral astrocytoma of infancy. Brain Pathol 1993 ; 3 : 275-81.
PubMed
15) Lellouch-Tubuiana MC, et al. The management of desmoplastic neuroepithelial tumors in childhood. Childs Nerv Syst 2000 ; 16 : 8-14.
 
16) Kuchelmeister K, et al. Desmoplastic ganglioglioma : Report of two non infantile cases. Acta Neuropathol 1993 ; 85 : 190-204.
 
17) Duffner PK, et al. Desmoplastic infantile ganglioglioma : An approach to therapy. Neurosurgery 1994 : 34 : 583-9.
PubMed
18) Jay V, et al. Unique desmoplastic cerebral tumor in a patient with complex partial seizures. Pediatr Dev Pathol 1998 ; 1 : 234-42.
 
19) Sugiyama K, et al. Good clinical course in infants with desmoplastic cerebral neuroepithelial tumor treated by surgery alone. J Neurooncol 2002 : 59 : 63-9.
PubMed
20) Duffner PK, et al. Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed inadiation : A Pediatric Oncology Group study. Ann Neurol 1998 ; 44 : 313-6.
 
21) Vital A, et al. Lhermitte-Duclos type cerebellar hamartoma and Cowden disease. Clin Neuropathol 1994 ; 13 : 229-31.
PubMed
22) Takeshima H, et al. Postoperative regression of desmoplastic infantile gangliogliomas : Report of two cases. Neurosurgery 2003 ; 53 : 979-84.
PubMed
23) Daumas-Duport C, et al. Dysembryoplastic neuroepithelial tumor. In : Kleihues P, Cavence WK, editors. Pathology & Genetics Tumours of the Nervous System. Lyon : IARC Press ; 2000. p. 103-6.
 
24) Daumas-Duport C, et al. Dysembryoplastic neuroepithelial tumor : A surgically curable tumor of young patients with intractable partial seizure : Report of thirty-nine cases. Neurosurgery 1988 : 23 : 545-56.
PubMed
25) Okazaki H. Personal communication.
 
26) Daumas-Duport C, et al. Dysembryoplastic neuroepithelial tumor : Nonspecifie histological forms. A study of 40 cases. J Neurooncol 1999 : 41 : 267-80.
 
27) Honavar M, et al. Histological heterogeneity of dysembryoplastic neurocpithelial tumor : Identification and differential diagnosis in a series of 74 cases. Histopathology 1999 : 34 : 342-56.
 
28) Ostertum B, et al. Dysembryoplastic neuroepithelial tumor : MR and CT evaluation. AJNR Am J Neuroradiol 1996 ; 17 : 419-30.
 
29) Daumas-Duport C, et al. Dysembryoplastic neuroepithelial tumors. Brain Pathol 1993 : 3 : 283-95.
PubMed
30) Hirose T, et al. Dysembryoplastic neuroepithelial tumor (DNT) : An immunohistochemical and ultrastructural study. J Neuropathol Exp Neurol 1994 : 53 : 1184-95.
 
31) Hirose T, et al. Mixed dysembryoplastic neuroepithelial tumor and ganglioglioma. Acta Neuropathol 1998 : 95 : 649-54.
PubMed
32) Thom M, et al. Spontaneous intralesional haemorrhage in dysembryoplastic neuroepithelial thmors. J Neurol Neurosurg Psychiatry 1999 ; 67 : 97-101.
PubMed
33) Nelson JS, et al. Ganglioglioma and gangliocytoma. In : Kleihues P, Cavenee WK, editors. Pathology & Genetics Tumours of the Nervous System Lyon : IARC Press : 2000. p. 96-8.
 
34) Burger PC, et al. Ganglioglioma and gangliocytoma. In : Burger PC, Schcithaucr BW, editors. Tumors of the Central Nervous System. Washington DC : AFIP ; 1994 p. 163-72.
 
35) Courville CB. Ganglioglioma Tumor of the central nervous system : Review of the literature and report of two cases. Arch Neurol Psychiat 1930 ; 24 : 439-91.
 
36) Bigner DD, et al. Ganglioneuromas (gangliocytomas) and gangliogliomas. In : Bigner DD, et al, editors Russel & Rubinstein's Pathology of Tumors of the Central Nervous System. London : Arnold ; 1998. p. 493-504.
 
37) Perkins OC. Ganglioglioma. Arch Pathol Lab Med 1926 : 2 : 11-7.
 
38) Baily P, et al. Tumors of the glioma group. Philaderphia : JB Lippincott ; 1926.
 
39) Hirose T, et al. Ganglioglioma : An ultastructural and immunohistochemical study. Cancer 1997 ; 79 : 989-1003.
 
40) Burger PC, et al. Gangliocytoma and ganglioglioma. In : Burger PC, et al, editors Surgical Pathology of the Nervous System and its Coverings. Philadelphia : Churchill Livingstone ; 2002. p. 264-73.
 
41) Becker LE. Central neuronal tumors in childhood : Relationship to dysplasia. J Neurooncol 1995 : 24 : 13-9.
PubMed
42) Wolf HK, et al. Gangliogloma : A detailed histopathological and immunohistochcmical analysis of 61 cases. Acta Neuropathol (Berl) 1994 ; 88 : 166-73.
 
43) Bigner DD, et al. Intrasellar, endocrinologically active gangliocytoma. In : Bigner DD, et al, editors. Russel & Rubinstein's Pathology of Tumors ofthe Central Nervous System. London : Arnold : 1998. p. 504-5.
 
44) The Committee of Brain Tumor Registry of Japan. Report of brain tumor registry of Japan (1969-1993). Neurol Med Chir (Tokyo) 2003 : 40 : 5-12.
 
45) Zentner J, et al. Ganglioglioma : Clinical, radiological, and histopathological findings in 51 cases. J Neurol Neurosurg Psychiatry 1994 ; 57 : 1497-502.
 
46) Krouwer HGJ, et al. Gangliogliomas : A clinicopathological study of 25 cases and review of the literature. J Neurooncol 1993 : 17 : 139-54.
 
47) Costantini S, et al. Intramedullary spinal cord tumors in children under the age of 3 years. J Neurosurg 1996 ; 85 : 1036-43.
 
48) Johnston JH Jr, et al. Clinical outcome of pediatric gangliogliomas : Ninety-nine cases over 20 years. Pediatl Neurosurg 1997 : 27 : 203-7.
 
49) Lang FF, et al. Central nervous system gangliogliomas Part 2 : Clinical outcome. J Neurosurg 1993 : 79 : 867-73.
PubMed
50) Harvey AS, et al. Hemifacial seizure and cerebellar ganglioglioma : An epilepsy syndrome of infancy with seizures of cerebellar origin. Ann Neurol 1996 ; 40 : 91-8.
PubMed
51) Sugiyama K, et al. Ganglioglioma of the optic pathway : A case report. Surg Neurol 1992 ; 37 : 22-5.
PubMed
52) Fujimura M, et al. Ganglioglioma in the basal ganglia totally resected by a trans-distal sylvian approach. Tohoku J Exp Med 1995 : 175 : 211-8.
PubMed
53) Faillot T, et al. Ganglioglioma of the pineal region : Case report and review of the literature. Surg Neulol 1998 : 49 : 104-8.
PubMed
54) Prayson RA, et al. Cortical architectural abnormalities and MIB-1 immunoreactivity in gangliogliomas : A study of 60 patients with intracranial tumors. J Neuropathol Exp Neurol 1995 : 54 : 513-20.
PubMed
55) Rumana CS, et al. Prognostic factors in supratcntorial ganglioghomas. Acta Neurochir (Wien) 1999 ; 141 : 63-9.
PubMed
56) Park CK, et al. Intramedullary spinal cord ganglioglioma : A report of five cases. Acta Neurochir (Wien) 2000 : 142 : 547-52.
PubMed
57) Mesiwala AH, et al. Focal motor seizure with secondary generalization arising in the cerebellum. J Neurosurg 2002 ; 97 : 190-6.
PubMed
58) Chae JH, et al. Hemifacial seizure of cerebellal ganglioglioma origin : Seizure control by tumor resection. Epilepsia 2001 : 42 : 1204-7.
PubMed
59) Matsumoto K, et al. Cerebral gangliogliomas : Clintal characteristics, CT and MRI. Acta Neurochir (Wien) 1999 ; 141 : 135-41.
PubMed
60) Hashimoto M, et al. Magnetic resonance imagings of ganglion cell tumours. Neuroradiology 1993 : 35 : 181-4.
PubMed
61) Koeller KK, et al. From the archives of the AFIP. Superficial gliomas : Radiologic-pathologic correlation. Radiographics 2001 : 21 : 1533-56.
PubMed
62) Shin JH, et al. Neuronal tumors of the central nervous system : Radiologic findings and pathologic correlation. Radiographics 2002 ; 22 : 1177-89.
PubMed
63) Provenzale JM, et al. Comparison of patients age with MR imaging featurers of gangliogliomas. AJR Am J Roentgenol 2000 : 174 : 859-62.
 
64) Siddique K, et al. Ganglioglioma presenting as a meningioma : Case report and review of the literature. Neurosurgery 2002 : 50 : 1133-6.
PubMed
65) Lantos P, et al. Tumours of the nervous system. In : Graham D, Lantos O, editors. Greenfield's Neuropathology London : Arnold ; 1997 : p. 654-76.
 
66) 小森隆司. Glioneural tumor-拡大する疾患概念. 脳神外科 2003 : 55 : 387-98.
 
67) Miller DC, et al. Central nervous system gangliogliomas. Part 1 : Pathology. J Neurosurg 1993 ; 79 : 859-66.
PubMed
68) Miller DC, et al. Synaptophysin : A sensitive and specific marker for ganglion cells in central nervous system neoplasms. Hum Pathol 1990 : 21 : 93-8.
PubMed
69) Quinn B. Synaptophysin staining in normal brain : Importance for diagnosis of ganglioglioma. Am J Surg Pathol 1998 ; 22 : 550-6.
PubMed
70) Hirose T, et al. Anaplastic ganglioglioma of the brain stem demonstating active neurosecretory features of neoplastic neuronal cells. Acta Neuropathol (Berl) 1992 ; 83 : 367-70.
 
71) Towfighi J, et al. Ganglion cell-containing tumors of the pituitary gland. Arch Pathol Lab Med 1996 ; 120 : 369-77.
PubMed
72) Burger PC, et al. Extraventricular (parenchymal) neurocytic neoplasms. In : Burger PC, et al, editors. Surgical Pathology of the Nervous System and its Coverings. Philadelphia : Churchill Livingstone ; 2002. p. 287-90.
 
73) Vajtai I, et al. Pleomorphic xanthoastrocytoma with gangliogliomatous component. Pathol Res Pract 1997 : 193 : 617-21.
PubMed
74) Evans AJ, et al. Combined plcomorphic xanthoastocytoma-ganglioglioma of the cerebellum. Arch Pathol Lab Med 2000 ; 124 : 1707-9.
 
75) Giannini C, et al. Immunophenowpe of pleomorphic xanthoastrocytoma. Am J Surg Pathol 2002 ; 26 : 479-85.
PubMed
76) Hirose T, et al. Ultrastructural features of pleomorphic xanthoastrocytoma : A comparative study with glioblastoma multiforme. Ultrastruct Pathol 2001 : 25 : 469-78.
PubMed
77) Kepes JJ. Pleomorphic xanthoastrocytoma : The birth of a diagnosis and concept. Brain Pathol 1993 ; 3 : 269-74.
PubMed
78) Majos C, et al. Intraventricular ganglioglioma. Case report. Neuroradiology 1998 ; 40 : 377-9.
PubMed
79) Chan A, et al. Ganglioglioma mimicking a malignant tumor : Case report with a literature review of the MRI appearance of neurocytoma and ganglioglioma. J Neuroimaging 2001 ; 11 : 45-50.
 
80) Wolf HK, et al. Surgical pathology of chronic epilepic seizure disorders. Braln Pathol 1995 ; 3 : 371-80.
 
81) Figarella-Branger D, et al. Cental neurocytoma. In : Kleihues P, Cavenee WK, editors. Pathology & Genetics Tumours of the Nervous System. Lyon : IARC Press ; 2000. p. 107-9.
 
82) Hirano A. Personal communication.
 
83) Hassoun J, et al. Fine structure of intercellular junctions and blood vessles in medulloblastoma. Acta Neuropathol (Berl) 1975 : 33 : 67-78.
 
84) Rubinstein LJ. Oligodendrogliomas. In : Rubinstein LJ, editor. Tumors of the Central Nervous System. Washington DC : AFIP ; 1972. p. 85-104.
 
85) Zulch KJ. Ependymomas. In : Zulch KJ, editor Brain Tumors : Their Biology and Pathology. Berlin : Springer-Verlag ; 1986. p. 258-70.
 
86) Hassoun J, et al. Central neurocytoma : An electron-microscopic study of two cases. Acta Neuopathol (Berl) 1982 ; 56 : 151-6.
 
87) Ojeda VJ, et al. Primary cerebral neuroblastomas : A clinical study of one adolescent and five adult patients. Pathology 1986 ; 18 : 41-9.
 
88) Wilson AJ, et al. Differentiated cerebral neuroblastoma : A tumour in need of discovery. Hum Pathol 1985 ; 16 : 647-9.
PubMed
89) Pearl GS, et al. Intraventricular neuroblastoma in adults : Report of three cases. Neurosurgery 1985 ; 16 : 847-9.
PubMed
90) Hassoun J, et al. Central neurocytoma : A synopsis of clinical and histological features. Brain Pathol 1993 ; 3 : 297-306.
PubMed
91) 峰浦一喜. Central neurocytoma. 脳神外科 2000 ; 28 : 583-97.
 
92) Warmuth-Metz M, et al. Cental neurocytoma of the fourth ventricle : Case report. J Neurosurg 1999 : 91 : 506-9.
 
93) Hsu PW, et al. Fourth ventricle central neurocytoma : Case report. Neurosurge, 2002 ; 50 : 1356-7.
 
94) Yasargil MG, et al. Central neurocytoma : Histopathological variants and therapeutic approaches. J Neurosurg 1992 ; 76 : 32-7.
PubMed
95) Roche PH, et al. Giant central neurocytoma with tetaventricular and exra-axial extension : Case report. Acta Neurochir (Wien) 1995 ; 133 : 95-100.
 
96) Tatter SB, et al. Central neurocytoma of the cervical spinal cord. J Neurosurg 1994 ; 81 : 288-93.
PubMed
97) Martin AJ, et al. Neurocytoma of the thoracic spinal cord. Acta Neurochir (Wien) 2002 ; 144 : 823-8.
PubMed
98) Stephan CL, et al. Neurocytoma of the cauda equina : Case report. J Neurosurg 1999 ; 90 : 247-51.
PubMed
99) Araki Y, et al. Central neurocytoma presenting with gianism : Case report. Surg Neurol 1992 ; 38 : 141-5.
PubMed
100) Parker DR. Neuroradiology case of the day : Central neurocytoma. AJR Am J Roentgenol 1991 ; 156 : 1311-3.
PubMed
101) Wichmann W, et al. Neuroradiology of central neurocytoma. Neuroradiology 1991 ; 33 : 143-8.
PubMed
102) Nishio S, et al. Tumours around the foramen of Monro : Clinical and neuroimaging features and their differential diagnosis. J Clin Neurosci 2002 : 9 : 137-41.
PubMed
103) Schild SE, et al. Central neurocytomas. Cancer 1997 ; 79 : 790-5.
PubMed
104) Kulkarni V, et al. Long-term outcome in patients with central neurocytoma following stercotactic biopsy and radiation therapy. Br J Neurosurg 2002 ; 16 : 126-32.
 
105) Tyler-Kabara E, et al. Stereotacic radiosurgery for residual neurocytoma : Report of four cases. J Neurosurg 2001 ; 95 : 879-82.
 
106) Martin JM, et al. Linear accelerator radiosurgery on treatment of central neurocytomas. Acta Newochir (Wien) 2003 ; 145 : 749-54.
PubMed
107) Brandes AA, et al. Chemotherapy in patients with recurrent and progressive central neurocytoma. Cancer 2000 ; 88 : 169-74.
PubMed
108) Kubota T, et al. Central neurocytoma : Immunohistochemical and ultrastructural study. Acta Neuropathol (Berl) 1991 : 81 : 418-27.
PubMed
109) Kubota T, et al. Differential diagnosis of oligodendrogliomas : Immunohistochemical and ultrastructural study. Brain Tumor Pathol 1991 : 8 : 17-24.
 
110) Tuchida T, et al. Neuronal and glial characteristics of central neurocytoma : Electron microscopical analysis of two cases. Acta Neuropathol (Berl) 1996 ; 91 : 573-7.
 
111) Baisdcn BL, et al. Dysembryoplastic neuroepithelial tumor-like neoplasm of the septum pellucidum : A lesion often misdiagnosed as glioma. Report of 10 cases. Am J Surg Pathol 2001 ; 25 : 494-9.
 
112) Cervera PP, et al. Dysembryoplastic neuroepithelial tumor located in the caudate nucleus area : Report of four cases. Neurosurgery 1997 ; 40 : 1065-70.
 
113) Giangaspero F, et al. Extraventricular neoplasum with neurocytoma features : A clinicopathological study of 11 cases. Am J Surg Pathol 1997 ; 21 : 206-12.
PubMed
114) Nishio S, et al. Cerebral neurocytoma. A new subset of benign neuronal tumors of the cerebrum. Cancer 1992 : 70 : 529-37.
PubMed
115) Kleihues P, et al. Cerebellar liponeurocytoma. In : Kleihues P, Cavenee WK, editors. Pathology & Genetics Tumours of the Nervous System. Lyon : IARC Press ; 2000. p. 110-1.
 
116) Hirano A, Shin WY Unattached presynaptic terminals in a cerebellar neuroblastoma in the human. Neuropathol Appl Neurobiol 1979 ; 5 : 63-70.
 
117) Giangaspero F, et al. Medulloblastoma with extensive nodulanty : A variant with favorable prognosis. J Neurosurg 1999 ; 91 : 971-7.
PubMed
118) Bennet JP Jr, Rubinstein LJ. The biological behavior of primary cerebral neuroblastoma : A reappraisal of the clinical course in a series of 70 cases. Ann Neurol 1984 : 16 : 21-7.
 
119) 杉山一彦ほか. Embryonal tumors. 橋本信夫編. 脳神経外科治療指針. 東京 : 中外医学社 ; 2002. p. 312-20.
 
120) Louis DN, et al. Central nervous system neurocytoma and neuroblastoma in adults : Report of eight cases. J Neurooncol 1990 ; 9 : 231-8.
 
121) Hassler RB, et al. Cytoskeletal immunohistochemistry of central neurocytomas. Am J Surg Pathol 1992 : 16 : 1031-8.
 
122) Perry A, et al. Oligodendrogliomas with neurocytic differentiation : A report of 4 cases with diagnostic and histogenetic implications. J Neuropathol Exp Neurol 2002 ; 61 : 947-55.
PubMed
123) Takao H, et al. Central neurocytoma with craniospinal dissemination. J Neurooncol 2003 ; 61 : 255-9.
PubMed
124) Kim DG, et al. Central neurocytona : Proliferative potential and biological behavior. J Neurosurg 1996 ; 84 : 742-7.
PubMed
125) Soylemezoglu F, et al. Atypical central neurocytoma. J Neuropathol Exp Neurol 1997 ; 56 : 551-6.
PubMed
126) Bertalanffy A, et al. Gamma knife radiosurgery of recurrent central neurocytomas : A preliminary report. J Neurol Neurosurg Psychiatry 2001 : 70 ; 489-93.
PubMed
127) Bechtel JT, et al. Mixed mesenchymal and neuroectodermal tumor of cerebellum. Acta Neuropathol (Berl) 1978 : 41 : 261-3.
PubMed
128) Budka H, et al. Lipomatous medullobastoma in adults : A new tumor type with possible favorable prognosis. Hum Pathol 1994 ; 25 : 730-1.
 
129) Davis DG, et al. Lipidized medulloblastoma in adults. Hum Pathol 1993 ; 24 : 990-5.
PubMed
130) Soylemezoglu F, et al. Lipomttous medulloblastoma in adults : A distinct clinicopathological entity. Am J Surg Pathol 1996 : 20 : 413-8.
PubMed
131) Ellison DW, et al. Neurocytoma/lipoma (neurolipoma) of the cerebellum. Neuropathol Appl Neurobiol 1993 ; 19 : 85-8.
 
132) Giangaspero F, et al. Medulloblastoma (lipidized medulloblastoma). A cerebellar neoplasm of adult with favorable prognosis. Am J Surg Pathol 1996 ; 20 : 656-64.
PubMed
133) Lipper S, et al. Paraganglioma of the cauda equine. A histologic, immunohistochemical, and ultrastructural study and review of the literature. Surg Neurol 1984 : 22 : 415-20.
 
134) Caccamo DV, et al. Cauda equine tumor with ependymal and paraganglionic differentiation. Hum Pathol 1992 ; 23 : 835-8.
 
135) Hirano A. Some contributions of electron microscopy to diagnosis of brain tumors. Acta Neuropathol (Berl) 1978 : 43 : 199-28.
 
136) Soffer D, et al. Paragaglioma. In : Kleihues P, Cavenee WK, editors. Pothology & Genetics Tumours of the Nervous System. Lyon : IARC Press : 2000. p. 112-4.
 
137) Enzinger FM, et al. Paraganglioma. In : Enzinger FM, Weisse SW, editors. Soft Tissue Tumors. Philadelphia Mosby : 1995. p. 965-90.
 
138) Sonneland PR, et al. Paraganglioma of the cauda equine region. Clinicopathological study of 31 cases with special reference to immunocytology and ultrastructure. Cancer 1986 : 58 : 1720-35.
 
139) Sundgren P, et al. Paraganglioma of the spinal canal. Neuroradiology 1999 : 41 : 788-94.
PubMed
140) Toyota B, et al. Hemodynamic activity associated with a paraganglioma of the cauda equina. J Neurosurg 1993 : 79 : 451-5.
PubMed
141) Kliewer KE, et al. A review of the histology, ultrastructure, immunohistology, and molecular biology of extra-adrenal paragangliomas. Arch Pathol Lab Med 1989 ; 113 : 1209-18.
PubMed
142) Linea JF, et al. Gangliocytic Paraganglioma in cauda equine region, with biochemical and ncuropathological studies. Case report. J Neurosurg 1982 ; 56 : 280-2.
 
143) Strommer KN, et al. Symptomatic cerebellar metastasis and the late local recurrence of a cauda equine paraganglioma. Case report. J Neurosurg 1995 ; 83 : 166-9.
 
P.405 掲載の参考文献
1) Whang-Peng J, et al. Translocation t (11 : 22) in esthesioneuroblastoma. Cancer Genet Cytogenet 1987 ; 29 : 155-7.
PubMed
2) Sorensen PH, et al. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proc Natl Acad Sci USA 1996 ; 93 : 1038-43.
PubMed
3) Nelson RS, et al. Is esthesioneuroblastoma a peripheral neuroectodermal tumor? Hum Pathol 1995 ; 26 : 639-41.
PubMed
4) Mezzelam A, et al. Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing's group. Br J Cancer 1999 ; 81 : 586-91.
 
5) Argani P, et al. Olfactory neuroblastoma is not related to the Ewing family of tumors : Absence of EWS/FLI1 gene fusion and MIC2 expression. Am J Surg Pathol 1998 ; 22 : 391-8.
PubMed
6) Papadaki H, et al. Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma. Am J Surg Pathol 1996 ; 20 : 715-21.
PubMed
7) Kadish S, et al. Olfactory neuroblastoma : A clinical analysis of 17 cases. Cancer 1976 ; 37 : 1571-6.
PubMed
8) Arnesen MA, et al. Cushing's syndrome secondary to olfactory neuroblastoma. Ultrastruct Pathol 1994 ; 18 : 61-8.
PubMed
9) al Ahwal M, et al. Olfactory neuroblastoma : Report of a case associated with inappropriate antidiuretic hormone secretion. J Otolaryngol 1994 ; 23 : 437-9.
PubMed
10) Hyams VJ. Tumors of the upper respiratory tract and ear. In : Hyams VJ, editor. Atlas of Tumor Pathology, 2nd Series, Fascicle 25. Washington DC : Armed Forces Institute of Pathology ; 1988. p. 240-8.
 
11) Hirose T, et al. Olfactory neuroblastoma : An immunohistochemical, ultrastructural, and flow cytometric study. Cancer 1995 ; 76 : 4-19.
PubMed
12) Hurst RW, et al. Computed tomographic features of esthesioneuroblastoma. Neuroradiology 1989 ; 31 : 253-7.
PubMed
13) Derdeyn CP, et al. MRI of esthesioneuroblastoma. J Comput Assist Tomogr 1994 ; 18 : 16-21.
PubMed
14) Takahashi H, et al. Esthesioneuroblastoma : A tumor of true olfactory epithelium origin. An ultrastructural and immunohistochemical study. Acta Neuropathol (Berl) 1987 ; 75 : 147-55.
PubMed
15) Bi;ler HF, et al. Esthesioneuroblastoma : Surgical treatment without radiation. Laryngoscope 1990 ; 100 : 1199-201.
 
16) Derome PJ. The transbasal approach to tumors invading the base of the skull. In : Scmidek HH, Sweet WH, editors. Operative Neurosurgical Techniques. Orlando, Florida : Grune and Strafton ; 1988. p. 619-33.
 
17) Ohnishi T, et al. Primary meningioma of paranasal sinus treated by the transbasal approach. Surg Neurol 1987 ; 27 : 195-9.
PubMed
18) McElroy EA Jr, et al. Chemotherapy for advanced esthesioneuroblastoma : Mayo Clinic experience. Neurosurgery 1998 ; 42 : 1023-8.
 
19) Morita A, et al. Esthesioneuroblastoma : Prognosis and management. Neurosurgery 1993 ; 32 : 706-15.
PubMed
20) Eden BV, et al. Esthesioneuroblastoma : Long term outcome and pattern of failure. The University of Virginia experience. Cancer 1994 ; 73 : 2556-62.
PubMed
21) Zappia JJ, et al. Olfactory neuroblastoma : The results of modern treatment approaches at the University of Michigan. Head Neck 1993 ; 15 : 190-6.
PubMed
22) Przygodzki RM, et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuoendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol 1996 ; 148 : 1531-41.
 
23) The Committee of Brain Tumor Registry of Japan. Report of Brain Tumor Registry of Japan (1969-1993) 10th ed. Neurol Med Chir (Tokyo) 2000 ; 40 (Suppl) : 5-15.
 
24) Bennet JP Jr, Rubinstein LJ. The biological behavior of primary cerebral neuroblastoma : A reappraisal of the clinical course in a series of 70 cases. Ann Neurol 1984 ; 16 : 21-7 .
 
25) Horten BC, Rubinstein LJ. Primary cerebral neuroblastoma : A clinicopathological study of 35 cases. Brain 1976 ; 99 : 735-56.
PubMed
26) Berger MS, et al. Primary cerebral neuroblastoma. Long-term follow-up review and therapeutic guidelines. J Neurosurg 1983 ; 59 : 418-23.
PubMed
27) Davis PC, et al. Primary cerebral neuroblastoma : CT and MR findings in 12 cases. Am J Neuroradiol 1990 ; 11 : 115-20.
 
28) Russell DS, Rubinstein LJ. Pathology of Tumours of the Nervous System. 5th ed. London : Edward Arnold ; 1989. p. 279-89.
 
29) Sakai S, et al. A cerebral neuroblastoma with extracranial metastasis. Surg Neurol 1981 ; 16 : 53-9.
 
P.416 掲載の参考文献
1) Krabbe KH. The pineal gland, especially in relation to the problem on its supposed significance in sexual development. Endocrinology 1923 ; 7 : 379-414.
 
2) del Rio-Hortega P. Pineal Gland. Vol 2. New York : Hoeber ; 1932.
 
3) Kleihues P, et al. Histological Typing of Tumors of the Central Nervous Sysem. 2nd ed. Berlin, Heidelberg : Springer Verlag ; 1993.
 
4) Mena H, et al. Pineal parenchymal tumours. In : Kleihues P, Cavenee WK, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press ; 2000. p. 115-22.
 
5) The Committee of Brain Tumor Registry of Japan. Report of Brain Tumor Registry of Japan (1969-1993). Neurol Med Chir (Tokyo) 2000 ; 40 (Suppl) : 1-106.
 
6) Fauchon F, et al. Parenchymal pineal tumors : A clinicopathological study of 76 cases. Int J Radiat Oncol Biol Phys 2000 ; 46 : 959-68.
PubMed
7) Jouvet A, et al. Pineal parenchymal tumors : A correlation of histological features with prognosis in 66 cases. Brain Pathol 2000 ; 10 : 49-60.
PubMed
8) Mena H, et al. Tumors of pineal parenchymal cells : A correlation of histological features, including nucleolar organizer regions, with survival in 35 cases. Hum Pathol 1995 : 26 : 20-30.
 
9) Schild SE, et al. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer 1993 : 72 : 870-80.
PubMed
10) Borit A, et al. The separation of pineocytoma from pineoblastoma. Cancer 1980 ; 45 : 1408-18.
PubMed
11) Lesnick JE, et al. Familial pineoblastoma : Report of two cases. J Neurosurg 1985 ; 62 : 930-2.
 
12) Lueder GT, et al. Heritable retinoblastoma and pinealoma. Arch Ophthalmol 1991 ; 109 : 1707-9.
PubMed
13) De Potter P, et al. Clinical variations of trilateral retinoblastoma : A report of 13 cases. J Pediatr Ophthalmol Strabismus 1994 ; 31 : 26-31.
 
14) Bruce JN, et al. Pineal cell and germ cell tumors. In : Kaye AH, Laws ER, editors. Brain Tumors : An Encyclopedic Approach. 2nd ed. London : Churchill Livingstone ; 2001. p. 771-800.
 
15) Chang T, et al. CT of pineal tumors and intracranial germ-cell tumors. AJR Am J Roentgenol 1989 ; 153 : 1269-74.
PubMed
16) Ganti SR, et al. CT of pineal region tumors. AJR Am J Roentgenol 1986 ; 146 : 451-8.
PubMed
17) Chiechi MV, et al. Pineal parenchymal tumors : CT and MR features. J Comput Assist Tomogr 1995 ; 19 : 509-17.
 
18) Korogi Y, et al. MRI of pineal region tumors. J Neurooncol 2001 ; 54 : 251-61 .
PubMed
19) Nakagawa H, et al. MR imaging of pineocytoma : Report of two cases. AJNR Am J Neuroradiol 1990 ; 11 : 195-8.
PubMed
20) Herrick MK, Rubinstein LJ. The cytological differentiating potential of pineal parenchymal neoplasms (true pinealomas) : A clinicopathological study of 28 tumours. Brain 1979 ; 102 : 289-320.
PubMed
21) Russell DS, Rubinstein LJ. Tumours of specialized tissues of central neuroepithelial origin. In : Russell DS, Rubinstein LJ, editors. Pathology of Tumours of the Central Nervous System. Baltimore : Williams & Wilkins ; 1989. p. 351-420.
 
22) Erlich SS, Apuzzo ML. The pineal gland : Anatomy, physiology, and clinical significance. J Neurosurg 1985 ; 63 : 321-41.
PubMed
23) Perentes E, et al. S-antigen immunoreactivity in human pineal glands and pineal parenchymal tumors : A monoclonal antibody study. Acta Neuropathol (Berl) 1986 ; 71 : 224-7.
PubMed
24) Hirato J, Nakazato Y. Pathology of pineal region tumors. J Neurooncol 2001 ; 54 : 239-49.
PubMed
25) Tsumanuma I, et al. Clinicopathological study of pineal parenchymal tumors : Correlation between histopathological features, proliferative potential, and prognosis. Brain Tumor Pathol 1999 ; 16 : 61-8.
PubMed
26) Jouvet A, et al. Structural and ultrastructural characteristics of human pineal gland, and pineal parenchymal tumors. Acta Neuropathol (Berl) 1994 ; 88 : 334-48.
PubMed
27) Numoto RT. Pineal parenchymal tumors : Cell differentiation and prognosis. J Cancer Res Clin Oncol 1994 ; 120 : 683-90.
PubMed
28) Coca S, et al. Immunohistochemical characterization ofpineocytomas. Clin Neuropathol 1992 ; 11 : 298-303.
PubMed
29) Washiyama K, et al. An immunohistochemical study on synaptophysin in pinealomas (in Japanese). Brain Tumor Pathol 1989 ; 6 : 51-4.
 
30) Yamane Y, et al. Immunohistochemical characterization of pineal parenchymal tumors using novel monoclonal antibodies to the pineal body. Neuropathology 2002 ; 22 : 66-76.
 
31) Okuda Y, et al. Pineoblastoma with neuronal differentiation-immunohistochemical and immunocytochemical studies. J Neurooncol 1988 ; 6 : 193-8.
PubMed
32) Korf HW, et at. S-antigen-like immunoreactivity in a human pineocytoma. Acta Neuropathol (Berl) 1986 ; 69 : 165-7.
 
33) Tsumanuma I, et al. Demonstration of hydroxyindole-O-methyltransferase (HIOMT) mRNA expression in pineal parenchymal tumors : Histochemical in situ hybridization. J Pineal Res 2000 ; 28 : 203-9.
PubMed
34) Min KW, et al. Pineal parenchymal tumors : An ultrastructural study with prognostic implications. Ultrastruct Pathol 1994 ; 18 : 69-85.
PubMed
35) Chang SM, et al. Pineoblastoma in adults. Neurosurgery 1995 ; 37 : 383-90 ; discussion 390-81.
 
36) Lutterbach J, et al. Malignant pineal parenchymal tumors in adult patients : Pattems of care and prognostic factors. Neurosurgery 2002 ; 51 : 44-55 ; discussion 55-6.
 
37) D'AndreaAD, etal. Pineocytomas of childhood : A reappraisal of natural history and response to therapy. Cancer 1987 ; 59 : 1353-7.
 
38) Stein BM, Bruce JN. Surgical management of pineal region tumors. Clin Neurosurg 1992 ; 39 : 509-32.
PubMed
39) Lesoin F, et al. Extraneural metastasis of a pineal tumor : Report of 3 cases and review of the literature. Eur Neurol 1987 ; 27 : 55-61.
PubMed
40) Vaquero J, et al. Clinicopathological experience with pineocytomas : Report of five surgically treated cases. Neurosurgery 1990 ; 27 : 612-8 ; discussion 618-9.
 
41) Krause F. Chirurgie des Gehims und Riickenmarks. Berlin : Urban & Schwazenberg ; 1911.
 
42) Stein BM. Supracerebellar approach for pineal region neoplasms. In : Schmideck H, Sweet W, editors. Operative Neurosurgical Techniques. Vol 1. New York : Grune & Stratton ; 1982. p. 599-607.
 
43) Little KM, et al. Surgical approaches to pineal region tumors. J Neurooncol 2007 ; 54 : 287-99.
 
44) Horrax G. Extirpation of a huge pinealoma from a patient with pubertas praecox. Arch Neurol Psychiatry 1937 ; 37 : 385-97.
 
45) Poppen JL. The right occipital approach to a pinealoma. J Neurosurg 1966 ; 25 : 706-10.
PubMed
46) Tanaka R. Occipital transtentrial approach in lateral-semiprone position of pineal region tumors. Neurosurgeons 1989 ; 8 : 124-32.
 
47) Ghim TT, et al. Response to neoadjuvant chemotherapy in children with pineoblastoma. Cancer 1993 ; 72 : 1795-800.
PubMed
48) Kurisaka M, et al. Combination chemotherapy (cisplatin, vinblastin) and low-dose irradiation in the treatment of pineal parenchymal cell tumors. Childs Nerv Syst 1998 ; 14 : 564-9.
PubMed
49) Hasegawa T, et al. The role of radiosurgery for the treatment of pineal parenchymal tumors. Neurosurgery 2002 ; 51 : 880-9.
PubMed
P.433 掲載の参考文献
1) Kleihues P, Cavenee WK, editors World Health Organization Classification of Tumors Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press : 2000.
 
2) Bailey P, Cushing H Medulloblastoma cerebelli : A common type of midcerebellar glioma of childhood. Arch Neurol Psychiat 1925 : 14 : 192-224.
 
3) McLendon R, et al. Medulloepithelioma Tumors of central neuroepithelial origin. In : Bigner D, et al, editors. Russel and Rubinstein's Pathology of thc Nervous System. 6th ed London : Arnold ; 1998. p. 453-6.
 
4) 高橋均. Medulloepithelioma. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第2版. 東京 : 医学書院 ; 1999. p74-5.
 
5) Molloy T, et al. Central nervous system medulloepithelioma : A series of eight cases including two arising in the pons. J Neurosurg 1996 : 84 : 430-6.
 
6) Becker J, et al. Medulloepithelioma. In : Kleihues P, Cavenee WK, editors. World Health Organization Classincation of Tumors. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press ; 2000. p. 124-6.
 
7) Becker J, cruz-Sanchez F. Ependymoblastoma. In : Kleihues P, Cavenee WK, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press : 2000. p. 127-8.
 
8) Rubinstein L. The definition of the ependymoblastoma. Arch Pathol 1970 ; 90 : 35-45.
PubMed
9) Mandel M, et al. Ependymoblastoma in an HIV-positive hemophilic girl. Med Pediatr Oncol 1994 : 23 : 441-3.
 
10) 新宅雅幸. Ependymoblastoma. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第2版. 東京 : 医学書院 ; 1999. p. 79.
 
11) Dorsay T, et al. Ependymoblastoma : MR presentation. A case report and review of the literature. Pediatr Radiol 1995 ; 25 : 433-5.
PubMed
12) 尾崎義丸, 長嶋和郎. Medulloblastoma. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第2版. 東京 : 医学書院 ; 1999. p. 80-3.
 
13) Giangaspero F, et al. Medulloblastoma. In : Kleihues P, Cavenee WK, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press : 2000. p. 129-37.
 
14) The Committee of Brain Tumor Registry of Japan. Report of Brain Tumor REgistry of Japan (1969-1993). 10th ed. Neurol Med Chir (Tokyo) 2000 : 40 (Suppl) : 5-12.
 
15) 脳腫瘍全国統計委員会, 日本病理学会編. 臨床・病理 脳腫瘍取り扱い規約. 髄芽腫. 東京 : 金原出版 ; 1995. p. 90.
 
16) Matsuda M, et al. Origin of the medulloblastoma experimentally induced by human polyomavirus JC. J Natl Cancer Inst 1987 : 79 : 585-91.
PubMed
17) McLendon E, et al, editors. Medulloblastoma. In : Pathology of Tumors of the Cental Nervous System. London : Arnold : 2000. p. 186-99.
 
18) McLendon R, et al. Medulloepitheliomal Tumors of central neuroepithelial origin. In : Bigner D, et al, editors. Russel and Rubinstein's Pathology of the Nervous System. 6th ed London : Arnold ; 1998. p. 456-79.
 
19) Chang C, et al. An opcrative staging system and megavoltage radiotherapeutic technique for cerebellar medulloblastoma. Radiology 1969 ; 93 : 1351-9.
 
20) 丸野元春, 吉峰俊樹. Ependymal tumors. 橋本信夫編. 脳神経外科臨床指針. 東京 : 中外医学社 ; 2002. p. 308-11.
 
21) Packer R, et al. Quality of life in children with primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Pediatr Neurosci 1987 : 13 : 169-75.
PubMed
22) Kobayashi S, et al. Inflatentorial approach to the pineal region in the prone position : Concorde position. Technical note. J Neurosurg 1983 : 58 (1) : 141-3.
 
23) 松島俊夫ほか. 第4脳室のMRI解剖と微小外科解剖-特にCerebellomedullary fissureについて, 山本勇夫編. 顕微鏡下手術のための脳神経外科解剖 III-脳槽, 脳裂と脳溝. 東京 : サイメッド・パブリケーションズ ; 1990, p. 165-77.
 
24) Mussi A, Rhoton A Jr. Telovelar approach to the fourth ventricle : Microsurgical anatomy. J Neurosurg 2000 : 92 (5) : 812-23.
 
25) Matsushima T, et al. Transcerebcllomcdullary issure approach with special reference to methods of dissecting the fissure. J Neurosurg 2001 : 94 (2) : 257-64.
 
26) Sagiuchi T, et al. Bilateral crossed cerebello-cerebral diaschisis and mutism after surgery for cerebellar medulloblastoma. Ann Nucl Med 2001 : 15 (2) : 157-60.
PubMed
27) Giordana M, Wiestler O. Medullomyoblastoma. In : Kleihues P, Cavenee WK, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press : 2000. p. 138-9.
 
28) Rorke LB. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 1983 : 42 : 1-15.
PubMed
29) Geyer JR, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in one day : A report from the Children's Cancer Group. J Clin Oncol 1994 : 12 : 1607-15.
 
30) Duffner PK, et al. The treatment of malignant brain tumors in infants and very young children : An update of the Pediatric Oncology Group experience Neuro-oncol 1999 ; 1 : 152-61.
PubMed
31) Rubinstein L. Embryonal central neuroepithelial tumors and their differentiating potential : A cytogenic view of a complex neuro-oncological problem. J Neurosurg 1985 ; 62 : 795-805.
 
32) 生田房弘. WHOの新しい脳腫瘍分類1993が生まれた前後. 脳と神 1994 : 46 : 1122-5.
 
33) Kleihues P, Webster C0 WHO classification of tumours of the central nervous system. In : Kleihues P, Cavenee WK, editors. World Health Organization Classification of Tumors Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press : 2000. p. 6-7.
 
34) Rorke L, et al. Supratentorial primitive neuroectodermal tumour (PNET). In : Kleihues P, Cavenee WK, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press : 2000. p. 141-4.
 
35) 長嶋和郎, 川野信之. Primitive neuroectodermal tumor (PNET). 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第2版. 東京 : 医学書院 ; 1999. p84-6.
 
36) Rorke L, Biegel J. Atypical teratoid/rhabdoid tumour. In : Kleihues P, Cavenee WK, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Nervous System. Lyon : IARC Press : 2000. p. 145-8.
 
37) Oka H, Scheithaucr B. Clinicopathological characteristics of atypical teratoid/rhabdoid tumor. Neurol Med Chir (Tokyo) 1999 : 39 : 510-7.
 
38) Biegel J, et al. Germ-line and acquired mutations of INIl in atypical teratoid/rhabdoid tumors. Cancer Res 1999 : 59 : 74-9.
 
39) 平戸純子. Atypical teratoid/rhabdoid tumor (AT/RT) 異型奇形腫様・類横紋筋腫瘍. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 第2版. 東京 : 医学書院 ; 1999. p. 73.
 
40) Rorke LB, et al. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood : DeiniJon of an entity. J Neurosurg 1996 ; 85 : 56-65.
PubMed
41) Hilden J, et al. Central nervous system atypical teratoid/rhabdoid tumors : Response of intensive therapy and review of the literature. J Neurooncol 1998 ; 40 : 265-75.
PubMed
42) Evans A, et al. The treament of medulloblastoma : Results of a prospective randonized trial of radiation therapy with and without CCNU, Vincristine and Prednisone. J Neurosurg 1990 ; 72 : 572-82.
 
43) Packer R, et al. Outcome for children with medulloblastoma treated with radiation, cisplatin, CCNU and vineristine chemotherapy. J Neurosurg 1994 ; 81 : 690-8.
 
44) 松谷雅生. 髄芽腫. 太田富雄, 松谷雅生編. 脳神経外科. 第8版. 京都 : 金芳堂 ; 2000. p. 525-33.
 
45) Packer R, et al. Treatment of children with medulloblastoma with rcduced-dose craniospinal radiadon therapy and attuvant chemothcrapy : A Children's Cancer Group study. J Clin Oncol 1999 ; 17 : 2127-36.
 
46) Krischer J, et al. Nitrogen mustard, vincristine, procarbazine and predonisone as adJuvant therapy in the treatment of medulloblastoma. A Pediamc Oncology Group study. J Neurosurg 1991 ; 74 : 905-9.
 
47) Pendergrass TW, et al. Eight drugs in one daychemotherapy for brain tumors : Experience in 107 children and rationale for preradiation chcmotherapy J Clin Oncol 1987 ; 5 : 1221-31.
PubMed
48) Cohen B, et al. Prognostic factors and treatment rcsults for supratentorial primitive neuroectodermal tumors in children using radiation and chemothcrapy : A Children Cancer Group study. J Clin Oncol 1995 ; 13 : 1687-96.
 
49) Sawamura Y, et al. Combined irradiation and chcmotherapy using ifosmide, cisplatin, and etoposide for children with medulloblastoma/postenor fossa primitive neuroectodermal tumor : Results of a pilot study. Neurol Med Chir (Tokyo) 1996 ; 36 : 632-8
 
50) Duffner P, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumoss. N Engl J Med 1993 ; 328 : 1725-31.
PubMed
51) Sugiyama K, et al. Myelodysplastic syndrome following therapy for brain tumors : Two case report. Neurol Med Chir (Tokyo) 2002 ; 42 : 170-4.
PubMed
52) 杉山一彦, 栗栖薫. Embryonal tumors. 橋本信夫編. 脳神経外科臨床指針. 東京 : 中外医学社 ; 2002. p. 312-20.
 

6章 血液系腫瘍

P.447 掲載の参考文献
1) 須知泰山ほか. 非ホジキンリンパ腫病理組織診断の問題点-新分類の提案. 最新医 1979 ; 34 : 2049-62.
Medical*Online
2) National Cancer Institute. National Cancer Insitute sponsored study of classifications of non-Hodgkin's lymphomas : Summary and description of a Working Formulaion for Clinical Usage. Cancer 1982 : 49 ; 2112-35.
 
3) Hams NL, et al. A revised European-American classification of lymphoma study group Blood 1994 ; 84 : 1361-92.
 
4) Lennert K, Feller AC. Histopathology of Non-Hodgkin Lymphomas (based on the update Kiel classification) 2nd ed. Berlin : Springer-Verlag : 1992.
 
5) Rappaport H. Tumors of hematopoietic system. In : Atlas of Tumor Pathology section 3, fascicle 8. Washington DC : AFIP : 1966.
 
6) Cote TR, et al. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996 ; 88 : 675-9.
 
7) Forsyth PA, DeAngelis LM. Biology and management of AIDS-associated primary CNS lymphomas. Hematol Oncol Clin North Am 1996 ; 10 : 1125-34.
PubMed
8) Geser A, et al. Final case reporing from the Ugandan prospective study of the relationship between EBV and Burkin's lymphoma. Int J Cancer 1982 : 29 : 397-400.
 
9) MacMahon EM, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991 ; 338 : 969-73.
PubMed
10) Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC : 1997. p. 154-9.
 
11) 竹内浩明. 悪性リンパ腫. 久保田紀彦編. 脳腫瘍の病理と臨床. 東京 : 診断と治療社 ; 2002. p. 264-8.
 
12) DeAngelis LM. Cerebral lymphoma presenting as a nonenhancing lesion on computed tomographic/magnetic resonance scan. Ann Neurol 1993 : 33 : 308-11.
PubMed
13) 岡本浩一郎. 悪性リンパ腫. 青木茂樹, 阿部修編. これでわかる拡散MRI. 東京 : 秀潤社 ; 2002. p.186-7.
 
14) Hayakawa T, et al. Primary central nervous system lymphoma in Japan. J Neurooncol 1994 : 19 : 197-215.
 
15) 鈴木康夫ほか. 頭蓋内腫瘍におけるβ2-microglobulinの臨床意義-Carcinoembryonic antigcnとのcombination assayも含めて. 脳と神 1987 ; 39 : 965-70.
 
16) Hoffman JM, et al. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 1993 : 34 : 567-75.
PubMed
17) Lorberboym M, et al. Rapid diffelential diagnosis of cerebral toxoplasmosis and primary central nervous system lymphoma by thallium-201 SPECT. J Nucl Med 1996 : 37 : 1150-4.
PubMed
18) CNS Lymphoma Study Groupほか. New Lecture 4. 中枢神経系悪性リンパ腫. 東京 : 篠原出版 ; 1994.
 
19) Wick MR, et al. Reassessment of malignant "angioendotheliomatosis" : Evidence in favor of its reclassification as "intravascular lymphomatosis". Am J Surg Pathol 1986 ; 10 : 112-23.
PubMed
20) 早渕尚文ほか. 中枢神経系初発リンパ腫の臨床的特徴と治療成績. 日放線腫会誌 1997 ; 9 : 285-95.
 
21) Watanabe M, et al. Correlaion of computed tomography with the histopathology of pHmary malignant lymphoma of the brain Neuroradiology 1992 : 34 : 36-42.
 
22) Hiraga S, et al. Rapid infusion of high-dose methotrexate resuling in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas. J Neurosurg 1999 ; 91 : 221-30.
 
23) 大西丘倫, 吉峰俊樹. CNSリンパ腫に対する治療の進歩. 脳神外ジャーナル 2001 ; 10 : 135-41.
 
24) Neuwelt EA, et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption : Prolonged survival and preservadon of cognitive function. J Clin Oncol 1991 ; 9 : 1580-90.
PubMed
25) Ferren AJ, et al. A multicenter study of treatment of primary CNS lymphoma. Neurology 2002 ; 58 : 1513-20.
 
26) Plasswilm L, et al. Primary central nervous system (CNS) lymphoma in immunocompetent patients. Am Hematol 2002 ; 81 : 415-23.
 
27) Bleyer WA. A comprehensive guide to the therapeutic use of methotrexate in bladder cancer, Phladelpha. In : Hall RR, editor. A comprehensive Guide to the Therapeutic Use of Methotrexate in Bladder Cancer. Chicago : Pharma LibH ; 1983. p. 51-69.
 
28) 梅田透ほか. High-dose MTX療法における重篤な副作用の検討-骨肉腫54例, のべ365回について. 癌と化療 1984 ; 11 : 285-94.
Medical*Online
29) Baehring JM, et al. A new approach to the diagnosis and treatment of intravascular lymphoma. J Neurooncol 2003 ; 61 : 237-48.
 
30) Grote TH, et al. Primary lymphoma of the central nervous system : A report of 20 cases and a review of the literature. Am J Clin Oncol 1989 ; 12 : 93-100.
 
31) 清水恵司. 脳のリンパ腫. 日常診療と血 1996 ; 6 : 939-45.
 
32) Lachance D, et al. Cyclophosphamide, doxombicin, vincristine, and prednisone for primary central nervous system lymphoma : short-duration response and mulifocal intracerebral recurrence preceding radiotherapy. Neuroloogy 1994 ; 44 : 1721-7.
 
33) Schultz C, et al. Preirradiation chemotherapy with cyclophosphamide, doxombicin, vincristine, and dexamethasone for primary CNS lymphomas : Initial report of radiaion therapy oncology group protocol 88-06. J Clin Oncol 1996 : 14 : 556-64.
 
34) Okamoto K, et al. Solitary plasmacytomas of the occipital bone : A report of two cases. Eur Radiol 1997 ; 7 : 503-6.
PubMed
35) Benli K, Inci S. Solitary dural plasmacytoma : Case report. Neurosurgery 1995 ; 36 : 1206-9.
PubMed
36) Bindal AK, et al. Management of intacranial plasmacytoma. J Neurosurg 1995 ; 83 : 218-21.
 
37) Wisneiewski T, et al. Inracerebral solitary plasmacytoma. Neurosurgery 1990 ; 27 : 826-9.
 
38) 鷲山和雄, 田中隆一. Plasmacytoma. 河本圭司ほか編. 脳腫瘍臨床病理カラーアトラス. 東京 : 医学書院 ; 1999. p. 125.
 
39) Goldman ID. Membrane transport consideraions in high-dose methotrexate regimens with leucovorin rescue. Cancer Treat Rep 1981 ; 65 : 13-7.
PubMed
40) Glass J, et al. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma : Long-term outcome. J Neurosurg 1994 ; 81 : 188-95.
PubMed

7章 胚細胞腫瘍

P.464 掲載の参考文献
1) Schneider DT, et al. Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents. Genes Chromosomes Cancer 2002 ; 34 : 115-25.
PubMed
2) The Commirtee of Brain Tumor Registry of Japan. Report of Brain Tumor Registry of Japan (1969-1996). 11th ed. Neurol Med Chir (Tokyo) 2003 ; 43 (Suppl) : 1-49.
 
3) Ikeda J, et al. Metachronous neurohypophyseal germinoma occuring eight years after total resection of mature teratoma. Surg Neurol 1998 : 49 : 205-9.
 
4) Yoshida K, Sawamura Y. Clinical findings and diagnosis, ophthalmological manifestations. In : Sawamura Y, et al, editors. Intracranial Germ Cell tumors. Wien : Springer Verlag ; 1998. p. 131-45.
 
5) Miyanohara O, et al. Diagnostic significance of soluble c-kit in the cerebrospinal fluid of patients with germ cell tumor. J Neurosurg 2002 ; 97 : 177-83.
PubMed
6) Kato T, et al. Occult neurohypophyseal germinomas in patients presenting with central diabetes insipidus. Neurosurg Focus 1998 ; 5 : 1-6.
PubMed
7) Matsutani M, et al. Primary intracranial germ cell tumors : A clinical analysis of 153 histologically verified cases. J Neurosurg 1997 : 86 : 446-55.
 
8) Sawamura Y : Current diagnosis and treatment of central nervous system germ cell tumours. Curr Opin Neurol 1996 ; 9 (6) : 419-23.
PubMed
9) Sawamura Y, et al. Germ cell tumors of the central nervous system : Treatment consideration based on 111 cases and their longterm clinical outcomes. Eur J Cancer 1998 : 34 : 104-10.
PubMed
10) Sawamura Y, et al. Recent advances in the treatment ofcentral nervous system germ cell tumors. Adv Tech Stand Neurosurg 1999 ; 25 : 141-59.
 
11) Sawamura Y, et al. Surgical management of primary intracranial germinomas : Diagnostic surgery or radical resection? J Neurosurg 1997 ; 87 : 262-6.
PubMed
12) Sawamura Y. Overview for management. In : Sawamura Y, et al, editors. Intracranial Germ Cell Tumors. Wien : Springer-Verlag ; 1998. p. 169-91.
 
13) Sawamura Y. Prognosis of central nervous system germ cell tumors. In : Sawamura Y, et al, editors. Intracranial Germ Cell Tumors. Wien : Springer Verlag ; 1998. p. 155-68.
 
14) Kochi M, et al. Successful treatment of intracranial nongerminomatous malignant germ cell tumors by administering neoadjuvant chemotherapy and radiotherapy before excision ofresidual tumors. J Neurosurg 2003 ; 99 106-14.
 
15) Ushio Y, et al. Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma : Report of five cases. J Neurosurg 1999 ; 90 : 133-1.
PubMed
16) Aoyama H, et al. Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors. J Clin Oncol 2002 : 20 : 857-65.
PubMed
17) Balmaceda C, et al. Chemotherapy without irradiation : A novel approach ior newly diagnosed CNS germ cell tumors : Results of an international cooperative trial. J Clin Oncol 1996 ; 14 : 2908-15.
 
18) Balmaceda C, et al. Chemotherapy for the central nervous system germ cell tumors. In : Sawamura Y, et al, editors. Intracranial Germ Cell Tumors. Wien : Springer-Verlag ; 1998. p. 243-81.
 
19) Calaminus G, et al. Secreting germ cell tumors of the central nervous system (CNS) : First results of the cooperative German/Italian pilot study (CNS sGCT). Klin Padiatr 1997 ; 209 : 222-7.
PubMed
20) de Wit R, et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good prognosis germ cell cancer : A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol 2001 ; 19 : 1629-40.
 
21) de Wit R, et al. Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular nonseminoma : A randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer. Br J Cancer 1998 ; 78 : 828-32.
 
22) Hinton S, et al. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors : Final analysis of an intergroup trial. Cancer 2003 ; 97 : 1869-75.
PubMed
23) Nichols CR, et al. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors : An Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. J Clin Oncol 1998 ; 16 : 1287-93.
PubMed
24) Sawamura Y, et al. Induction chemotherapy followed by reduced-volume irradiation for newly diagnosed CNS germinoma. J Neurosurg 1998 ; 88 : 66-72.
 
25) Yoshida J, et al. Prognosis of intracranial germ cell tumours : Effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16). Acta Neurochir (Wien) 1993 ; 120 : 111-7.
PubMed
26) Sawamura Y, et al. Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor. Neurol Med Chir (totyo) 1996 ; 36 : 632-8.
PubMed
27) Hinton S, et al. Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897) : A trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2002 ; 20 : 1859-63.
 
28) Sudo A, et al. Links : High uptake on (11) C-methionine positron emission tomographic scan of basal ganglia germinoma with cerebral hemiatrophy. AJNR Am J Neuroradiol 2003 ; 24 : 1909-11.
 
29) Bamberg M, et al. Radiation therapy for intracranial germinoma : Results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol 1999 ; 17 : 2585-92.
PubMed
30) Haddock MG, et al. Radiation therapy for histologically confirmed primary central nervous system germinoma. Int J Radiat Oncol Biol Phys 1997 ; 38 : 915-23.
PubMed
31) Merchant TE, et al. CNS germinoma Discasc control and long-tenn funcional outcome for 12 children treated with craniospinal irradiation. Int J Radiat Oncol Blol Phys 2000 ; 46 : 1171-6.
 
32) Shrato H, et al. Analysis of long tenn treatment of intracranial gerllunoma. Int J Radiat Oncol Blol Phys 1997 : 37 : 511-5.
 
33) Freilich RJ, et al. Adenocarcinomatous transfortnation of intracranial germ cell tumors. Am J Surg Pathol 1995 ; 19 : 537-44.
 
34) Jenning S MT, et al. Intracranial germ cell tumors : Natural history and pathogenesis. J Neurosurg 1985 ; 63 : 155-67.
 
35) Sawamura Y, et al. Teratomas of the central nervous system : Treatment consideration based on 34 cases. J Neurosurg 1998 ; 89 : 728-37.
 
36) Tapper D, Lack EE Teratomasin infancy and childhood Ann Surg 1983 ; 198 : 398-410.
PubMed
37) O'Callaghan AM, et al. The growing teratoma syndrome in a nongerminomatous germ cell tumor of the pineal gland : A case report and review. Cancer 1997 ; 80 : 942-7.
 
38) Meagher-villemure K. Pathology. On ; Sawamura Y, et al, editors. Intracranial Germ Cell thmors. Wien : Springer-Verlag ; 1998. p. 17-36.
 
39) Packer RJ, et al. Intracranial embwonal cell carcinoma. Cancer 1984 ; 54 : 520-4.
PubMed
40) Kida Y, et al. Chemotherapy with cisplatin for AFP-secreing germ-cell tumors of the central nervous system. J Neurosurg 1986 ; 65 : 470-5.
 
41) Sievers EL, et al. Long-term survival of a patient with primary sellar choriocarcinoma with pulmona, metastases : A case report. Med Pediatr Oncol 1996 ; 26 : 293-5.
 
42) Kawakanll Y, et al. Primary intracranial chonocarcinoma. J Neurosurg 1980 : 53 : 369-74.
 
43) Koyama S, et al. Choriocarcinoma of the septum pellucidum : Case report Surg Neurol 1991 : 35 : 478-82.
PubMed
44) Schechter NR, et al. Prognosis of paients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease. Gynecol Oncol 1998 : 168 : 183-92.
 
45) Chen LP, et al. PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma. Gynecol Oncol 1995 ; 56 : 231-4.
PubMed
46) Piamsomboon S, et al. Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE) : First report and review of literature. Eur J Gynaccol Oncol 1997 ; 18 : 453-6.
PubMed
47) Cho DY, et al. Primary intrasellar mixed germ-cell tumor with precocious puberty and diabetes insipidus. Child New Syst 1997 ; 13 : 42-6.
 
48) Furuhata S, et al. Mixed germ cell tumor of the basal ganglia : A case report Surg Neurol 1994 ; 41 : 490-3.
PubMed

書評

最近チェックした商品履歴

Loading...